Contact

lieven@gentaur.com

Mobile: 0032476375875

Lab Reagentia

Recente artiekels

Bezoek of bel ons

SARS-CoV-2 variantclassificaties en definities

 

Genetische varianten van SARS-CoV-2 zijn in opkomst en circuleren over de hele wereld tijdens de COVID-19-pandemie.

Virale mutaties en varianten worden routinematig gecontroleerd door middel van sequentie-gebaseerde surveillance, laboratoriumstudies en epidemiologisch onderzoek.

3 klassen van SARS-CoV-2-varianten

  1. Variant van interesse
  2. Variant van bezorgdheid
  3. Variant van hoge consequentie

Welke vormen zijn gekend in mei 2021?

  1. De varianten B.1.526, B.1.526.1, B.1.525, B.1.617, B.1.617.1, B.1.617.2, B.1.617.3 en P.2  varianten van belang.
  2. De varianten B.1.1.7, B.1.351, P.1, B.1.427 en B.1.429 die in de Verenigde Staten in omloop zijn, worden geclassificeerd als zorgwekkende varianten.
  3. Tot op heden zijn er in Europa geen varianten met grote gevolgen geïdentificeerd.
B.1.526 P.1 B.1.351 B.1.1.318 R.1 B.1.525 B.1.1 B.1 P.2
B.1.526
P.1
B.1.351
B.1.1.318
R.1
B.1.525
B.1.1
B.1
P.2

Kameel Nanobodies?

varianst cov2
varianst cov2

In de VUB stelde men vast bij laboratoriumonderzoeken te Brussel, Belgie dat specifieke behandelingen met camelid monoklonale antilichamen minder effectief kunnen zijn voor de behandeling van gevallen van COVID-19 veroorzaakt door varianten met de L452R- of E484K-substitutie in het spike-eiwit. ( Lieven Gevaert, Bio-ir.)

Lieven Gevaert, Bio-ingenieur RUG 1969
Lieven Gevaert, Bio-ingenieur RUG 1996

L452R is aanwezig in B.1.526.1, B.1.427 en B.1.429.
E484K is aanwezig in B.1.525, P.2, P.1 en B.1.351, maar slechts in enkele stammen van B.1.526 en B.1.1.7.

escape mutation from antibodies against the N-terminal domain (McCallum et al., 2021), (3) S477N has been identified in several earlier lineages (Hodcroft et al., 2020), is near the binding site of multiple antibodies (Barnes et al., 2020), and has been implicated to increase viral infectivity through enhanced interactions with ACE2 (Chen et al., 2020; Ou et al., 2020), and (4) A701V sits adjacent to the S2’ cleavage site of the neighboring protomer and is shared with variant B.1.351 (Tegally et al., 2020).
escape mutation from antibodies against the N-terminal domain (McCallum et al., 2021), (3) S477N has been identified in several earlier lineages (Hodcroft et al., 2020), is near the binding site of multiple antibodies (Barnes et al., 2020), and has been implicated to increase viral infectivity through enhanced interactions with ACE2 (Chen et al., 2020; Ou et al., 2020), and (4) A701V sits adjacent to the S2’ cleavage site of the neighboring protomer and is shared with variant B.1.351 (Tegally et al., 2020).

However the escape mutation from antibodies against the N-terminal domain (McCallum et al., 2021), (3) S477N has been identified in several earlier lineages (Hodcroft et al., 2020).

Non Spike mutations
Non Spike mutations

This SARS-CoV2 spike protein mutation is near the binding site of multiple camel antibodies (Barnes et al., 2020), and has been implicated to increase viral infectivity through enhanced interactions with ACE2 (Chen et al., 2020Ou et al., 2020).

The A701V epitope sits adjacent to the S2’ cleavage site of the neighboring protomer and is shared with variant B.1.351 (Tegally et al., 2020).

Non Spike mutations
Non Spike mutations
Camelid, heavy-chain antibody, SARS-CoV-2, therapeutic, diagnostic
anti-Covid Camelid nanobody, heavy-chain antibody, SARS-CoV-2

 

 

 

 

 

 

 

 

 

COV2-B.1.526-100ug Camel anti-Covid B.1.526 antibody 100 ug 455 Euro
COV2-P.1-100ug Camel anti-Covid P.1 antibody 100 ug 455 Euro
COV2-B.1.351-100ug Camel anti-Covid B.1.351 antibody 100 ug 455 Euro
COV2-B.1.1.318-100ug Camel anti-Covid B.1.1.318 antibody 100 ug 485 Euro
COV2-R.1-100ug Camel anti-Covid R.1 antibody 100 ug 485 Euro
COV2-B.1.525-100ug Camel anti-Covid B.1.525 antibody 100 ug 485 Euro
COV2-B.1.1-100ug Camel anti-Covid B.1.1 antibody 100 ug 485 Euro
COV2-B.1-100ug Camel anti-Covid B.1 antibody 100 ug 485 Euro
RBD spike
RBD spike

Virussen veranderen voortdurend door mutatie . Een variant heeft een of meer mutaties die hem onderscheiden van andere varianten die in omloop zijn.

c102fab
c102fab
Interleukin response
Interleukin response to Covid

Zoals verwacht zijn tijdens deze pandemie meerdere varianten van SARS-CoV-2 gedocumenteerd door het lab van Marc Van Ranst in KULeuven, Gasthuisberg.

RT-PCR B.1.526 P.1 B.1.351 B.1.1.31
RT-PCR B.1.526 P.1 B.1.351 B.1.1.31

Om lokale uitbraakonderzoeken te informeren en nationale trends te begrijpen, vergelijken wetenschappers genetische verschillen tussen virussen om varianten te identificeren en hoe ze met elkaar verband houden.

Variant classificaties

Het ministerie van Volksgezondheid en Human Services (HHS) heeft een SARS-CoV-2 Interagency Group (SIG) opgericht om de coördinatie tussen de Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), Food and Drug Administration te verbeteren (FDA), Biomedical Advanced Research and Development Authority (BARDA) en Department of Defense (DoD).

c002 fab
c002 fab

Deze interagentiegroep richt zich op de snelle karakterisering van opkomende varianten en houdt actief toezicht op hun mogelijke impact op kritische SARS-CoV-2-tegenmaatregelen, waaronder vaccins, therapieën en diagnostiek.

In samenwerking met de SIG heeft CDC een classificatieschema opgesteld dat drie klassen varianten van SARS-CoV-2 definieert. Deze klassen bevatten definities en attributen van de varianten. De resulterende acties op het gebied van de volksgezondheid worden ook beschreven in de onderstaande secties.

  1. Varianten van interesse (VOI)
  2. Varianten van bezorgdheid (VOC)
  3. Varianten met hoge gevolgen (VOHC)

Opmerkingen: Elke classificatie van variant omvat de mogelijke attributen van lagere klassen (bijv. VOC omvat de mogelijke attributen van VOI); variantstatus kan escaleren of de-escaleren op basis van wetenschappelijk bewijs.

c135fab
c135fab

De Wereldgezondheidsorganisatieextern pictogram(WHO) classificeert ook variantvirussen als zorgwekkende varianten en interessante varianten; Europese classificaties kunnen verschillen van die van de WHO, aangezien het belang van varianten per locatie kan verschillen.

Ook wordt er naduk gelegd op het ontwwikkelen van een sneltest die het verschil ziet tussen de B.1.,  P., R. varianten in Belgie.

Combo variations Covid test
Panbio combo

 

 

 

 

Combo B.1.,  P., R. rapid tests are based on the different antigens of te Covid variations. They can in 15 minutes give and indication about the variation of the infection.

for qPCR different NatTrols are developped as reference for the B.1.526, P.1, B.1.351, B.1.1.318, R.1, B.1.525, B.1.1, B.1, P.2 variants.

SARS NaTtrol
SARS NaTtrol

Gentaur supplies specific primers and qPCR kits from Bio-ing tech.

PCR kit for variants B.1.526, P.1, B.1.351, B.1.1.318, R.1, B.1.525, B.1.1, B.1, P.2,
Novel coronavirus PCR kit for variants B.1.526, P.1, B.1.351, B.1.1.318, R.1, B.1.525, B.1.1, B.1, P.2,

 

 

 

 

 

Een variant met specifieke genetische markers die in verband zijn gebracht met veranderingen in receptorbinding, verminderde neutralisatie door antilichamen die zijn gegenereerd tegen eerdere infectie of vaccinatie, verminderde werkzaamheid van behandelingen, mogelijke diagnostische impact of voorspelde toename in overdraagbaarheid of ernst van de ziekte.

cr3022fab
cr3022fab

 

 

 

 

.1 Variant van interesse

Mogelijke kenmerken van een variant van interesse:

Specifieke genetische markers waarvan wordt voorspeld dat ze de overdracht, diagnostiek, therapeutica of immuunontsnapping beïnvloeden
Bewijs dat het de oorzaak is van een groter aantal gevallen of unieke uitbraakclusters
Beperkte prevalentie of uitbreiding.

c669fab
c669fab

Voor een interessante variant zijn mogelijk een of meer passende maatregelen op het gebied van de volksgezondheid nodig, waaronder verbeterde sequentiebewaking, verbeterde laboratoriumkarakterisering of epidemiologisch onderzoek om te beoordelen hoe gemakkelijk het virus zich naar anderen verspreidt, de ernst van de ziekte, de werkzaamheid van therapieën en of momenteel goedgekeurde vaccins bescherming bieden.

Huidige varianten van interesse die worden gemonitord en gekarakteriseerd, staan ​​vermeld in de onderstaande tabel. De tabel wordt bijgewerkt wanneer een nieuwe interessante variant wordt geïdentificeerd.

Novel coronavirus variants B.1.526, P.1, B.1.351, B.1.1.318, R.1, B.1.525, B.1.1, B.1, P.2,
Interior structure of Coronavirus Covid-19. Scientifically accurate illustration of Covid corona virus cell. coronavirus variants B.1.526, P.1, B.1.351, B.1.1.318, R.1, B.1.525, B.1.1, B.1, P.2,

Geselecteerde kenmerken van SARS-CoV-2-varianten van interesse +

B.1.526 Spike: (L5F *), T95I, D253G, (S477N *), (E484K *), D614G, (A701V *) 20C / S: 484K V

4a8fab
4a8fab

Verminderde gevoeligheid voor de combinatie van behandeling met bamlanivimab en etesevimab monoklonale antilichamen; de klinische implicaties hiervan zijn echter niet bekend.

Er zijn alternatieve behandelingen met Kameel monoklonale antilichamen beschikbaar, UCL st Luc, Belgium.

Verminderde neutralisatie door herstellende en post-vaccinatie sera

B.1.526.1 Spike: D80G, Δ144, F157S, L452R, D614G, (T791I *), (T859N *), D950H 20C

Mogelijke vermindering van neutralisatie door sommige EUA-behandelingen met monoklonale antilichamen.

Sars-Cov2 coronavirus variants B.1.526, P.1, B.1.351, B.1.1.318, R.1, B.1.525, B.1.1, B.1, P.2,
bat Sars-Cov2 coronavirus variants B.1.526, P.1, B.1.351, B.1.1.318, R.1, B.1.525, B.1.1, B.1, P.2,

Mogelijke vermindering van neutralisatie door herstellende en post-vaccinatiesera

B.1.525 Spike : A67V, Δ69 / 70, Δ144, E484K, D614G, Q677H, F888L 20A / S: 484K Verenigd Koninkrijk / Nigeria – december 2020

Mogelijke vermindering van neutralisatie door sommige EUA-behandelingen met monoklonale antilichamen 7, 14
Mogelijke vermindering van neutralisatie door herstellende en post-vaccinatiesera

P.2 Spike : E484K, (F565L *), D614G, V1176F 20J Brazilië – april 2020

Mogelijke vermindering van neutralisatie door sommige EUA-behandelingen met monoklonale antilichamen 7, 14
Verminderde neutralisatie door sera 22, 23 na vaccinatie

B.1.617 Spike: L452R, E484Q, D614G 20A India – februari 2021
Mogelijke vermindering van neutralisatie door sommige EUA-behandelingen met monoklonale antilichamen 7, 14
Licht verminderde neutralisatie door sera 25, 26 na vaccinatie
B.1.617.1 Spike: (T95I), G142D, E154K, L452R, E484Q, D614G, P681R, Q1071H 20A / S: 154K India – december 2020
Mogelijke vermindering van neutralisatie door sommige EUA-behandelingen met monoklonale antilichamen 7, 14
Mogelijke vermindering van neutralisatie door sera na vaccinatie 26
B.1.617.2 Spike: T19R, (G142D), Δ156, Δ157, R158G, L452R, T478K, D614G, P681R, D950N 20A / S: 478K India – december 2020
Mogelijke vermindering van neutralisatie door sommige EUA-behandelingen met monoklonale antilichamen 7, 14
Mogelijke vermindering van neutralisatie door sera 21 na vaccinatie
B.1.617.3 Punt : T19R, G142D, L452R, E484Q, D614G, P681R, D950N 20A India – oktober 2020
Mogelijke vermindering van neutralisatie door sommige EUA-behandelingen met monoklonale antilichamen 7, 14
Mogelijke vermindering van neutralisatie door sera na vaccinatie 26
(*) = gedetecteerd in sommige reeksen, maar niet in alle

+ Deze varianten delen een specifieke mutatie genaamd D614G. Deze mutatie was een van de eerste die in de VS werd gedocumenteerd in de beginfase van de pandemie, nadat ze zich aanvankelijk in Europa had verspreid [13] . Er zijn aanwijzingen dat varianten met deze mutatie zich sneller verspreiden dan virussen zonder deze mutatie [ 12 ] .

a – Phylogenetic Assignment of Named Global Outbreak (PANGO) Lineages is een softwaretool ontwikkeld door leden van het Rambaut Lab. De bijbehorende webapplicatie is ontwikkeld door het Center for Genomic Pathogen Surveillance in South Cambridgeshire en is bedoeld om de dynamische nomenclatuur van SARS-CoV-2-lijnen, bekend als de PANGO-nomenclatuur, te implementeren.

b – Nextstrain, een samenwerking tussen onderzoekers in Seattle, VS en Bazel, Zwitserland, biedt open-source tools voor het visualiseren van de genetica van uitbraken. Het doel is om toezicht op de volksgezondheid te ondersteunen door het begrip van de verspreiding en evolutie van pathogenen te vergemakkelijken.

c – De Biodefense and Emerging Infections Research Resources (BEI Resources) is een door het NIAID gefinancierde opslagplaats om reagentia, tools en informatie te verstrekken aan de onderzoeksgemeenschap. De hier voorgestelde referentievirussen vergemakkelijken de harmonisatie van informatie tussen alle belanghebbenden in de COVID-19-pandemische onderzoeksgemeenschap. Houd er rekening mee dat de referentievirussen in de onderstaande tabellen zijn gebaseerd op wat momenteel beschikbaar is via de BEI-bronnen.

2 Variant van bezorgdheid

Een variant waarvoor er aanwijzingen zijn voor een toename van de overdraagbaarheid, een ernstigere ziekte (bijvoorbeeld meer ziekenhuisopnames of sterfgevallen), een significante afname van de neutralisatie door antilichamen die zijn gegenereerd tijdens een eerdere infectie of vaccinatie, een verminderde effectiviteit van behandelingen of vaccins, of mislukte diagnostische detectie .

Mogelijke kenmerken van een zorgwekkende variant:

Naast de mogelijke kenmerken van een variant van interesse

Bewijs van impact op diagnostiek, behandelingen of vaccins
Wijdverbreide interferentie met diagnostische testdoelen
Bewijs van aanzienlijk verminderde gevoeligheid voor een of meer therapieklassen
Bewijs van een significant verminderde neutralisatie door antilichamen die zijn gegenereerd tijdens een eerdere infectie of vaccinatie
Bewijs van verminderde door vaccinatie geïnduceerde bescherming tegen ernstige ziekte
Bewijs van verhoogde overdraagbaarheid
Bewijs van verhoogde ernst van de ziekte
Voor varianten van zorg kunnen een of meer passende maatregelen op het gebied van de volksgezondheid nodig zijn, zoals kennisgeving aan de WHO op grond van de internationale gezondheidsvoorschriften, rapportage aan CDC, lokale of regionale inspanningen om verspreiding te beheersen, meer testen of onderzoek om de effectiviteit van vaccins en behandelingen tegen de variant. Op basis van de kenmerken van de variant kunnen aanvullende overwegingen de ontwikkeling van nieuwe diagnostiek of de aanpassing van vaccins of behandelingen zijn.

cov2 variant
Scientist holds vial with sample of coronavirus OC43 in a specialized laboratory,

De huidige zorgwekkende varianten in de Verenigde Staten die nauwlettend worden gevolgd en gekenmerkt door federale agentschappen, zijn opgenomen in de onderstaande tabel. De tabel wordt bijgewerkt wanneer een nieuwe probleemvariant wordt geïdentificeerd.

Geselecteerde kenmerken van SARS-CoV-2 Variants of Concern +
Naam
( Pango-
afstammingextern pictogram) een Spike-eiwitvervangingen Naam
( Nextstrainextern pictogramextern pictogram) b Voor het eerst gedetecteerd BIJextern pictogramReferentie-isolaat c
Attributen d

B.1.1.7 Δ69 / 70, Δ144, (E484K *), (S494P *), N501Y, A570D, D614G, P681H, T716I, S982A, D1118H (K1191N *) 20I / 501Y.V1 Verenigd Koningkrijk GEEN-54000extern pictogram
~ 50% verhoogde transmissie 5
Mogelijk verhoogde ernst op basis van ziekenhuisopnames en sterftecijfers 6
Geen invloed op de gevoeligheid voor behandelingen met EUA-monoklonale antilichamen 7,14
Minimale impact op neutralisatie door herstellende en post-vaccinatiesera 8,9,10,11,12,13,19
P.1 L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I 20J / 501Y.V3 Japan /
Brazilië GEEN-54982extern pictogram
Significante afname van de gevoeligheid voor de combinatie van behandeling met bamlanivimab en etesevimab monoklonale antilichamen, 7 maar er zijn andere EUA-behandelingen met monoklonale antilichamen beschikbaar 14
Verminderde neutralisatie door herstellende en post-vaccinatie sera 15
B.1.351 D80A, D215G, Δ241 / 242/243, K417N, E484K, N501Y, D614G, A701V 20H / 501.V2 Zuid-Afrika GEEN-54009extern pictogram
~ 50% verhoogde transmissie 16
Significante afname van de gevoeligheid voor de combinatie van behandeling met bamlanivimab en etesevimab monoklonale antilichamen, 7 maar er zijn andere EUA-behandelingen met monoklonale antilichamen beschikbaar 14
Verminderde neutralisatie door herstellende en post-vaccinatie sera 8,12,18,19,20
B.1.427 L452R, D614G 20C / S: 452R Verenigde Staten- (Californië)
~ 20% verhoogde overdraagbaarheid 21
Bescheiden afname van de gevoeligheid voor de combinatie van bamlanivimab en etesevimab; de klinische implicaties van deze afname zijn echter niet bekend. 7 Er zijn alternatieve behandelingen met monoklonale antilichamen beschikbaar. 14
Verminderde neutralisatie door herstellende en post-vaccinatie sera 21
B.1.429 S13I, W152C, L452R, D614G 20C / S: 452R Verenigde Staten- (Californië)
~ 20% verhoogde overdraagbaarheid 21
Bescheiden afname van de gevoeligheid voor de combinatie van bamlanivimab en etesevimab; de klinische implicaties van deze afname zijn echter niet bekend. 7 Er zijn alternatieve behandelingen met monoklonale antilichamen beschikbaar. 14
Verminderde neutralisatie door herstellende en post-vaccinatie sera 21
(*) = gedetecteerd in sommige sequenties maar niet alle
+ Deze varianten delen één specifieke mutatie genaamd D614G. Deze mutatie was een van de eerste die in de VS werd gedocumenteerd in de beginfase van de pandemie, nadat ze zich aanvankelijk in Europa had verspreid [13] . Er zijn aanwijzingen dat varianten met deze mutatie zich sneller verspreiden dan virussen zonder deze mutatie [ 12 ] .

a – Phylogenetic Assignment of Named Global Outbreak (PANGO) Lineages is een softwaretool ontwikkeld door leden van het Rambaut Lab. De bijbehorende webapplicatie is ontwikkeld door het Center for Genomic Pathogen Surveillance in South Cambridgeshire en is bedoeld om de dynamische nomenclatuur van SARS-CoV-2-lijnen, bekend als de PANGO-nomenclatuur, te implementeren.

b – Nextstrain, een samenwerking tussen onderzoekers in Seattle, VS en Bazel, Zwitserland, biedt open-source tools voor het visualiseren van de genetica van uitbraken. Het doel is om toezicht op de volksgezondheid te ondersteunen door het begrip van de verspreiding en evolutie van pathogenen te vergemakkelijken.

c – De Biodefense and Emerging Infections Research Resources (BEI Resources) is een door het NIAID gefinancierde opslagplaats om reagentia, tools en informatie te verstrekken aan de onderzoeksgemeenschap. De hier voorgestelde referentievirussen vergemakkelijken de harmonisatie van informatie tussen alle belanghebbenden in de COVID-19-pandemische onderzoeksgemeenschap. Houd er rekening mee dat de referentievirussen in de onderstaande tabellen zijn gebaseerd op wat momenteel beschikbaar is via de BEI-bronnen.

d – De vermelde attributen zijn gebaseerd op gegevens die beschikbaar zijn van pseudovirussen of recombinante virussen die combinaties van substituties bevatten die kenmerkend zijn voor specifieke lijnen of van referentievirusisolaten.

3 Variant van hoge consequentie

Een variant met hoge consequenties heeft duidelijk bewijs dat preventiemaatregelen of medische tegenmaatregelen (MCM’s) de effectiviteit significant hebben verminderd in vergelijking met varianten die eerder circuleerden.

Mogelijke kenmerken van een variant met hoge gevolgen:

Naast de mogelijke kenmerken van een variant van zorg

Impact op medische tegenmaatregelen (MCM)
Aantoonbare storing van diagnostiek
Bewijs dat duidt op een significante afname van de effectiviteit van het vaccin, een onevenredig hoog aantal doorbraakgevallen op het gebied van vaccins of een zeer lage vaccin-geïnduceerde bescherming tegen ernstige ziekten

Aanzienlijk verminderde gevoeligheid voor meervoudige autorisatie voor noodgevallen (EUA) of goedgekeurde therapieën.

  • Ernstigere klinische ziekte en verhoogde ziekenhuisopnames
  • Een variant met grote gevolgen zou een kennisgeving aan de WHO vereisen op grond van de Internationale Gezondheidsregeling, rapportage aan CDC, een aankondiging van strategieën om overdracht te voorkomen of te beheersen, en aanbevelingen om behandelingen en vaccins bij te werken.

Momenteel zijn er geen SARS-CoV-2-varianten die oplopen tot het niveau van hoge gevolgen.

Behandelingsoverwegingen voor zorgverleners

Vervanging van zorg voor SARS-CoV-2 monoklonale antilichaamtherapieën

In de Verenigde Staten zijn er twee anti-SARS-CoV-2 monoklonale antilichaambehandelingen met FDA Emergency Use Authorization (EUA) voor de behandeling van COVID-19: bamlanivimab plus etesevimabextern pictogramen casirivimab plus imdevimab.extern pictogram

CDC’s nationale genomische surveillanceprogramma identificeert nieuwe en opkomende SARS-CoV-2-varianten om de implicaties te bepalen voor COVID-19-diagnostiek, behandelingen of vaccins die zijn goedgekeurd voor gebruik in de Verenigde Staten. Sequenties met vergelijkbare genetische veranderingen zijn gegroepeerd in lijnen, en meerdere lijnen kunnen dezelfde substituties hebben. De E484K-substitutie wordt bijvoorbeeld gevonden in lijnen B.1.351, P.1, B.1.526 en vele anderen. Inspanningen op het gebied van genoombewaking bieden de mogelijkheid om sneller virussen op te sporen die minder vatbaar zijn voor behandelingen.

In laboratoriumonderzoeken veroorzaken SARS-CoV-2-varianten die de L452R- of E484K-substitutie in het spike-eiwit bevatten een duidelijke vermindering van de gevoeligheid voor bamlanivimab en kunnen ze een lagere gevoeligheid hebben voor etesevimab en casirivimab.

De onderstaande tabel toont de nationale en regionale ongewogen verhoudingen van SARS-CoV-2 die de L452R- of E484K-substitutie bevatten. Als er nieuwe gegevens beschikbaar komen, kunnen aanvullende vervangingen aan de onderstaande tabel worden toegevoegd. De nationale en regionale verhoudingen in de onderstaande tabel worden wekelijks bijgewerkt.

Middelen
Monoklonaal antilichaam COVID-19-infusieextern pictogram

Verklaring over anti-SARS-CoV-2 monoklonale antilichamen EUA | COVID-19 behandelrichtlijnen (nih.gov)extern pictogram

Ongewogen proporties van SARS-CoV-2-substituties van therapeutische zorg
Spike-eiwitvervanging Nationaal aandeel a Regionale proporties b Gemeenschappelijke Pango-geslachten
met spike-eiwitvervangingen c

L452R

  1. B.1.526.1
  2. B.1.427
  3. B.1

E484K

  1. P.1
  2. B.1.351
  3. B.1.1.318
  4. R.1
  5. B.1.525
  6. B.1.1
  7. B.1
  8. P.2
COV2-B.1.526-100ugCamel anti-Covid B.1.526 antibody
human anti-Covid B.1.526 antibody

Strategie

  • a – Het ongewogen deel van SARS-CoV-2 dat circuleert en dat de aangewezen substitutie bevat, gebaseerd op> 20.000 sequenties verzameld via CDC’s nationale genoombewaking gedurende de periode van twee weken die eindigde op 10 april 2021.
  • b – Het ongewogen regionale aandeel van SARS-CoV-2 dat circuleert in elke HHS-regio die de aangewezen substitutie bevat, gebaseerd op> 20.000 sequenties verzameld via CDC’s nationale genomische surveillance gedurende de periode van twee weken die eindigde op 10 april 2021.
  • c – De vermelde lijnen zijn de meest voorkomende lijnen binnen CDC’s nationale genomische bewaking met deze substituties, maar deze lijst is niet bedoeld als een volledige lijst van de lijnen die de spike proteïne substituties bevatten.

 

Description Mutation Most common countries Earliest date Number designated Number assigned
A large European lineage the origin of which roughly corresponds to the Northern Italian outbreak early in 2020. SARS-CoV-2 B.1 variant United States of America 47.0%, United Kingdom 11.0%, Germany 5.0%, France 3.0%, Canada 3.0% 24-01-20 ### ###
A lineage predominantly circulating in California but with exports to other countries. Characterised by the spike L452R mutation but also has spike:W152C orf1ab:D5584Y and N:T205I. SARS-CoV-2 B.1.429 variant United States of America 99.0%, Mexico 1.0%, South_Korea 0.0%, Denmark 0.0%, Japan 0.0% 15-04-20 ### ###
A lineage predominantly circulating in New York but with a few exports to other countries. Characterised by spike mutations T95I and D253G, plus others. The most frequent spike mutation pattern is L5F T95I D253G E484K D614G A701V, with a smaller fraction having S477N instead of E484K. Spike mutation E484K is present in about half of this lineage (as of 2021-02-10) – Very possible not all new additions carry T95I and D253G (someone should check this, e.g. for USA/NY-Wadsworth-21008455-01/2021 and Aruba/AW-RIVM-11403/2021) SARS-CoV-2 B.1.526 variant United States of America 99.0%, Aruba 0.0%, United Kingdom 0.0%, Ecuador 0.0%, Spain 0.0% 23-11-20 215 ###
African lineage (Zambia, Zimbabwe) SARS-CoV-2 B.1.1.111 variant Zimbabwe 53.0%, Zambia 41.0%, United States of America 2.0%, Kenya 2.0%, United Kingdom 2.0% 01-05-20 50 58
Alias ​​of B.1.1.1.11 SARS-CoV-2 C.11 variant United Kingdom 35.0%, Peru 20.0%, Chile 17.0%, Belgium 4.0%, Denmark 4.0% 02-03-20 65 494
Alias ​​of B.1.1.1.25, Peru SARS-CoV-2 C.25 variant Peru 100.0% 20-03-20 8 8
Alias ​​of B.1.1.1.32, Peru SARS-CoV-2 C.32 variant Peru 97.0%, Denmark 3.0% 07-05-20 15 38
Alias ​​of B.1.1.1.33, Peru SARS-CoV-2 C.33 variant Peru 91.0%, Japan 9.0% 18-05-20 7 11
Alias ​​of B.1.1.33.7, Uruguay SARS-CoV-2 N.7 variant Uruguay 100.0% 18-06-20 27 30
Alias of B.1.1.1.1, South Africa SARS-CoV-2 C.1 variant South_Africa 94.0%, Zambia 3.0%, United States of America 1.0%, Mozambique 1.0%, Zimbabwe 0.0% 16-04-20 242 331
Alias of B.1.1.1.12, New Zealand SARS-CoV-2 C.12 variant New_Zealand 100.0% 12-08-20 120 123
Alias of B.1.1.1.13, Peruvian SARS-CoV-2 C.13 variant Peru 85.0%, United States of America 12.0%, Japan 3.0% 29-03-20 19 33
Alias of B.1.1.1.14, Peruvian SARS-CoV-2 C.14 variant Peru 92.0%, Japan 2.0%, Brazil 1.0%, Democratic Republic of the Congo 1.0%, United States of America 1.0% 20-03-20 73 179
Alias of B.1.1.1.16, Portugal originally, now pan-european SARS-CoV-2 C.16 variant France 19.0%, Portugal 15.0%, Angola 13.0%, United States of America 11.0%, Switzerland 9.0% 26-06-20 228 759
Alias of B.1.1.1.17, Egypt SARS-CoV-2 C.17 variant Egypt 52.0%, Germany 43.0%, United Kingdom 4.0% 02-06-20 9 23
Alias of B.1.1.1.18, Italy SARS-CoV-2 C.18 variant Italy 90.0%, Switzerland 7.0%, Germany 1.0%, Denmark 1.0%, Sweden 1.0% 01-07-20 132 167
Alias of B.1.1.1.19, Denmark SARS-CoV-2 C.19 variant Denmark 100.0% 07-12-20 23 37
Alias of B.1.1.1.2, South Africa and some European SARS-CoV-2 C.2 variant South_Africa 40.0%, Zimbabwe 38.0%, Denmark 8.0%, United Kingdom 8.0%, Australia 6.0% 09-06-20 25 48
Alias of B.1.1.1.2.1, Aruba and Curacao SARS-CoV-2 C.2.1 variant Aruba 73.0%, United States of America 13.0%, Curaçao 10.0%, Netherlands 3.0%, Zimbabwe 1.0% 18-12-20 58 124
Alias of B.1.1.1.20, Switzerland SARS-CoV-2 C.20 variant Switzerland 91.0%, Denmark 9.0% 26-10-20 8 11
Alias of B.1.1.1.21, Spain SARS-CoV-2 C.21 variant Spain 100.0% 15-09-20 7 7
Alias of B.1.1.1.22, Argentina SARS-CoV-2 C.22 variant Argentina 79.0%, Peru 21.0% 03-04-20 12 14
Alias of B.1.1.1.23, Mainly USA SARS-CoV-2 C.23 variant United States of America 90.0%, Pakistan 4.0%, Mexico 2.0%, Denmark 2.0%, Peru 2.0% 11-05-20 54 130
Alias of B.1.1.1.26, Chile SARS-CoV-2 C.26 variant Chile 83.0%, Argentina 17.0% 28-04-20 72 123
Alias of B.1.1.1.27, England SARS-CoV-2 C.27 variant United Kingdom 100.0% 19-04-20 36 50
Alias of B.1.1.1.28, USA SARS-CoV-2 C.28 variant United States of America 100.0% 30-04-20 17 17
Alias of B.1.1.1.29, Chile SARS-CoV-2 C.29 variant Chile 100.0% 25-06-20 6 16
Alias of B.1.1.1.3, England SARS-CoV-2 C.3 variant United Kingdom 100.0% 20-05-20 86 131
Alias of B.1.1.1.30, England SARS-CoV-2 C.30 variant United Kingdom 98.0%, Germany 1.0%, Austria 0.0%, Italy 0.0%, Ireland 0.0% 04-08-20 384 557
Alias of B.1.1.1.30.1, Denmark SARS-CoV-2 C.30.1 variant Denmark 100.0% 05-10-20 137 142
Alias of B.1.1.1.31, USA SARS-CoV-2 C.31 variant United States of America 88.0%, Canada 10.0%, Japan 2.0% 11-08-20 17 42
Alias of B.1.1.1.34, Canada SARS-CoV-2 C.34 variant Canada 100.0% 06-08-20 15 16
Alias of B.1.1.1.35, Central Europe, England SARS-CoV-2 C.35 variant Germany 20.0%, United Kingdom 19.0%, Switzerland 13.0%, Denmark 12.0%, Sweden 6.0% 06-04-20 508 ###
Alias of B.1.1.1.36, Egypt mainly and other countries SARS-CoV-2 C.36 variant Egypt 28.0%, United Kingdom 19.0%, United States of America 12.0%, Germany 10.0%, Denmark 8.0% 13-03-20 221 922
Alias of B.1.1.1.36.1, Canada SARS-CoV-2 C.36.1 variant Canada 97.0%, United States of America 3.0% 24-09-20 21 74
Alias of B.1.1.1.36.2, Switzerland SARS-CoV-2 C.36.2 variant Switzerland 86.0%, Norway 7.0%, Sweden 4.0%, Germany 4.0% 16-10-20 18 28
Alias of B.1.1.1.37, lineage in Peru, Chile, USA and Germany, from pango-designation issue #52 SARS-CoV-2 C.37 variant United States of America 43.0%, Chile 36.0%, Peru 10.0%, Germany 5.0%, Ecuador 2.0% 30-11-20 376 511
Alias of B.1.1.1.4, Peruvian SARS-CoV-2 C.4 variant Peru 93.0%, Turkey 3.0%, Republic of Serbia 1.0%, Switzerland 1.0%, United States of America 1.0% 19-05-20 24 76
Alias of B.1.1.1.5, Switzerland and Luxembourg SARS-CoV-2 C.5 variant Switzerland 91.0%, Luxembourg 9.0% 02-09-20 9 11
Alias of B.1.1.1.7, Denmark SARS-CoV-2 C.7 variant Denmark 100.0% 11-05-20 29 29
Alias of B.1.1.1.8, Canada and DRC SARS-CoV-2 C.8 variant Canada 81.0%, United Kingdom 7.0%, Peru 3.0%, Democratic Republic of the Congo 2.0%, Chile 2.0% 04-03-20 129 231
Alias of B.1.1.1.9, South Africa SARS-CoV-2 C.9 variant South_Africa 97.0%, United Kingdom 3.0% 20-04-20 30 32
Alias of B.1.1.10.1, Canadian lineage SARS-CoV-2 L.1 variant Canada 100.0% 26-03-20 370 528
Alias of B.1.1.10.2, Netherlands lineage SARS-CoV-2 L.2 variant Netherlands 77.0%, Germany 19.0%, Belgium 4.0% 23-03-20 61 77
Alias of B.1.1.10.3, Nigerian/ European lineage with long branch from B.1.1.10 SARS-CoV-2 L.3 variant Nigeria 30.0%, Germany 13.0%, Switzerland 13.0%, United Kingdom 13.0%, United States of America 11.0% 07-07-20 88 218
Alias of B.1.1.200.1, Sweden and Netherlands, from B.1.1.130 SARS-CoV-2 AN.1 variant 21 0
Alias of B.1.1.216.1, Portugal lineage SARS-CoV-2 AM.1 variant Portugal 78.0%, United Kingdom 11.0%, Japan 11.0% 23-10-20 6 9
Alias of B.1.1.216.2, Canadian lineage SARS-CoV-2 AM.2 variant Canada 50.0%, Japan 30.0%, Qatar 20.0% 03-08-20 5 10
Alias of B.1.1.216.3, UK lineage SARS-CoV-2 AM.3 variant United Kingdom 100.0% 30-10-20 7 30
Alias of B.1.1.216.4, Canadian lineage SARS-CoV-2 AM.4 variant Canada 98.0%, Japan 1.0%, Israel 1.0% 05-11-20 49 81
Alias of B.1.1.217.1, Latvian lineage, previously I.1 SARS-CoV-2 S.1 variant Latvia 90.0%, Finland 8.0%, United Kingdom 1.0%, Estonia 1.0%, Ireland 1.0% 20-08-20 41 170
Alias of B.1.1.231.1, Canada lineage SARS-CoV-2 AL.1 variant Canada 87.0%, United States of America 10.0%, Australia 3.0% 18-09-20 20 31
Alias of B.1.1.232.1, UK lineage SARS-CoV-2 AK.1 variant United Kingdom 99.0%, Germany 1.0% 07-08-20 56 71
Alias of B.1.1.232.2, German lineage SARS-CoV-2 AK.2 variant Germany 100.0% 19-09-20 13 22
Alias of B.1.1.240.1, Portugal lineage SARS-CoV-2 AJ.1 variant Portugal 72.0%, Gibraltar 28.0% 08-11-20 13 18
Alias of B.1.1.241.1, Swiss Lineage SARS-CoV-2 AH.1 variant Switzerland 88.0%, Portugal 12.0% 26-11-20 5 8
Alias of B.1.1.241.2, French Lineage SARS-CoV-2 AH.2 variant France 83.0%, Switzerland 11.0%, Portugal 6.0% 18-08-20 16 18
Alias of B.1.1.241.3, Finnish Lineage SARS-CoV-2 AH.3 variant Finland 94.0%, United Kingdom 4.0%, Sweden 1.0%, Italy 1.0% 23-10-20 92 138
Alias of B.1.1.25.2, Australia SARS-CoV-2 D.2 variant Australia 100.0%, Germany 0.0%, United States of America 0.0%, Bangladesh 0.0%, Latvia 0.0% 19-03-20 ### ###
Alias of B.1.1.25.3, Australia SARS-CoV-2 D.3 variant Australia 99.0%, Bangladesh 1.0% 14-06-20 139 151
Alias of B.1.1.25.4, Irish/ Northern Irish lineage SARS-CoV-2 D.4 variant United Kingdom 71.0%, Ireland 18.0%, Bangladesh 12.0% 13-08-20 11 17
Alias of B.1.1.25.5, Swedish/ Denmark lineage SARS-CoV-2 D.5 variant Sweden 58.0%, Denmark 40.0%, United Kingdom 1.0%, Bangladesh 1.0% 12-10-20 64 175
Alias of B.1.1.277.1, South Korean lineage SARS-CoV-2 K.1 variant South_Korea 97.0%, Russia 3.0% 23-07-20 35 34
Alias of B.1.1.277.2, Russian lineage SARS-CoV-2 K.2 variant Russia 91.0%, Japan 9.0% 26-07-20 15 22
Alias of B.1.1.277.3, Norway lineage SARS-CoV-2 K.3 variant Norway 100.0% 29-08-20 76 89
Alias of B.1.1.28.1, Brazilian lineage with a number of spike mutaions with likely functional significance E484K, K417T, and N501Y. Described in https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586. SARS-CoV-2 P.1 variant United States of America 53.0%, Brazil 19.0%, Italy 7.0%, Belgium 6.0%, Netherlands 2.0% 03-11-20 146 ###
Alias of B.1.1.28.1.1, European lineage in Italy and Germany SARS-CoV-2 P.1.1 variant United States of America 55.0%, Colombia 12.0%, Italy 8.0%, Japan 5.0%, Germany 5.0% 07-01-21 108 104
Alias of B.1.1.28.1.2, Netherlands/Brazil lineage. Imported into Netherlands, likely with local transmission here and continued circulation within and/or reintroduction into Brazil, pango-designation issue #56 SARS-CoV-2 P.1.2 variant United States of America 67.0%, Spain 33.0% 03-04-21 36 3
Alias of B.1.1.28.2, Brazilian lineage SARS-CoV-2 P.2 variant United States of America 44.0%, Brazil 34.0%, French_Guiana 3.0%, United Kingdom 2.0%, Suriname 2.0% 15-04-20 424 ###
Alias of B.1.1.28.3, Lineage predominantly in the Philippines with spike mutations E484K, N501Y, P681H, 141-143del. Described in Tablizo et al 2021: https://www.medrxiv.org/content/10.1101/2021.03.03.21252812v2 SARS-CoV-2 P.3 variant Philippines 72.0%, Germany 6.0%, Netherlands 5.0%, United Kingdom 4.0%, Japan 3.0% 16-01-21 31 114
Alias of B.1.1.294.1, Israel SARS-CoV-2 M.1 variant Israel 100.0% 07-12-20 18 43
Alias of B.1.1.294.2, Swiss Lineage SARS-CoV-2 M.2 variant Switzerland 86.0%, Iceland 7.0%, United Kingdom 7.0% 26-10-20 8 14
Alias of B.1.1.294.3, English Lineage SARS-CoV-2 M.3 variant United Kingdom 92.0%, Russia 8.0% 01-09-20 10 12
Alias of B.1.1.297.1, Netherlands lineage SARS-CoV-2 AG.1 variant Netherlands 77.0%, Germany 15.0%, Iceland 8.0% 12-09-20 8 13
Alias of B.1.1.305.1, Switzerland SARS-CoV-2 AF.1 variant Switzerland 50.0%, Japan 42.0%, Turkey 2.0%, Spain 2.0%, France 2.0% 27-03-20 18 48
Alias of B.1.1.306.1, Zambian SARS-CoV-2 AE.1 variant Zambia 91.0%, United Kingdom 9.0% 04-06-20 39 45
Alias of B.1.1.306.2, Bahrain SARS-CoV-2 AE.2 variant Bahrain 100.0% 23-06-20 14 14
Alias of B.1.1.306.3, Zambia and Rwanda SARS-CoV-2 AE.3 variant Zambia 86.0%, India 7.0%, Rwanda 7.0% 04-06-20 12 14
Alias of B.1.1.306.4, Bahrain SARS-CoV-2 AE.4 variant Bahrain 78.0%, Canada 17.0%, Qatar 6.0% 23-06-20 17 18
Alias of B.1.1.306.5, Zambia SARS-CoV-2 AE.5 variant Zambia 92.0%, Switzerland 4.0%, United Kingdom 4.0% 28-06-20 23 25
Alias of B.1.1.306.6, Bahrain SARS-CoV-2 AE.6 variant Bahrain 100.0% 11-10-20 24 24
Alias of B.1.1.306.7, Bahrain SARS-CoV-2 AE.7 variant Bahrain 100.0% 11-09-20 12 12
Alias of B.1.1.306.8, Canada lineage SARS-CoV-2 AE.8 variant Canada 100.0%, South_Korea 0.0%, United States of America 0.0% 11-08-20 801 ###
Alias of B.1.1.315.1, Denmark lineage SARS-CoV-2 AD.1 variant Denmark 100.0% 02-11-20 194 235
Alias of B.1.1.315.2, UK lineage SARS-CoV-2 AD.2 variant United Kingdom 98.0%, Greece 0.0%, Netherlands 0.0%, Portugal 0.0%, Italy 0.0% 21-07-20 ### ###
Alias of B.1.1.315.2.1, Lithuanian lineage SARS-CoV-2 AD.2.1 variant Lithuania 100.0% 04-12-20 7 20
Alias of B.1.1.316.1, Sublineage of B.1.1.316 with 3 additional spike mutations, circulating in a number of countries. pango-designation issue #17 SARS-CoV-2 R.1 variant Japan 57.0%, United States of America 32.0%, Germany 3.0%, Sweden 2.0%, Austria 1.0% 24-10-20 72 ###
Alias of B.1.1.316.2, Sublineage of B.1.1.316 with E484K. pango-designation issue #18 SARS-CoV-2 R.2 variant United States of America 100.0% 23-12-20 6 64
Alias of B.1.1.317.1, UK lineage SARS-CoV-2 AS.1 variant United Kingdom 93.0%, Canada 7.0% 06-10-20 61 67
Alias of B.1.1.317.2, UK lineage SARS-CoV-2 AS.2 variant United Kingdom 95.0%, Turkey 5.0% 05-10-20 39 63
Alias of B.1.1.33.1, US SARS-CoV-2 N.1 variant United States of America 92.0%, Brazil 8.0% 25-03-20 27 38
Alias of B.1.1.33.10, Brazilian lineage described in https://virological.org/t/identification-of-a-new-b-1-1-33-sars-cov-2-variant-of-interest-voi-circulating-in-brazil-with-mutation-e484k-and-multiple-deletions-in-the-amino-n-terminal-domain-of-the-spike-protein/675 SARS-CoV-2 N.10 variant Brazil 94.0%, Germany 6.0% 04-01-21 17 18
Alias of B.1.1.33.2, European lineage SARS-CoV-2 N.2 variant France 46.0%, Suriname 31.0%, Iceland 8.0%, Chile 8.0%, Spain 8.0% 25-06-20 13 13
Alias of B.1.1.33.3, Argentinian SARS-CoV-2 N.3 variant Argentina 99.0%, Hong_Kong 1.0%, Chile 1.0% 17-04-20 81 148
Alias of B.1.1.33.4, Chilean SARS-CoV-2 N.4 variant Chile 95.0%, Brazil 2.0%, Peru 1.0%, Switzerland 0.0%, Canada 0.0% 25-03-20 123 218
Alias of B.1.1.33.5, Argentinian SARS-CoV-2 N.5 variant Argentina 74.0%, United States of America 17.0%, Spain 3.0%, United Kingdom 2.0%, Germany 2.0% 25-04-20 59 189
Alias of B.1.1.33.6, Chilean SARS-CoV-2 N.6 variant Chile 99.0%, United States of America 1.0% 16-02-20 93 126
Alias of B.1.1.33.8, Kenyan SARS-CoV-2 N.8 variant Kenya 100.0% 23-06-20 6 30
Alias of B.1.1.33.9, Brazilian lineage SARS-CoV-2 N.9 variant Brazil 89.0%, Ireland 3.0%, India 3.0%, United States of America 1.0%, Germany 1.0% 11-11-20 32 75
Alias of B.1.1.370.1, Russia and Finland lineage from pango-designation issue #47 SARS-CoV-2 AT.1 variant Russia 80.0%, Finland 20.0% 26-02-21 6 10
Alias of B.1.1.39.1, Finland lineage SARS-CoV-2 AQ.1 variant Finland 93.0%, Switzerland 7.0% 08-11-20 9 14
Alias of B.1.1.39.2, Denmark lineage SARS-CoV-2 AQ.2 variant Denmark 100.0% 24-08-20 9 9
Alias of B.1.1.405.1, UK lineage SARS-CoV-2 AC.1 variant United Kingdom 100.0% 21-10-20 17 25
Alias of B.1.1.70.1, Wales lineage SARS-CoV-2 AP.1 variant United Kingdom 95.0%, Germany 4.0%, Denmark 1.0%, Switzerland 0.0%, Slovenia 0.0% 04-09-20 395 661
Alias of B.1.160.16.1, Denmark, grown out of big swiss cluster SARS-CoV-2 AB.1 variant Denmark 99.0%, Switzerland 1.0% 01-12-20 81 114
Alias of B.1.177.15.1, European Lineage SARS-CoV-2 AA.1 variant Germany 40.0%, Spain 26.0%, Netherlands 8.0%, Switzerland 6.0%, United Kingdom 6.0% 11-08-20 29 131
Alias of B.1.177.15.2, Welsh Lineage SARS-CoV-2 AA.2 variant United Kingdom 100.0% 14-11-20 65 130
Alias of B.1.177.15.3, Welsh Lineage SARS-CoV-2 AA.3 variant United Kingdom 100.0% 21-10-20 27 37
Alias of B.1.177.15.4, Welsh Lineage SARS-CoV-2 AA.4 variant United Kingdom 100.0% 22-10-20 29 111
Alias of B.1.177.15.5, Welsh Lineage SARS-CoV-2 AA.5 variant United Kingdom 100.0% 05-12-20 40 62
Alias of B.1.177.15.6, Welsh Lineage SARS-CoV-2 AA.6 variant United Kingdom 100.0% 01-11-20 48 58
Alias of B.1.177.15.7, Welsh Lineage SARS-CoV-2 AA.7 variant United Kingdom 100.0% 04-11-20 84 108
Alias of B.1.177.15.8, Welsh Lineage SARS-CoV-2 AA.8 variant United Kingdom 100.0% 25-11-20 30 45
Alias of B.1.177.50.1, UK lineage SARS-CoV-2 Z.1 variant United Kingdom 80.0%, Spain 12.0%, Latvia 3.0%, Germany 1.0%, Switzerland 1.0% 02-06-20 156 373
Alias of B.1.177.52.1, Portuguese lineage SARS-CoV-2 Y.1 variant Portugal 84.0%, Switzerland 8.0%, United Kingdom 4.0%, Netherlands 1.0%, Ireland 1.0% 03-11-20 61 76
Alias of B.1.177.53.1, French and US lineage SARS-CoV-2 W.1 variant United States of America 44.0%, France 31.0%, Aruba 6.0%, Portugal 4.0%, Netherlands 2.0% 02-10-20 44 90
Alias of B.1.177.53.2, Dutch lineage SARS-CoV-2 W.2 variant Netherlands 93.0%, Belgium 5.0%, Germany 1.0%, Luxembourg 1.0%, Norway 1.0% 30-09-20 51 195
Alias of B.1.177.53.3, UK lineage SARS-CoV-2 W.3 variant United Kingdom 99.0%, Switzerland 1.0% 18-08-20 133 178
Alias of B.1.177.53.4, UK lineage SARS-CoV-2 W.4 variant United Kingdom 98.0%, Switzerland 2.0% 02-06-20 508 726
Alias of B.1.177.54.1, Northern Irish and Irish lineage SARS-CoV-2 V.1 variant United Kingdom 64.0%, Ireland 33.0%, Switzerland 2.0% 05-10-20 28 45
Alias of B.1.177.54.2, Northern Irish lineage SARS-CoV-2 V.2 variant United Kingdom 97.0%, Ireland 3.0% 20-10-20 25 31
Alias of B.1.177.60.1, England SARS-CoV-2 U.1 variant United Kingdom 99.0%, Lithuania 1.0% 15-12-20 57 78
Alias of B.1.177.60.2, Denmark SARS-CoV-2 U.2 variant Denmark 93.0%, Lithuania 5.0%, Sweden 2.0% 11-11-20 21 99
Alias of B.1.177.60.3, Norway and Latvia SARS-CoV-2 U.3 variant Latvia 85.0%, Norway 14.0%, United Kingdom 1.0% 11-01-21 10 191
Alias of B.1.258.2.1, UK lineage SARS-CoV-2 G.1 variant United Kingdom 100.0% 10-09-20 17 24
Argentinian SARS-CoV-2 B.1.1.442 variant 37 0
Australia SARS-CoV-2 B.1.338 variant Australia 84.0%, United States of America 13.0%, Senegal 1.0%, South_Africa 1.0%, Germany 1.0% 30-03-20 97 128
Australia SARS-CoV-2 B.1.517.1 variant Australia 98.0%, United States of America 2.0% 02-12-20 172 177
Australia SARS-CoV-2 B.1.535 variant Australia 91.0%, Egypt 6.0%, Kenya 3.0% 25-03-20 29 35
Australia and Canada SARS-CoV-2 B.1.1.431 variant Canada 76.0%, Australia 8.0%, United States of America 4.0%, Germany 4.0%, United_Arab_Emirates 2.0% 23-06-20 47 50
Australian lineage SARS-CoV-2 B.1.1.136 variant Australia 76.0%, Turkey 20.0%, United Kingdom 2.0%, Italy 2.0% 03-06-20 36 46
Australian lineage SARS-CoV-2 B.1.1.142 variant Australia 45.0%, United States of America 37.0%, Germany 8.0%, Turkey 5.0%, Bangladesh 3.0% 16-03-20 38 38
Australian lineage (previously a couple part of B.1.25, B.1.295) SARS-CoV-2 B.1.434 variant Australia 93.0%, United States of America 7.0% 22-03-20 16 15
Austrian lineage SARS-CoV-2 B.1.1.331 variant Austria 98.0%, Switzerland 2.0% 26-02-20 85 86
Austrian lineage SARS-CoV-2 B.1.1.415 variant Austria 100.0% 28-11-20 20 20
Austrian lineage SARS-CoV-2 B.1.224 variant Austria 95.0%, Portugal 5.0% 16-03-20 40 40
Bahrain lineage SARS-CoV-2 B.1.281 variant Bahrain 95.0%, Denmark 3.0%, United States of America 3.0% 08-04-20 37 37
Balkans, Finland SARS-CoV-2 B.1.1.374 variant Latvia 37.0%, Lithuania 26.0%, Germany 18.0%, Poland 7.0%, Finland 3.0% 22-10-20 15 293
Bangladesh SARS-CoV-2 B.1.1.175 variant Bangladesh 100.0% 29-04-20 10 12
Bangladesh Lineage SARS-CoV-2 B.1.1.25 variant Bangladesh 61.0%, Canada 14.0%, United States of America 9.0%, United Kingdom 7.0%, Australia 4.0% 31-03-20 741 ###
Belgian SARS-CoV-2 B.1.177.37 variant Belgium 100.0% 12-10-20 27 36
Belgian lineage SARS-CoV-2 B.1.1.75 variant Qatar 43.0%, Belgium 41.0%, Sweden 6.0%, New_Zealand 3.0%, United Kingdom 1.0% 17-03-20 53 95
Belgian lineage SARS-CoV-2 B.1.1.221 variant Belgium 72.0%, Peru 9.0%, United States of America 6.0%, Mexico 3.0%, Japan 2.0% 29-03-20 79 99
Belgian lineage SARS-CoV-2 B.1.1.483 variant Belgium 100.0% 06-12-20 24 25
Belgian lineage SARS-CoV-2 B.1.6 variant Belgium 71.0%, Democratic Republic of the Congo 11.0%, France 7.0%, United Kingdom 4.0%, South_Africa 2.0% 05-03-20 51 55
Belgian lineage SARS-CoV-2 B.1.83 variant Belgium 91.0%, India 2.0%, Australia 2.0%, France 2.0%, United States of America 2.0% 20-03-20 59 65
Belgium SARS-CoV-2 B.1.9.3 variant Belgium 100.0% 17-03-20 25 26
Belgium and Luxembourg SARS-CoV-2 B.1.160.28 variant Belgium 42.0%, Germany 22.0%, Luxembourg 19.0%, Netherlands 5.0%, France 5.0% 05-09-20 182 311
Belgium and Luxembourg lineage SARS-CoV-2 B.1.526.3 variant United States of America 92.0%, Luxembourg 4.0%, Belgium 4.0% 18-01-21 10 141
Belgium lineage SARS-CoV-2 B.1.1.436 variant Belgium 100.0% 23-03-20 38 38
Belgium lineage SARS-CoV-2 B.1.1.522 variant 45 0
Belgium, England SARS-CoV-2 B.1.321 variant United Kingdom 44.0%, Belgium 41.0%, Chile 7.0%, Spain 4.0%, United States of America 4.0% 09-03-20 20 27
Belgium/ Luxembourg lineage SARS-CoV-2 B.1.211 variant Luxembourg 54.0%, Belgium 31.0%, France 14.0% 04-03-20 33 35
Belgium/ Luxembourg lineage SARS-CoV-2 B.1.221.4 variant Belgium 54.0%, Luxembourg 42.0%, Germany 2.0%, Netherlands 1.0%, Poland 0.0% 02-11-20 117 212
Benelux + Denmark SARS-CoV-2 B.1.177.77 variant Belgium 27.0%, Denmark 20.0%, Germany 13.0%, Luxembourg 13.0%, Netherlands 11.0% 19-06-20 704 ###
Big indian lineage, exports to Zambia, Bahrain and Canada SARS-CoV-2 B.1.1.306 variant India 83.0%, United Kingdom 10.0%, United States of America 3.0%, Zambia 1.0%, Bahrain 0.0% 12-01-20 ### ###
Bolivia/ Spain lineage SARS-CoV-2 B.1.600 variant Spain 56.0%, Bolivia 16.0%, Chile 7.0%, Germany 4.0%, Argentina 3.0% 04-04-20 78 103
Brazil mostly, absorbed B.1.1.94 and B.1.1.143 SARS-CoV-2 B.1.1.28 variant Brazil 67.0%, United States of America 11.0%, United Kingdom 7.0%, Japan 2.0%, Portugal 2.0% 03-03-20 874 ###
Brazilian lineage SARS-CoV-2 B.1.1.393 variant Brazil 57.0%, Singapore 29.0%, United States of America 14.0% 04-11-20 4 7
Brazillian SARS-CoV-2 B.1.1.33 variant Brazil 82.0%, United States of America 5.0%, Chile 4.0%, Uruguay 2.0%, Canada 1.0% 01-03-20 935 ###
Brazillian Lineage SARS-CoV-2 B.1.1.332 variant Brazil 100.0% 01-07-20 7 12
Canada SARS-CoV-2 B.1.36.36 variant Canada 100.0%, Australia 0.0% 08-09-20 555 557
Canada SARS-CoV-2 B.1.36.37 variant Canada 98.0%, United Kingdom 2.0%, United_Arab_Emirates 1.0% 17-10-20 114 123
Canada SARS-CoV-2 B.1.350 variant Canada 91.0%, United States of America 2.0%, Portugal 2.0%, Spain 2.0%, Denmark 1.0% 13-03-20 191 251
Canada SARS-CoV-2 B.1.547 variant Panama 48.0%, Canada 42.0%, Peru 5.0%, Brazil 2.0%, United States of America 2.0% 13-03-20 16 40
Canada SARS-CoV-2 B.1.615 variant Canada 100.0% 26-07-20 22 24
Canada (BC) SARS-CoV-2 B.1.573 variant 162 0
Canada (from NY) SARS-CoV-2 B.1.598 variant Canada 98.0%, United States of America 2.0% 30-03-20 37 47
Canada lineage SARS-CoV-2 B.1.1.417 variant Canada 93.0%, United States of America 4.0%, United Kingdom 1.0%, Senegal 1.0%, Turkey 1.0% 23-06-20 64 119
Canada lineage SARS-CoV-2 B.1.316 variant Canada 100.0% 29-04-20 5 7
Canada lineage SARS-CoV-2 B.1.369.1 variant Canada 96.0%, United States of America 4.0% 29-12-20 25 26
Canada lineage SARS-CoV-2 B.1.438.1 variant Canada 91.0%, United States of America 6.0%, United_Arab_Emirates 1.0%, United Kingdom 1.0%, Germany 1.0% 16-09-20 454 348
Canada lineage SARS-CoV-2 B.1.564.1 variant Canada 98.0%, United States of America 2.0%, Australia 0.0% 23-08-20 150 251
Canada lineage SARS-CoV-2 B.1.611 variant Canada 96.0%, France 4.0% 09-06-20 23 24
Canada mostly SARS-CoV-2 B.1.422 variant Canada 80.0%, United States of America 16.0%, Germany 1.0%, Ireland 1.0%, Spain 1.0% 11-03-20 423 570
Canada, England SARS-CoV-2 B.1.167 variant United Kingdom 42.0%, Canada 32.0%, United States of America 19.0%, Brazil 6.0% 27-03-20 21 31
Canada/UK SARS-CoV-2 B.1.36.38 variant Canada 73.0%, United Kingdom 12.0%, Belgium 6.0%, United States of America 3.0%, India 2.0% 08-06-20 215 309
Canadian lineage SARS-CoV-2 B.1.1.121 variant Canada 69.0%, United States of America 28.0%, Russia 1.0%, United Kingdom 0.0%, Spain 0.0% 01-06-20 85 278
Canadian lineage SARS-CoV-2 B.1.1.157 variant Canada 100.0% 20-05-20 192 678
Canadian lineage SARS-CoV-2 B.1.1.176 variant Canada 99.0%, United States of America 0.0%, Singapore 0.0%, Belgium 0.0%, Monaco 0.0% 12-03-20 319 888
Canadian lineage SARS-CoV-2 B.1.1.343 variant Canada 100.0% 09-11-20 8 13
Canadian lineage SARS-CoV-2 B.1.1.464 variant United States of America 97.0%, Switzerland 1.0%, United Kingdom 1.0%, Israel 1.0%, Australia 0.0% 20-03-20 421 520
Canadian lineage SARS-CoV-2 B.1.36.18 variant Canada 94.0%, India 4.0%, New_Zealand 1.0%, Hong_Kong 0.0%, United States of America 0.0% 25-08-20 369 866
Canadian lineage SARS-CoV-2 B.1.147 variant Canada 86.0%, Belize 4.0%, United Kingdom 3.0%, France 3.0%, Belgium 2.0% 04-03-20 758 ###
Canadian lineage SARS-CoV-2 B.1.270 variant Canada 100.0% 18-03-20 20 24
Canadian lineage SARS-CoV-2 B.1.279 variant Canada 99.0%, United States of America 1.0%, South_Africa 0.0% 15-03-20 ### ###
Canadian lineage SARS-CoV-2 B.1.592 variant Canada 100.0% 30-03-20 24 23
Canda / USA SARS-CoV-2 B.1.36.26 variant Canada 95.0%, United Kingdom 4.0%, United States of America 1.0% 26-08-20 86 158
Canda, Switzerland and DRC SARS-CoV-2 B.1.128 variant Canada 93.0%, Democratic Republic of the Congo 3.0%, Switzerland 3.0%, United Kingdom 0.0%, France 0.0% 13-03-20 ### ###
Central Europe SARS-CoV-2 B.1.1.347 variant Austria 52.0%, Germany 25.0%, United Kingdom 12.0%, Romania 5.0%, United States of America 2.0% 19-07-20 11 40
Central Europe lineage SARS-CoV-2 B.1.1.297 variant Germany 46.0%, Belgium 30.0%, Luxembourg 13.0%, Netherlands 8.0%, France 1.0% 16-07-20 196 382
Chilean Lineage SARS-CoV-2 B.1.1.324 variant Chile 100.0% 22-05-20 12 18
Chilean/ US and Australia lineage SARS-CoV-2 B.1.110 variant Chile 55.0%, United States of America 37.0%, Argentina 5.0%, Australia 3.0%, New_Zealand 0.0% 02-03-20 195 218
Chilean/ US lineage SARS-CoV-2 B.1.110.1 variant Chile 90.0%, United States of America 10.0% 18-03-20 9 10
Chinese Lineage SARS-CoV-2 B.1.1.330 variant China 94.0%, Indonesia 6.0% 02-01-21 15 16
Colombian lineage SARS-CoV-2 B.1.420 variant Colombia 63.0%, United States of America 36.0%, United Kingdom 1.0% 11-03-20 29 76
Colorado lineage from pango-designation issue #37 SARS-CoV-2 B.1.429.1 variant United States of America 100.0% 02-12-20 28 61
Columbian lineage SARS-CoV-2 B.1.1.388 variant Colombia 92.0%, Ecuador 8.0% 26-04-20 5 12
Congo/ Cameroon/ USA lineage SARS-CoV-2 B.1.544 variant United States of America 88.0%, Republic_of_the_Congo 9.0%, Canada 2.0%, France 1.0%, Cameroon 1.0% 25-06-20 51 126
Congo/ France lineage SARS-CoV-2 B.1.214.1 variant Republic_of_the_Congo 77.0%, France 23.0% 05-12-20 21 35
Costa Rica SARS-CoV-2 B.1.291 variant Costa_Rica 90.0%, United States of America 8.0%, Australia 2.0% 28-03-20 40 49
Costa Rica and Florida SARS-CoV-2 B.1.1.328 variant Costa_Rica 57.0%, United States of America 39.0%, Poland 4.0% 11-06-20 10 46
Costa Rica lineage SARS-CoV-2 B.1.1.389 variant Costa_Rica 90.0%, Spain 5.0%, United States of America 4.0%, Australia 1.0% 01-06-20 87 138
Costa Rica lineage SARS-CoV-2 B.1.1.516 variant Costa_Rica 100.0% 02-06-20 8 14
Curacao SARS-CoV-2 B.1.22.1 variant Curacao 81.0%, Sint_Eustatius 12.0%, France 6.0% 07-09-20 31 32
Curacao and Aruba SARS-CoV-2 B.1.240.1 variant Aruba 50.0%, Curaçao 37.0%, Netherlands 8.0%, Canada 5.0% 04-08-20 28 38
Czech lineage SARS-CoV-2 B.1.1.266 variant Czech_Republic 47.0%, United Kingdom 21.0%, Germany 7.0%, Switzerland 5.0%, Austria 4.0% 23-05-20 75 81
Czech Republic/ Ukraine lineage SARS-CoV-2 B.1.527 variant Estonia 33.0%, Czech_Republic 18.0%, Germany 9.0%, United States of America 7.0%, Finland 5.0% 24-03-20 69 188
Danish SARS-CoV-2 B.1.118 variant Denmark 100.0% 09-03-20 108 114
Danish SARS-CoV-2 B.1.177.12 variant Denmark 100.0%, Latvia 0.0%, Spain 0.0%, Germany 0.0%, Switzerland 0.0% 30-03-20 ### ###
Danish SARS-CoV-2 B.1.177.27 variant Denmark 100.0% 12-10-20 21 100
Danish SARS-CoV-2 B.1.177.42 variant Denmark 87.0%, Sweden 13.0%, Croatia 0.0%, Republic of Serbia 0.0%, Norway 0.0% 26-10-20 643 ###
Danish SARS-CoV-2 B.1.177.76 variant Denmark 92.0%, Spain 5.0%, Sweden 3.0%, France 1.0%, United Kingdom 0.0% 01-10-20 189 398
Danish SARS-CoV-2 B.1.263 variant Denmark 94.0%, United States of America 6.0% 19-03-20 17 18
Danish and swedish SARS-CoV-2 B.1.177.41 variant Sweden 54.0%, Denmark 43.0%, Norway 2.0%, United Kingdom 1.0%, Iceland 0.0% 20-09-20 123 343
Danish Lineage SARS-CoV-2 B.1.1.288 variant Denmark 98.0%, United Kingdom 1.0%, Turkey 0.0%, France 0.0%, Germany 0.0% 20-07-20 484 511
Danish lineage SARS-CoV-2 B.1.177.70 variant Denmark 99.0%, France 1.0% 09-11-20 109 169
Danish lineage SARS-CoV-2 B.1.221.3 variant Denmark 99.0%, Germany 0.0%, Netherlands 0.0%, Switzerland 0.0% 14-09-20 858 ###
Danish lineage SARS-CoV-2 B.1.258.9 variant Denmark 99.0%, Australia 1.0%, Switzerland 1.0% 31-08-20 181 199
Danish lineage SARS-CoV-2 B.1.258.11 variant Denmark 98.0%, Luxembourg 0.0%, Germany 0.0%, Switzerland 0.0%, Belgium 0.0% 14-09-20 ### ###
Danish lineage SARS-CoV-2 B.1.258.15 variant Denmark 100.0% 23-11-20 43 47
Danish lineage SARS-CoV-2 B.1.258.19 variant Denmark 100.0% 23-11-20 113 139
Danish lineage SARS-CoV-2 B.1.358 variant Denmark 95.0%, United States of America 5.0% 01-04-20 19 21
Danish lineage SARS-CoV-2 B.1.372 variant Denmark 93.0%, United Kingdom 3.0%, Sweden 2.0%, Finland 1.0% 30-03-20 90 91
Danish lineage (amalgam of Danish sequences from B.1.358, B.1.288, B.1.262) SARS-CoV-2 B.1.428 variant Qatar 62.0%, Denmark 32.0%, Australia 2.0%, United States of America 1.0%, Sweden 1.0% 03-03-20 333 955
Danish lineage (amalgam of Danish sequences from B.1.358, B.1.288, B.1.262), split out from B.1.428 SARS-CoV-2 B.1.613 variant Denmark 100.0% 06-04-20 37 37
Danish lineage, contains some previous B.1.177.1 SARS-CoV-2 B.1.177.24 variant Denmark 98.0%, Sweden 1.0%, Spain 0.0%, Iceland 0.0%, Norway 0.0% 17-08-20 609 747
Danish lineage. SARS-CoV-2 B.1.214.4 variant Denmark 100.0% 25-01-21 88 110
Danish, some Israel more recently SARS-CoV-2 B.1.177.35 variant Denmark 66.0%, Sweden 23.0%, Israel 8.0%, Finland 1.0%, Germany 1.0% 17-10-20 656 ###
Danish/ Norway lineage SARS-CoV-2 B.1.177.14 variant Denmark 55.0%, Norway 43.0%, United Kingdom 1.0%, Spain 1.0% 29-07-20 134 139
Danish/ USA lineage, previously part of B.1.21 SARS-CoV-2 B.1.371 variant United States of America 100.0%, Turkey 0.0%, Denmark 0.0%, Ecuador 0.0% 08-03-20 717 757
Demark SARS-CoV-2 B.1.36.33 variant Denmark 73.0%, Sweden 9.0%, United Kingdom 5.0%, Belgium 4.0%, Qatar 2.0% 23-05-20 102 132
Denmark SARS-CoV-2 B.1.1.191 variant Denmark 100.0% 17-08-20 206 1
Denmark SARS-CoV-2 B.1.1.272 variant Denmark 92.0%, United Kingdom 5.0%, Canada 2.0%, Poland 1.0%, United States of America 1.0% 17-08-20 184 190
Denmark SARS-CoV-2 B.1.1.377 variant Denmark 100.0%, United States of America 0.0% 19-10-20 423 715
Denmark SARS-CoV-2 B.1.36.25 variant Denmark 100.0%, United Kingdom 0.0% 12-10-20 329 466
Denmark SARS-CoV-2 B.1.39 variant Denmark 91.0%, Iceland 3.0%, Singapore 2.0%, United Kingdom 2.0%, New_Zealand 1.0% 09-03-20 227 250
Denmark SARS-CoV-2 B.1.127 variant Denmark 98.0%, Sweden 2.0%, Switzerland 0.0% 26-10-20 359 488
Denmark SARS-CoV-2 B.1.160.8 variant Denmark 90.0%, Sweden 7.0%, France 3.0%, Belgium 0.0%, Iceland 0.0% 05-10-20 507 763
Denmark SARS-CoV-2 B.1.160.17 variant Denmark 99.0%, France 1.0% 09-11-20 504 569
Denmark SARS-CoV-2 B.1.160.24 variant Denmark 96.0%, Sweden 4.0% 23-11-20 151 218
Denmark SARS-CoV-2 B.1.177.21 variant Denmark 96.0%, Sweden 3.0%, Germany 1.0%, United Kingdom 0.0%, Iceland 0.0% 24-08-20 ### ###
Denmark SARS-CoV-2 B.1.179 variant Denmark 86.0%, United States of America 4.0%, United Kingdom 4.0%, Germany 2.0%, Kenya 1.0% 09-03-20 215 251
Denmark SARS-CoV-2 B.1.254 variant United Kingdom 100.0% 06-04-20 26 39
Denmark SARS-CoV-2 B.1.343 variant Denmark 81.0%, United States of America 7.0%, Poland 5.0%, Latvia 2.0%, Germany 2.0% 09-03-20 40 43
Denmark SARS-CoV-2 B.1.534 variant Denmark 96.0%, India 1.0%, United States of America 1.0%, United Kingdom 1.0% 17-05-20 56 83
Denmark SARS-CoV-2 B.1.536 variant Denmark 100.0% 26-10-20 27 42
Denmark (some German) SARS-CoV-2 B.1.1.224 variant Denmark 76.0%, Lithuania 12.0%, Germany 10.0%, United States of America 1.0% 31-08-20 52 68
Denmark and Sweden SARS-CoV-2 B.1.488 variant Sweden 80.0%, Denmark 20.0% 13-07-20 5 5
Denmark and Switzerland, some B.1.1.281 SARS-CoV-2 B.1.1.433 variant Denmark 87.0%, Croatia 3.0%, Switzerland 2.0%, Slovenia 2.0%, United Kingdom 2.0% 09-08-20 399 666
Denmark lineage SARS-CoV-2 B.1.1.100 variant Denmark 100.0% 21-09-20 24 25
Denmark Lineage SARS-CoV-2 B.1.1.298 variant Denmark 100.0%, Faroe_Islands 0.0% 20-04-20 958 ###
Denmark lineage SARS-CoV-2 B.1.1.346 variant Denmark 100.0% 21-09-20 34 34
Denmark/ Luxemboug lineage SARS-CoV-2 B.1.474 variant Sweden 50.0%, Luxembourg 20.0%, Denmark 18.0%, France 7.0%, Switzerland 3.0% 21-09-20 148 456
DRC lineage SARS-CoV-2 B.1.84 variant Democratic Republic of the Congo 92.0%, Zambia 6.0%, France 3.0% 31-03-20 35 36
DRC lineage SARS-CoV-2 B.1.149 variant Slovenia 41.0%, Democratic Republic of the Congo 21.0%, United Kingdom 14.0%, Netherlands 10.0%, Switzerland 7.0% 17-03-20 69 135
DRC lineage SARS-CoV-2 B.1.178 variant Democratic Republic of the Congo 60.0%, France 20.0%, South_Africa 4.0%, Hong_Kong 4.0%, Malaysia 4.0% 15-03-20 19 25
DRC with some UAE and England SARS-CoV-2 B.1.1.275 variant Democratic Republic of the Congo 51.0%, Angola 24.0%, United Kingdom 14.0%, United_Arab_Emirates 8.0%, Germany 3.0% 19-03-20 26 37
DRC/ Congo lineage SARS-CoV-2 B.1.214 variant Democratic Republic of the Congo 46.0%, Switzerland 20.0%, Republic_of_the_Congo 10.0%, Belgium 8.0%, Uganda 6.0% 18-04-20 45 80
Dutch SARS-CoV-2 B.1.177.34 variant Netherlands 93.0%, Germany 7.0% 06-12-20 12 15
Dutch SARS-CoV-2 B.1.177.36 variant Netherlands 97.0%, Switzerland 3.0% 25-08-20 35 65
Dutch SARS-CoV-2 B.1.177.38 variant Netherlands 94.0%, Austria 2.0%, Sweden 1.0%, Spain 1.0%, United Kingdom 1.0% 11-09-20 41 88
Dutch SARS-CoV-2 B.1.177.40 variant Netherlands 83.0%, Denmark 9.0%, Spain 3.0%, Belgium 2.0%, Germany 1.0% 15-08-20 126 184
Dutch, Central Europe SARS-CoV-2 B.1.1.71 variant Netherlands 34.0%, United Kingdom 16.0%, United_Arab_Emirates 9.0%, Australia 7.0%, Belgium 7.0% 06-03-20 126 148
Eastern Europe SARS-CoV-2 B.1.164 variant Latvia 57.0%, Belarus 17.0%, Norway 7.0%, Germany 5.0%, Australia 5.0% 24-04-20 55 60
Eastern Europe plus Belgium and Denmark SARS-CoV-2 B.1.1.325 variant Denmark 58.0%, Belgium 11.0%, Turkey 8.0%, Lithuania 8.0%, Ukraine 5.0% 16-07-20 31 38
Eastern Europe, Central Europe, UK SARS-CoV-2 B.1.1.243 variant Lithuania 58.0%, Norway 7.0%, Ukraine 6.0%, United Kingdom 6.0%, Denmark 5.0% 24-04-20 76 227
Ecuador and US SARS-CoV-2 B.1.1.411 variant United States of America 68.0%, Ecuador 20.0%, Switzerland 6.0%, Spain 2.0%, Denmark 2.0% 22-03-20 20 50
Egypt UAE SARS-CoV-2 B.1.170 variant United States of America 31.0%, France 16.0%, Egypt 13.0%, United_Arab_Emirates 11.0%, United Kingdom 5.0% 19-03-20 38 55
Emergent lineage in Arizona with a number of defining amino acid mutations, including S:E484K and S:V213G. Described in Skidmore et al 2021. https://www.medrxiv.org/content/10.1101/2021.03.26.21254367v1.full.pdf. SARS-CoV-2 B.1.243.1 variant 16 0
England SARS-CoV-2 B.1.1.1 variant United Kingdom 61.0%, United States of America 5.0%, Peru 4.0%, Belgium 3.0%, Spain 2.0% 05-03-20 ### ###
England SARS-CoV-2 B.1.1.8 variant United Kingdom 68.0%, United States of America 18.0%, India 5.0%, Australia 2.0%, Singapore 1.0% 15-03-20 224 275
England SARS-CoV-2 B.1.1.12 variant United Kingdom 91.0%, Lithuania 8.0%, Czech_Republic 1.0%, Bangladesh 1.0% 02-06-20 77 119
England SARS-CoV-2 B.1.1.89 variant United Kingdom 98.0%, Australia 2.0% 21-03-20 87 80
England SARS-CoV-2 B.1.1.97 variant United Kingdom 94.0%, India 3.0%, Germany 3.0% 06-05-20 25 36
England SARS-CoV-2 B.1.1.107 variant United Kingdom 100.0% 06-06-20 24 31
England SARS-CoV-2 B.1.1.130 variant United Kingdom 100.0% 31-07-20 34 64
England SARS-CoV-2 B.1.1.147 variant United Kingdom 100.0% 04-06-20 8 12
England SARS-CoV-2 B.1.1.165 variant United Kingdom 100.0% 28-08-20 51 65
England SARS-CoV-2 B.1.1.178 variant United Kingdom 100.0% 02-04-20 22 24
England SARS-CoV-2 B.1.1.193 variant United Kingdom 100.0% 30-09-20 7 9
England SARS-CoV-2 B.1.1.194 variant United Kingdom 81.0%, India 8.0%, Germany 3.0%, Poland 2.0%, Russia 2.0% 13-03-20 83 116
England SARS-CoV-2 B.1.1.213 variant United Kingdom 98.0%, Togo 2.0% 13-03-20 37 47
England SARS-CoV-2 B.1.1.227 variant United Kingdom 100.0% 13-06-20 121 228
England SARS-CoV-2 B.1.1.361 variant United Kingdom 100.0% 04-06-20 14 21
England SARS-CoV-2 B.1.1.365 variant United Kingdom 99.0%, Sri_Lanka 1.0% 01-06-20 94 176
England SARS-CoV-2 B.1.1.369 variant United Kingdom 98.0%, Iceland 1.0%, Uganda 0.0%, Canada 0.0%, Australia 0.0% 02-03-20 ### ###
England SARS-CoV-2 B.1.1.372 variant United Kingdom 89.0%, Russia 2.0%, United States of America 2.0%, Switzerland 2.0%, Germany 1.0% 11-03-20 876 ###
England SARS-CoV-2 B.1.36.12 variant United Kingdom 99.0%, Turkey 1.0% 12-06-20 87 102
England SARS-CoV-2 B.1.97 variant United Kingdom 100.0% 24-03-20 31 39
England SARS-CoV-2 B.1.104 variant United Kingdom 83.0%, United States of America 12.0%, Singapore 3.0%, Canada 1.0%, Colombia 0.0% 02-03-20 169 247
England SARS-CoV-2 B.1.105 variant United Kingdom 95.0%, Italy 3.0%, United States of America 1.0%, Mexico 1.0% 06-03-20 79 102
England SARS-CoV-2 B.1.160.23 variant United Kingdom 99.0%, Hungary 1.0%, United States of America 1.0% 07-09-20 142 186
England SARS-CoV-2 B.1.165 variant United Kingdom 76.0%, United States of America 24.0% 27-04-20 46 89
England SARS-CoV-2 B.1.173 variant United Kingdom 97.0%, Netherlands 3.0% 16-05-20 25 37
England SARS-CoV-2 B.1.177.10 variant United Kingdom 88.0%, Spain 6.0%, Italy 4.0%, Belgium 1.0%, Switzerland 1.0% 02-09-20 658 ###
England SARS-CoV-2 B.1.177.20 variant United Kingdom 99.0%, Germany 1.0%, New_Zealand 0.0%, Ireland 0.0% 21-03-20 422 619
England SARS-CoV-2 B.1.177.30 variant United Kingdom 100.0%, Germany 0.0% 23-10-20 216 338
England SARS-CoV-2 B.1.177.47 variant United Kingdom 89.0%, Spain 8.0%, Gibraltar 2.0%, Turkey 2.0% 27-10-20 43 65
England SARS-CoV-2 B.1.240.2 variant United Kingdom 97.0%, Canada 3.0% 24-08-20 27 33
England SARS-CoV-2 B.1.249 variant United Kingdom 100.0% 09-03-20 14 16
England SARS-CoV-2 B.1.250 variant United Kingdom 97.0%, Singapore 3.0% 12-03-20 63 67
England SARS-CoV-2 B.1.251 variant United Kingdom 100.0% 01-06-20 36 45
England SARS-CoV-2 B.1.350.1 variant United Kingdom 100.0% 25-05-20 7 7
England SARS-CoV-2 B.1.491 variant United Kingdom 100.0% 14-03-20 18 17
England SARS-CoV-2 B.1.531 variant United Kingdom 100.0% 09-10-20 11 1
England SARS-CoV-2 B.1.532 variant United Kingdom 100.0% 04-07-20 106 161
England (previously part of B.1.369 that jumped to a new part of the tree – could also be withdrawn). SARS-CoV-2 B.1.607 variant United Kingdom 81.0%, United States of America 19.0% 29-03-20 18 21
England + Europe SARS-CoV-2 B.1.389 variant United Kingdom 85.0%, Denmark 4.0%, Germany 2.0%, Switzerland 2.0%, Belgium 1.0% 24-05-20 590 680
England and Denmark SARS-CoV-2 B.1.1.425 variant Denmark 57.0%, United Kingdom 33.0%, India 5.0%, Germany 5.0% 05-06-20 18 21
England and Ecuador SARS-CoV-2 B.1.1.203 variant United Kingdom 80.0%, Russia 7.0%, Ecuador 7.0%, Denmark 3.0%, United_Arab_Emirates 3.0% 11-04-20 17 30
England and Ireland SARS-CoV-2 B.1.177.55 variant United Kingdom 74.0%, Ireland 21.0%, Italy 2.0%, Switzerland 1.0%, Germany 1.0% 28-08-20 286 418
England and South Africa SARS-CoV-2 B.1.1.67 variant United Kingdom 90.0%, Latvia 5.0%, Japan 2.0%, United States of America 1.0%, South_Africa 1.0% 18-03-20 146 236
England base, to Ireland SARS-CoV-2 B.1.562 variant Ireland 67.0%, United Kingdom 23.0%, Netherlands 4.0%, Denmark 2.0%, Pakistan 2.0% 10-10-20 21 52
England Lineage SARS-CoV-2 B.1.1.3 variant United Kingdom 100.0% 18-03-20 89 110
England with Global records SARS-CoV-2 B.1.36.24 variant United Kingdom 78.0%, Germany 8.0%, Denmark 6.0%, Singapore 1.0%, India 1.0% 04-06-20 98 142
England, Australia, Sweden, Norway SARS-CoV-2 B.1.480 variant Denmark 47.0%, Sweden 14.0%, Germany 11.0%, United Kingdom 8.0%, Australia 7.0% 03-07-20 59 284
England, Ireland, Northern Ireland, Northern Europe SARS-CoV-2 B.1.1.234 variant United Kingdom 75.0%, Germany 10.0%, Ireland 7.0%, Austria 3.0%, France 3.0% 27-07-20 56 59
England, Northern Europe SARS-CoV-2 B.1.1.355 variant United Kingdom 84.0%, United States of America 11.0%, Belgium 3.0%, Germany 3.0% 22-09-20 49 37
England, Russia, Latvia SARS-CoV-2 B.1.1.162 variant Latvia 25.0%, United Kingdom 25.0%, Russia 17.0%, Iceland 8.0%, Germany 8.0% 21-03-20 10 12
England, some Wales SARS-CoV-2 B.1.177.19 variant United Kingdom 98.0%, Germany 1.0%, Ireland 0.0%, New_Zealand 0.0%, India 0.0% 03-09-20 351 563
England, some Wales, parent is mainland Europe SARS-CoV-2 B.1.177.18 variant United Kingdom 95.0%, Ireland 3.0%, United States of America 1.0%, Spain 1.0%, Italy 0.0% 14-09-20 513 799
England, Thailand, Russia, USA SARS-CoV-2 B.1.1.274 variant United Kingdom 43.0%, United States of America 23.0%, Russia 13.0%, Thailand 4.0%, Spain 2.0% 03-04-20 88 198
England, USA, Russia, Germany SARS-CoV-2 B.1.1.370 variant Russia 42.0%, United States of America 23.0%, Japan 16.0%, United Kingdom 9.0%, Madagascar 2.0% 05-04-20 21 43
Engligh lineage SARS-CoV-2 B.1.1.41 variant United Kingdom 100.0% 21-03-20 131 153
English SARS-CoV-2 B.1.1.155 variant United Kingdom 100.0% 02-06-20 13 14
English lineage SARS-CoV-2 B.1.1.4 variant United Kingdom 100.0% 31-03-20 177 331
English lineage SARS-CoV-2 B.1.1.55 variant United Kingdom 97.0%, Japan 3.0% 12-04-20 46 76
English lineage SARS-CoV-2 B.1.1.92 variant United Kingdom 100.0% 07-06-20 13 30
English lineage SARS-CoV-2 B.1.1.95 variant United Kingdom 100.0% 18-05-20 25 31
English Lineage SARS-CoV-2 B.1.1.149 variant United Kingdom 100.0% 01-05-20 33 61
English Lineage SARS-CoV-2 B.1.1.279 variant United Kingdom 98.0%, France 1.0%, India 0.0%, Hong_Kong 0.0%, Portugal 0.0% 21-03-20 544 895
English Lineage SARS-CoV-2 B.1.76 variant United Kingdom 97.0%, Italy 1.0%, South_Africa 1.0% 01-03-20 51 79
English lineage SARS-CoV-2 B.1.77 variant United Kingdom 96.0%, United States of America 4.0% 18-05-20 17 24
English Lineage SARS-CoV-2 B.1.160.7 variant United Kingdom 100.0%, Denmark 0.0%, Italy 0.0% 03-10-20 321 401
English lineage SARS-CoV-2 B.1.177.2 variant United Kingdom 93.0%, Ireland 5.0%, Belgium 2.0%, Denmark 0.0% 03-09-20 157 214
English lineage with some Australian, New Zealand and European sequences SARS-CoV-2 B.1.153 variant United Kingdom 21.0%, India 14.0%, United States of America 12.0%, Germany 10.0%, Turkey 8.0% 24-01-20 43 277
English Welsh lineage SARS-CoV-2 B.1.177.15 variant United Kingdom 98.0%, Sweden 0.0%, Belgium 0.0%, Hong_Kong 0.0%, Italy 0.0% 01-09-20 990 ###
Equatorial Guinea SARS-CoV-2 B.1.192 variant Equatorial_Guinea 100.0% 21-04-20 97 107
Eruopean lineage SARS-CoV-2 B.1.1.58 variant Germany 43.0%, Switzerland 17.0%, Slovenia 13.0%, Indonesia 10.0%, Macedonia 7.0% 08-04-20 52 143
Europe, Turkey, Iran SARS-CoV-2 B.1.1.413 variant United States of America 67.0%, United Kingdom 33.0% 15-06-20 39 3
European (Turkey, Denmark, UK) SARS-CoV-2 B.1.469 variant United Kingdom 31.0%, Germany 22.0%, Turkey 19.0%, Denmark 9.0%, Switzerland 6.0% 01-04-20 97 232
European lineage SARS-CoV-2 B.1.1.5 variant Belgium 44.0%, United Kingdom 22.0%, Iceland 12.0%, Austria 4.0%, Germany 4.0% 16-03-20 95 113
European lineage SARS-CoV-2 B.1.1.10 variant United Kingdom 60.0%, Iceland 7.0%, United States of America 6.0%, Canada 4.0%, Ireland 3.0% 01-03-20 538 763
European Lineage SARS-CoV-2 B.1.1.70 variant Denmark 25.0%, Switzerland 21.0%, Germany 17.0%, Slovenia 8.0%, United Kingdom 5.0% 06-03-20 ### ###
European lineage SARS-CoV-2 B.1.1.159 variant Denmark 25.0%, Latvia 9.0%, Germany 8.0%, Lithuania 8.0%, United Kingdom 7.0% 14-08-20 76 160
European lineage SARS-CoV-2 B.1.1.189 variant Turkey 34.0%, Germany 17.0%, United Kingdom 15.0%, Switzerland 10.0%, Denmark 9.0% 11-04-20 246 582
European lineage SARS-CoV-2 B.1.1.218 variant United Kingdom 58.0%, Denmark 14.0%, Germany 11.0%, Switzerland 5.0%, Belgium 4.0% 11-05-20 63 76
European lineage SARS-CoV-2 B.1.1.241 variant France 34.0%, United Kingdom 25.0%, Madagascar 6.0%, Belgium 6.0%, Denmark 6.0% 30-07-20 196 260
European lineage SARS-CoV-2 B.1.1.269 variant United Kingdom 39.0%, Spain 17.0%, France 12.0%, Denmark 11.0%, Switzerland 7.0% 19-05-20 351 430
European lineage SARS-CoV-2 B.1.1.277 variant Denmark 48.0%, United Kingdom 18.0%, Switzerland 8.0%, Norway 5.0%, Germany 5.0% 17-03-20 938 ###
European lineage SARS-CoV-2 B.1.1.521 variant Germany 44.0%, Turkey 16.0%, Switzerland 13.0%, United Kingdom 9.0%, Denmark 9.0% 15-05-20 95 193
European lineage SARS-CoV-2 B.1.131 variant United Kingdom 27.0%, Germany 18.0%, Denmark 17.0%, Norway 8.0%, United States of America 6.0% 27-05-20 62 106
European lineage SARS-CoV-2 B.1.177.51 variant Switzerland 43.0%, Italy 19.0%, United Kingdom 15.0%, Spain 6.0%, Denmark 5.0% 07-10-20 84 148
European lineage SARS-CoV-2 B.1.177.52 variant Portugal 36.0%, United Kingdom 26.0%, Germany 18.0%, Luxembourg 4.0%, Netherlands 3.0% 18-08-20 277 507
European lineage SARS-CoV-2 B.1.220 variant Netherlands 48.0%, United Kingdom 27.0%, France 11.0%, Canada 3.0%, Reunion 3.0% 14-03-20 77 79
European lineage SARS-CoV-2 B.1.221 variant Netherlands 20.0%, Germany 16.0%, Denmark 14.0%, Belgium 11.0%, Sweden 9.0% 09-02-20 ### ###
European lineage SARS-CoV-2 B.1.258.17 variant Slovenia 68.0%, Switzerland 9.0%, Germany 9.0%, Sweden 6.0%, Austria 2.0% 28-08-20 420 ###
European lineage SARS-CoV-2 B.1.277 variant Portugal 41.0%, United Kingdom 34.0%, Iceland 9.0%, France 6.0%, Belgium 3.0% 04-03-20 30 32
European lineage SARS-CoV-2 B.1.398 variant Denmark 46.0%, Germany 15.0%, Lebanon 8.0%, United Kingdom 7.0%, Saudi_Arabia 5.0% 27-03-20 198 313
European lineage (mostly France and England) SARS-CoV-2 B.1.367 variant United Kingdom 34.0%, France 19.0%, Switzerland 12.0%, Denmark 8.0%, Italy 7.0% 07-07-20 571 812
European lineage with 3 clear SNPs `28881GA`,`28882GA`,`28883GC` SARS-CoV-2 B.1.1 variant United Kingdom 36.0%, United States of America 12.0%, Japan 7.0%, Germany 5.0%, Russia 4.0% 16-02-20 ### ###
European lineage within diversity of B.1.416. Previously assigned E.1 SARS-CoV-2 B.1.416.1 variant Switzerland 41.0%, United Kingdom 18.0%, Spain 13.0%, France 9.0%, Mayotte 7.0% 24-07-20 325 506
European sublinage highly represented in Turkey SARS-CoV-2 B.1.9.5 variant Turkey 27.0%, Germany 13.0%, Switzerland 11.0%, United Kingdom 9.0%, Denmark 8.0% 14-03-20 110 150
European wide lineage with active cases with activity in Switzerland SARS-CoV-2 B.1.9.4 variant Germany 87.0%, Switzerland 4.0%, Denmark 3.0%, United Kingdom 2.0%, Norway 2.0% 09-07-20 24 156
European wide lineage with active sublineages SARS-CoV-2 B.1.9 variant Netherlands 24.0%, Turkey 23.0%, Belgium 18.0%, Germany 10.0%, United Kingdom 7.0% 14-03-20 120 136
European, mostly dutch and spanish, some north american SARS-CoV-2 B.1.356 variant Spain 21.0%, Netherlands 20.0%, United Kingdom 18.0%, France 16.0%, United States of America 9.0% 28-02-20 425 501
European/Denmark SARS-CoV-2 B.1.36.1 variant Switzerland 32.0%, Sweden 24.0%, Germany 11.0%, United Kingdom 8.0%, Norway 6.0% 01-07-20 260 767
European/Switzerland SARS-CoV-2 B.1.36.35 variant Switzerland 64.0%, United Kingdom 11.0%, Norway 10.0%, Germany 7.0%, Denmark 3.0% 01-09-20 125 353
Finland SARS-CoV-2 B.1.463 variant Finland 98.0%, United States of America 2.0%, Denmark 1.0% 10-09-20 121 123
Finland lineage SARS-CoV-2 B.1.158 variant Finland 100.0% 13-03-20 6 18
Finland. SARS-CoV-2 B.1.490 variant Finland 100.0% 20-04-20 9 10
France lineage, pango-designation issue #31 SARS-CoV-2 B.1.616 variant France 100.0% 29-01-21 8 28
France, Algeria (previously part of B.1.367 that jumped to a new part of the tree) SARS-CoV-2 B.1.597 variant France 38.0%, Spain 24.0%, Tunisia 8.0%, Algeria 6.0%, Ireland 5.0% 24-03-20 36 66
France, Belgium and Mayotte lineage. SARS-CoV-2 B.1.214.3 variant Belgium 39.0%, France 19.0%, Switzerland 15.0%, Mayotte 9.0%, Spain 4.0% 14-12-20 58 99
France/ West African lineage SARS-CoV-2 B.1.482 variant Cote_d’Ivoire 33.0%, France 33.0%, Japan 22.0%, Ghana 11.0% 17-03-20 7 9
French Guiana SARS-CoV-2 B.1.160.25 variant French_Guiana 85.0%, France 12.0%, Germany 2.0%, Brazil 1.0% 16-12-20 65 86
French lineage SARS-CoV-2 B.1.159 variant France 68.0%, Germany 12.0%, Bangladesh 5.0%, Democratic Republic of the Congo 5.0%, Canada 3.0% 17-03-20 61 65
French lineage SARS-CoV-2 B.1.177.78 variant France 98.0%, Germany 2.0% 23-10-20 77 95
French lineage SARS-CoV-2 B.1.208 variant France 83.0%, United Kingdom 13.0%, United States of America 4.0% 15-03-20 21 23
French lineage SARS-CoV-2 B.1.273 variant France 90.0%, Cote_d’Ivoire 5.0%, Republic_of_the_Congo 5.0% 13-03-20 19 20
French lineage SARS-CoV-2 B.1.387 variant France 96.0%, Switzerland 4.0% 06-03-20 24 25
French lineage SARS-CoV-2 B.1.529 variant France 95.0%, Italy 5.0% 02-04-20 18 19
Gambia SARS-CoV-2 B.1.292 variant Gambia 93.0%, United States of America 7.0% 01-04-20 14 14
Gambia and Switzerland SARS-CoV-2 B.1.1.242 variant Gambia 61.0%, Switzerland 35.0%, United Kingdom 4.0% 21-07-20 18 23
Gambian lineage SARS-CoV-2 B.1.1.466 variant Gambia 100.0% 04-06-20 42 43
Germain and Austrian lineage SARS-CoV-2 B.1.1.271 variant Austria 69.0%, Germany 31.0% 11-03-20 16 16
German SARS-CoV-2 B.1.329 variant Germany 100.0% 20-05-20 223 230
German and Danish lineage SARS-CoV-2 B.1.177.86 variant Germany 48.0%, Denmark 32.0%, Sweden 17.0%, Switzerland 1.0%, Austria 0.0% 21-09-20 ### ###
German lineage SARS-CoV-2 B.1.1.338 variant Germany 98.0%, Switzerland 2.0% 02-12-20 31 54
German Lineage SARS-CoV-2 B.1.1.385 variant Germany 88.0%, France 7.0%, Switzerland 3.0%, Croatia 1.0%, Denmark 1.0% 11-09-20 18 277
German lineage SARS-CoV-2 B.1.1.515 variant Germany 92.0%, United States of America 4.0%, Taiwan 2.0%, United Kingdom 2.0% 16-03-20 35 51
German lineage SARS-CoV-2 B.1.221.2 variant Germany 95.0%, Israel 3.0%, Luxembourg 1.0%, United Kingdom 1.0%, Norway 0.0% 21-03-20 29 218
German lineage SARS-CoV-2 B.1.475 variant Germany 88.0%, United States of America 12.0% 05-04-20 7 8
Germany lineage SARS-CoV-2 B.1.1.405 variant Germany 92.0%, Russia 8.0% 14-09-20 11 12
Germany, Switzerland, Netherlands SARS-CoV-2 B.1.177.62 variant Germany 77.0%, Netherlands 10.0%, Switzerland 9.0%, Lithuania 2.0%, Belgium 0.0% 23-10-20 61 747
Germany/ UK lineage SARS-CoV-2 B.1.406 variant Germany 57.0%, Denmark 22.0%, Switzerland 7.0%, Sweden 6.0%, United Kingdom 5.0% 06-07-20 101 143
Ghana and Denmark SARS-CoV-2 B.1.1.359 variant Ghana 66.0%, Denmark 21.0%, Burkina_Faso 7.0%, United States of America 3.0%, Togo 3.0% 06-07-20 11 29
Ghana, Burkina Faso, Luxembourg, Germany SARS-CoV-2 B.1.1.404 variant Burkina_Faso 45.0%, Germany 27.0%, Ghana 9.0%, Togo 6.0%, Cote_d’Ivoire 3.0% 25-05-20 20 33
Ghanan Lineage SARS-CoV-2 B.1.1.485 variant United States of America 47.0%, Ghana 28.0%, Peru 12.0%, Russia 4.0%, United Kingdom 1.0% 09-04-20 22 83
Gibralter lineage SARS-CoV-2 B.1.177.25 variant Gibraltar 93.0%, Spain 5.0%, United Kingdom 2.0% 14-10-20 41 41
Global lineage (inc. merge of B.1.274) SARS-CoV-2 B.1.441 variant United Kingdom 31.0%, United States of America 28.0%, Kuwait 13.0%, Denmark 6.0%, India 5.0% 16-03-20 65 85
Global lineage containing two new sublineages (see below) SARS-CoV-2 B.1.466 variant Egypt 29.0%, Sweden 17.0%, Italy 14.0%, Germany 6.0%, United Kingdom 6.0% 30-04-20 18 35
Global many subliniages (see below) SARS-CoV-2 B.1.36 variant India 26.0%, Canada 15.0%, United Kingdom 13.0%, Denmark 8.0%, Hong_Kong 5.0% 16-02-20 ### ###
Hong Kong lineage SARS-CoV-2 B.1.1.63 variant Hong_Kong 82.0%, Japan 8.0%, Australia 3.0%, Malaysia 1.0%, South_Korea 1.0% 24-06-20 112 554
Hong Kong lineage, initially associated with travellers from Nepal. Epidemiologically and phylogenetically supported. SARS-CoV-2 B.1.36.27 variant Hong_Kong 99.0%, Thailand 1.0%, South_Korea 0.0% 18-09-20 15 318
Huge UK lineage SARS-CoV-2 B.1.1.311 variant United Kingdom 99.0%, Denmark 0.0%, Ireland 0.0%, Norway 0.0%, Japan 0.0% 25-07-20 ### ###
Hungarian lineage SARS-CoV-2 B.1.1.87 variant Hungary 100.0% 10-04-20 15 15
Iceland SARS-CoV-2 B.1.177.45 variant Iceland 100.0%, Switzerland 0.0%, Italy 0.0%, Denmark 0.0%, Sweden 0.0% 13-08-20 ### ###
Iceland, Sweden, North America (could be dissolved) SARS-CoV-2 B.1.510 variant Denmark 32.0%, Iceland 16.0%, Sweden 16.0%, Norway 11.0%, United States of America 5.0% 07-03-20 16 19
Icelandic SARS-CoV-2 B.1.1.17 variant Iceland 93.0%, Madagascar 2.0%, United States of America 2.0%, Germany 2.0%, Reunion 2.0% 06-03-20 29 56
India SARS-CoV-2 B.1.36.29 variant India 88.0%, United Kingdom 5.0%, Singapore 1.0%, United States of America 1.0%, Canada 1.0% 29-01-20 329 ###
India SARS-CoV-2 B.1.184 variant India 100.0% 18-06-20 14 16
India SARS-CoV-2 B.1.247 variant India 86.0%, United States of America 4.0%, Germany 4.0%, Argentina 2.0%, Switzerland 2.0% 04-05-20 40 50
India SARS-CoV-2 B.1.458 variant India 69.0%, United States of America 31.0% 25-04-20 9 13
India SARS-CoV-2 B.1.537 variant India 97.0%, United States of America 3.0% 24-05-20 20 31
India SARS-CoV-2 B.1.538 variant India 97.0%, Canada 3.0% 16-05-20 24 38
India SARS-CoV-2 B.1.540 variant India 92.0%, United States of America 1.0%, Panama 1.0%, Switzerland 1.0%, United Kingdom 1.0% 27-03-20 34 73
India SARS-CoV-2 B.1.548 variant India 96.0%, Germany 4.0% 04-04-20 24 25
India SARS-CoV-2 B.1.560 variant India 94.0%, United States of America 2.0%, Germany 2.0%, Bahrain 1.0%, Australia 1.0% 13-05-20 49 102
India and Singapore and Texas SARS-CoV-2 B.1.1.201 variant India 53.0%, United States of America 18.0%, Singapore 18.0%, United Kingdom 12.0% 29-04-20 17 17
India lineage in West Bengal, pango-designation issue #46 SARS-CoV-2 B.1.618 variant India 95.0%, United States of America 1.0%, Germany 1.0%, Singapore 1.0%, Turkey 1.0% 25-10-20 81 141
Indian Lineage SARS-CoV-2 B.1.1.326 variant India 97.0%, Germany 1.0%, United Kingdom 1.0%, Bahrain 0.0%, Canada 0.0% 23-03-20 378 492
Indian Lineage SARS-CoV-2 B.1.1.340 variant India 87.0%, Japan 4.0%, Spain 4.0%, United States of America 4.0% 06-04-20 19 23
Indian lineage SARS-CoV-2 B.1.1.414 variant India 100.0% 14-07-20 7 7
Indian lineage SARS-CoV-2 B.1.113 variant India 98.0%, Indonesia 2.0% 03-06-20 61 62
Indian lineage SARS-CoV-2 B.1.143 variant India 83.0%, United Kingdom 4.0%, Bulgaria 4.0%, United States of America 4.0%, Estonia 2.0% 28-03-20 33 53
Indian lineage SARS-CoV-2 B.1.145 variant India 100.0% 21-04-20 13 14
Indian lineage SARS-CoV-2 B.1.210 variant India 90.0%, Japan 3.0%, United Kingdom 3.0%, Australia 1.0%, Luxembourg 1.0% 10-03-20 319 367
Indian lineage (two US) SARS-CoV-2 B.1.1.101 variant India 62.0%, United States of America 31.0%, United Kingdom 3.0%, Russia 1.0%, Turkey 1.0% 31-03-20 47 89
Indonesia SARS-CoV-2 B.1.459 variant Indonesia 54.0%, Papua_New_Guinea 24.0%, Japan 7.0%, Singapore 4.0%, Australia 2.0% 17-03-20 85 204
Indonesia SARS-CoV-2 B.1.466.2 variant Indonesia 48.0%, Papua_New_Guinea 14.0%, Australia 14.0%, Singapore 10.0%, Malaysia 7.0% 12-11-20 47 566
Indonesia/Sinagpore. Seq names missassigned in original file SARS-CoV-2 B.1.468 variant Indonesia 47.0%, Singapore 19.0%, Saudi_Arabia 10.0%, India 6.0%, United Kingdom 3.0% 13-02-20 56 125
Indonesia/Singapore SARS-CoV-2 B.1.470 variant Indonesia 69.0%, Singapore 6.0%, South_Korea 6.0%, Japan 5.0%, Turkey 3.0% 30-03-20 112 354
International lineage with E484K, del69-70 among other defining mutations. SARS-CoV-2 B.1.525 variant Denmark 19.0%, United States of America 19.0%, Germany 13.0%, United Kingdom 11.0%, France 9.0% 11-12-20 135 ###
International lineage with spike mutation Q677H, parent of lineage R.1 and R.2 which have additional mutations including E484K mutation SARS-CoV-2 B.1.1.316 variant United States of America 97.0%, Mexico 2.0%, Canada 1.0%, Spain 0.0%, Turkey 0.0% 17-05-20 189 790
Iraq SARS-CoV-2 B.1.428.1 variant Iraq 64.0%, Qatar 36.0% 27-04-20 29 45
Ireland SARS-CoV-2 B.1.177.59 variant Ireland 92.0%, Iceland 3.0%, United Kingdom 3.0%, Belgium 3.0% 05-09-20 13 38
Ireland SARS-CoV-2 B.1.177.64 variant Ireland 82.0%, Switzerland 9.0%, Denmark 9.0% 04-01-21 5 11
Ireland andNorthern Ireland SARS-CoV-2 B.1.177.39 variant Ireland 57.0%, Denmark 29.0%, United Kingdom 6.0%, Australia 3.0%, Spain 2.0% 02-09-20 45 65
Irish lineage SARS-CoV-2 B.1.1.267 variant Ireland 100.0% 24-03-20 85 92
Irish lineage SARS-CoV-2 B.1.1.399 variant Ireland 90.0%, Nigeria 10.0% 15-04-20 8 10
Irish lineage SARS-CoV-2 B.1.177.66 variant Ireland 100.0% 23-10-20 22 24
Irish lineage SARS-CoV-2 B.1.177.67 variant Ireland 97.0%, United Kingdom 2.0%, Australia 1.0% 05-11-20 47 124
Irish lineage SARS-CoV-2 B.1.177.68 variant Ireland 86.0%, United Kingdom 14.0% 05-12-20 12 76
Irish lineage (has sub-lineage G.1) SARS-CoV-2 B.1.258.2 variant Ireland 86.0%, United Kingdom 14.0%, Norway 0.0% 03-07-20 202 222
Israel and England (was B.1.3.3) SARS-CoV-2 B.1.504 variant Israel 90.0%, United Kingdom 10.0% 19-04-20 26 29
Israel and england (was B.1.3.4) SARS-CoV-2 B.1.505 variant Canada 72.0%, United Kingdom 20.0%, Israel 8.0%, Turkey 1.0% 15-03-20 44 172
Israel and Palestine SARS-CoV-2 B.1.1.50 variant Israel 87.0%, Palestine 5.0%, United Kingdom 4.0%, Denmark 1.0%, United States of America 1.0% 29-03-20 530 ###
Israel and UK SARS-CoV-2 B.1.115 variant Israel 53.0%, United Kingdom 32.0%, United States of America 15.0% 17-03-20 30 34
Israel lineage SARS-CoV-2 B.1.362 variant Israel 83.0%, United States of America 12.0%, United Kingdom 4.0%, Switzerland 1.0%, France 0.0% 03-04-20 176 553
Italian lineage SARS-CoV-2 B.1.177.75 variant Italy 57.0%, Germany 31.0%, Switzerland 4.0%, United Kingdom 2.0%, Bulgaria 1.0% 02-09-20 243 738
Italian lineage SARS-CoV-2 B.1.177.83 variant Italy 63.0%, Germany 18.0%, Croatia 12.0%, Netherlands 2.0%, Sweden 2.0% 25-08-20 148 505
Italian lineage SARS-CoV-2 B.1.258.14 variant Italy 75.0%, Germany 14.0%, Switzerland 9.0%, Netherlands 1.0%, Denmark 1.0% 06-10-20 79 457
Italian lineage SARS-CoV-2 B.1.258.24 variant Italy 85.0%, Germany 15.0% 21-12-20 30 34
Italian lineage from pango-designation issue #19 SARS-CoV-2 B.1.177.88 variant Italy 99.0%, Sweden 1.0% 01-12-20 22 70
Italy SARS-CoV-2 B.1.1.202 variant Italy 100.0% 10-05-20 12 11
Ivory Coast lineage SARS-CoV-2 B.1.388 variant Cote_d’Ivoire 78.0%, Burkina_Faso 22.0% 10-06-20 8 9
Japan SARS-CoV-2 B.1.1.48 variant Japan 99.0%, United Kingdom 1.0%, United States of America 0.0% 27-03-20 19 316
Japan SARS-CoV-2 B.1.1.214 variant Japan 100.0%, South_Korea 0.0%, Switzerland 0.0%, Australia 0.0%, Cambodia 0.0% 22-02-20 103 ###
Japan SARS-CoV-2 B.1.1.283 variant Japan 100.0% 16-03-20 10 39
Japan SARS-CoV-2 B.1.1.284 variant Japan 100.0%, South_Korea 0.0%, Australia 0.0%, Hong_Kong 0.0%, Thailand 0.0% 22-05-20 139 ###
Japan/ USA lineage SARS-CoV-2 B.1.1.285 variant Japan 80.0%, United States of America 17.0%, Mexico 2.0%, Belgium 2.0%, South_Korea 1.0% 25-03-20 47 133
Japanese lineage SARS-CoV-2 B.1.1.465 variant Japan 83.0%, Israel 17.0% 23-04-20 5 6
Jordan lineage SARS-CoV-2 B.1.1.312 variant Jordan 89.0%, United States of America 7.0%, Sweden 1.0%, Japan 1.0%, Turkey 0.0% 11-06-20 440 485
Jordan/Saudi Arbia (single recent record from USA) SARS-CoV-2 B.1.36.10 variant United States of America 48.0%, Jordan 8.0%, India 6.0%, France 6.0%, Saudi_Arabia 5.0% 26-02-20 111 793
Kenya SARS-CoV-2 B.1.530 variant Kenya 53.0%, United States of America 13.0%, Greece 6.0%, Indonesia 5.0%, Germany 4.0% 28-10-20 10 94
Kenya + England SARS-CoV-2 B.1.549 variant Kenya 72.0%, United Kingdom 26.0%, Canada 1.0% 26-06-20 32 76
Kenyan lineage SARS-CoV-2 B.1.596.1 variant United States of America 62.0%, Kenya 28.0%, Australia 7.0%, Finland 3.0% 03-08-20 8 29
Large European lineage SARS-CoV-2 B.1.177.81 variant Germany 38.0%, Netherlands 32.0%, United Kingdom 7.0%, Denmark 5.0%, France 4.0% 10-08-20 ### ###
Large European lineage, sequences from BeNeLuX, Denmark, Switzerland, Hungary and UK. SARS-CoV-2 B.1.160 variant Denmark 17.0%, France 17.0%, Switzerland 12.0%, United Kingdom 9.0%, Germany 8.0% 27-01-20 ### ###
Latvia and Finland SARS-CoV-2 B.1.1.429 variant Latvia 96.0%, Denmark 1.0%, Finland 1.0%, Estonia 1.0%, Belgium 1.0% 15-09-20 22 158
Latvian lineage SARS-CoV-2 B.1.1.350 variant Latvia 80.0%, India 7.0%, Hungary 7.0%, United States of America 7.0% 23-03-20 13 15
Latvian lineage SARS-CoV-2 B.1.177.79 variant Lithuania 45.0%, Latvia 37.0%, Denmark 10.0%, Sweden 3.0%, Estonia 2.0% 17-08-20 28 ###
Lineage circulating in multiple countries SARS-CoV-2 B.1.438 variant United Kingdom 28.0%, Denmark 19.0%, United_Arab_Emirates 18.0%, Turkey 12.0%, Luxembourg 6.0% 08-06-20 62 85
Lineage circulating in multiple countries with a number of variants of concern (Spike D614G, Spike D796H, Spike E484K, Spike P681H, Spike T95I, Spike Y144del). pango-designation issue #15 SARS-CoV-2 B.1.1.318 variant United States of America 37.0%, United Kingdom 22.0%, Germany 10.0%, Greece 4.0%, Switzerland 4.0% 07-01-21 15 651
Lineage from Belgium with a number of key spike mutations and a 9bp spike insertion. SARS-CoV-2 B.1.214.2 variant Belgium 47.0%, Switzerland 20.0%, France 18.0%, Republic_of_the_Congo 3.0%, Indonesia 3.0% 22-11-20 352 983
Lineage in multiple countries, potentially originated in Cameroon and introduced into Europe, pango-designation issue #44 SARS-CoV-2 B.1.619 variant 43 0
Lineage in multiple countries, potentially originated in Cameroon and spread within Europe post-introduction, pango-designation issue #54 SARS-CoV-2 B.1.620 variant Lithuania 33.0%, France 23.0%, Germany 14.0%, United Kingdom 8.0%, Belgium 7.0% 06-02-21 37 132
Lineage of concern detected in South Africa SARS-CoV-2 B.1.351 variant South_Africa 17.0%, Germany 10.0%, France 10.0%, United States of America 8.0%, Sweden 7.0% 11-05-20 ### ###
Lineage predominantly in Colombia with several spike mutations, pango-designation issue #57 SARS-CoV-2 B.1.621 variant Colombia 59.0%, United States of America 32.0%, Spain 6.0%, Denmark 2.0%, Netherlands 2.0% 11-01-21 12 123
Lineage reassigned. Withdrawn, merged with B.1.1.115 SARS-CoV-2 B.1.1.235 variant 0 0
Lineage reassigned. Withdrawn, now part of B.1.177.17 SARS-CoV-2 B.1.177.13 variant 0 0
Lineage reassigned. Withdrawn: Alias F.1 New Zealand lineage SARS-CoV-2 B.1.36.17.1 variant 0 0
Lineage reassigned. Withdrawn: Alias of B.1.1.1.15, Denmark lineage SARS-CoV-2 C.15 variant 0 0
Lineage reassigned. Withdrawn: Argentinian lineage SARS-CoV-2 B.1.3.2 variant 0 0
Lineage reassigned. Withdrawn: Australian lineage SARS-CoV-2 B.1.25 variant 0 0
Lineage reassigned. Withdrawn: Australian/ New Zealand lineage SARS-CoV-2 B.1.197 variant 0 0
Lineage reassigned. Withdrawn: Bangladesh lineage SARS-CoV-2 B.1.1.80 variant 0 0
Lineage reassigned. Withdrawn: Bangladesh lineage SARS-CoV-2 B.1.1.103 variant 0 0
Lineage reassigned. Withdrawn: Brazil lineage SARS-CoV-2 B.1.1.94 variant 0 0
Lineage reassigned. Withdrawn: Brazilian lineage reassigned B.1.1.28 SARS-CoV-2 B.1.1.248 variant 0 0
Lineage reassigned. Withdrawn: Brazilian lineage, merged into lineage B.1.1.28 SARS-CoV-2 B.1.1.143 variant 0 0
Lineage reassigned. Withdrawn: Brazilian lineage, previously part of B.1.1.33 SARS-CoV-2 B.1.1.314 variant 0 0
Lineage reassigned. Withdrawn: Colombian lineage, reassigned B.1.420 SARS-CoV-2 B.1.5.32 variant 0 0
Lineage reassigned. Withdrawn: Danish lineage SARS-CoV-2 B.1.36.3 variant 0 0
Lineage reassigned. Withdrawn: Danish lineage SARS-CoV-2 B.1.36.14 variant 0 0
Lineage reassigned. Withdrawn: Danish lineage SARS-CoV-2 B.1.160.5 variant 0 0
Lineage reassigned. Withdrawn: Danish lineage SARS-CoV-2 B.1.258.8 variant 0 0
Lineage reassigned. Withdrawn: Danish lineage, reassigned B.1.160 lack of resolution in current tree SARS-CoV-2 B.1.160.6 variant 0 0
Lineage reassigned. Withdrawn: Denmark SARS-CoV-2 B.1.177.1 variant 0 0
Lineage reassigned. Withdrawn: Denmark/ E European lineage SARS-CoV-2 B.1.1.167 variant 0 0
Lineage reassigned. Withdrawn: DRC and Senegal base, into Switzerland SARS-CoV-2 B.1.481 variant 0 0
Lineage reassigned. Withdrawn: England (all were B.1.275) SARS-CoV-2 B.1.477 variant 0 0
Lineage reassigned. Withdrawn: England and Denmark (was part of B.1.160) SARS-CoV-2 B.1.472 variant 0 0
Lineage reassigned. Withdrawn: England with a spanish base SARS-CoV-2 B.1.1.215 variant 0 0
Lineage reassigned. Withdrawn: England, split from B.1.117 SARS-CoV-2 B.1.519 variant 0 0
Lineage reassigned. Withdrawn: English lineage SARS-CoV-2 B.1.1.313 variant 0 0
Lineage reassigned. Withdrawn: English lineage SARS-CoV-2 B.1.152 variant 0 0
Lineage reassigned. Withdrawn: English lineage (now B.1.471) SARS-CoV-2 B.1.160.4 variant 0 0
Lineage reassigned. Withdrawn: English lineage, reassigned B.1 SARS-CoV-2 B.1.34 variant 0 0
Lineage reassigned. Withdrawn: France and USA (MI) SARS-CoV-2 B.1.484 variant 0 0
Lineage reassigned. Withdrawn: France lineage SARS-CoV-2 B.1.275 variant 0 0
Lineage reassigned. Withdrawn: French lineage SARS-CoV-2 B.1.258.1 variant 0 0
Lineage reassigned. Withdrawn: French, swiss, UK, Belgian SARS-CoV-2 B.1.1.211 variant 0 0
Lineage reassigned. Withdrawn: Gambian lineage SARS-CoV-2 B.1.1.293 variant 0 0
Lineage reassigned. Withdrawn: Iceland lineage SARS-CoV-2 B.1.419 variant 0 0
Lineage reassigned. Withdrawn: India (from B.1.247) SARS-CoV-2 B.1.461 variant 0 0
Lineage reassigned. Withdrawn: India (was part of B.1.160) SARS-CoV-2 B.1.454 variant 0 0
Lineage reassigned. Withdrawn: India and Nepal SARS-CoV-2 B.1.464 variant 0 0
Lineage reassigned. Withdrawn: Indian (split from B.1.1.32) SARS-CoV-2 B.1.1.179 variant 0 0
Lineage reassigned. Withdrawn: Indian (split from B.1.1.32) SARS-CoV-2 B.1.1.212 variant 0 0
Lineage reassigned. Withdrawn: Indian lineage SARS-CoV-2 B.1.1.32 variant 0 0
Lineage reassigned. Withdrawn: Indian lineage SARS-CoV-2 B.1.95 variant 0 0
Lineage reassigned. Withdrawn: Indian lineage reassigned B.1, lacks any structure in current tree SARS-CoV-2 B.1.5.35 variant 0 0
Lineage reassigned. Withdrawn: Indian lineage reassigned to B.1.136 SARS-CoV-2 B.1.5.36 variant 0 0
Lineage reassigned. Withdrawn: Indian lineage, previously part of B.1.1.32 SARS-CoV-2 B.1.1.281 variant 0 0
Lineage reassigned. Withdrawn: Indonesian lineage (now B.1.470) SARS-CoV-2 B.1.160.3 variant 0 0
Lineage reassigned. Withdrawn: Irish lineage SARS-CoV-2 B.1.36.13 variant 0 0
Lineage reassigned. Withdrawn: Israel lineage SARS-CoV-2 B.1.3.3 variant 0 0
Lineage reassigned. Withdrawn: Israel/ UK lineage SARS-CoV-2 B.1.3.4 variant 0 0
Lineage reassigned. Withdrawn: Latvian lineage SARS-CoV-2 B.1.1.102 variant 0 0
Lineage reassigned. Withdrawn: Luxembourg lineage SARS-CoV-2 B.1.109 variant 0 0
Lineage reassigned. Withdrawn: Netherlands lineage SARS-CoV-2 B.1.36.4 variant 0 0
Lineage reassigned. Withdrawn: Netherlands lineage SARS-CoV-2 B.1.36.11 variant 0 0
Lineage reassigned. Withdrawn: Netherlands lineage SARS-CoV-2 B.1.414 variant 0 0
Lineage reassigned. Withdrawn: Netherlands/ Europe lineage SARS-CoV-2 B.1.1.104 variant 0 0
Lineage reassigned. Withdrawn: North American lineage, with other global diversity (Now all over tree) SARS-CoV-2 B.1.255 variant 0 0
Lineage reassigned. Withdrawn: North Macedonia, Switzerland SARS-CoV-2 B.1.9.6 variant 0 0
Lineage reassigned. Withdrawn: North Macedonian lineage SARS-CoV-2 B.1.394 variant 0 0
Lineage reassigned. Withdrawn: Northern Europe (UK, NL, Switzerland) and Northern Africa (Egypt and Morocco), Gambia (some B.1.1.55) SARS-CoV-2 B.1.1.247 variant 0 0
Lineage reassigned. Withdrawn: Northern Ireland lineage SARS-CoV-2 B.1.1.60 variant 0 0
Lineage reassigned. Withdrawn: Northern Ireland lineage SARS-CoV-2 B.1.1.81 variant 0 0
Lineage reassigned. Withdrawn: Northern Ireland lineage, previously B.1.1.60 (split) SARS-CoV-2 B.1.1.245 variant 0 0
Lineage reassigned. Withdrawn: Norway lineage SARS-CoV-2 B.1.36.6 variant 0 0
Lineage reassigned. Withdrawn: Previously part of B.1.1.55, USA lineage SARS-CoV-2 B.1.1.276 variant 0 0
Lineage reassigned. Withdrawn: Reassigned B.1.180, Romanian lineage SARS-CoV-2 B.1.5.13 variant 0 0
Lineage reassigned. Withdrawn: Reassigned B.1.181, USA lineage SARS-CoV-2 B.1.5.17 variant 0 0
Lineage reassigned. Withdrawn: Reassigned B.1.185, USA lineage SARS-CoV-2 B.1.5.15 variant 0 0
Lineage reassigned. Withdrawn: Reassigned B.1.189, USA/ Mexico lineage SARS-CoV-2 B.1.5.11 variant 0 0
Lineage reassigned. Withdrawn: Reassigned B.1.190, Netherlands lineage SARS-CoV-2 B.1.5.2 variant 0 0
Lineage reassigned. Withdrawn: Reassigned B.1.225 SARS-CoV-2 B.1.5.5 variant 0 0
Lineage reassigned. Withdrawn: Reassigned B.1.229 SARS-CoV-2 B.1.5.25 variant 0 0
Lineage reassigned. Withdrawn: Reassigned B.1.231 SARS-CoV-2 B.1.5.28 variant 0 0
Lineage reassigned. Withdrawn: Reassigned B.1.232 SARS-CoV-2 B.1.5.26 variant 0 0
Lineage reassigned. Withdrawn: Reassigned B.1.256 SARS-CoV-2 B.1.5.18 variant 0 0
Lineage reassigned. Withdrawn: Reassigned B.1.418, Scottish lineage SARS-CoV-2 B.1.5.21 variant 0 0
Lineage reassigned. Withdrawn: Reassigned B.1.523 English lineage SARS-CoV-2 B.1.160.1 variant 0 0
Lineage reassigned. Withdrawn: Reassigned B.1.523 English lineage SARS-CoV-2 B.1.160.2 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Australian lineage SARS-CoV-2 B.1.295 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Austrian lineage SARS-CoV-2 B.1.266 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Bangladesh lineage SARS-CoV-2 B.1.374.1 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Canadian lineage SARS-CoV-2 B.1.114 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Canadian lineage SARS-CoV-2 B.1.183 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Canadian lineage SARS-CoV-2 B.1.297.1 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Canadian lineage SARS-CoV-2 B.1.345 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Canadian lineage, previously part of B.1.114 lineage SARS-CoV-2 B.1.347 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Danish lineage SARS-CoV-2 B.1.258.13 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Danish lineage SARS-CoV-2 B.1.262 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Danish lineage SARS-CoV-2 B.1.327 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Danish lineage SARS-CoV-2 B.1.410 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Danish lineage, with USA and UK sequences SARS-CoV-2 B.1.107 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Denmark lineage SARS-CoV-2 B.1.288 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. English lineage SARS-CoV-2 B.1.75 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Equatorial Guinea lineage SARS-CoV-2 B.1.226 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. European lineage SARS-CoV-2 B.1.353 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. European lineage SARS-CoV-2 B.1.374 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. France/ Australian lineage SARS-CoV-2 B.1.272 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Iceland lineage SARS-CoV-2 B.1.102 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Indian lineage SARS-CoV-2 B.1.80 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Indian lineage Reassigned from B.1.80, split this assignment SARS-CoV-2 B.1.217 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Indian lineage, split up and reassigned to B.1 SARS-CoV-2 B.1.136 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Irish lineage SARS-CoV-2 B.1.339 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Previously B.1.5.21, Scottish lineage SARS-CoV-2 B.1.191 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Previously part of B.1.98, reassigned UK lineage SARS-CoV-2 B.1.200 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Saudi Arabian lineage that previously was part of B.1.160 SARS-CoV-2 B.1.244 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Saudi Arabian lineage, previously some assigned B.1.160 SARS-CoV-2 B.1.246 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Scottish lineage SARS-CoV-2 B.1.90 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Scottish lineage SARS-CoV-2 B.1.156 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Scottish lineage, first wave of N439K SARS-CoV-2 B.1.141 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Slovenian lineage SARS-CoV-2 B.1.269 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Small Australian lineage SARS-CoV-2 B.1.138 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Small Portuguese lineage SARS-CoV-2 B.1.135 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. Swedish lineage SARS-CoV-2 B.1.373 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. UK lineage SARS-CoV-2 B.1.82 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. UK lineage SARS-CoV-2 B.1.89 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. UK lineage SARS-CoV-2 B.1.253 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. UK lineage SARS-CoV-2 B.1.257 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. UK/ Australia lineage, previously part of B.1.13 SARS-CoV-2 B.1.278 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. US lineage SARS-CoV-2 B.1.386 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage SARS-CoV-2 B.1.154 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage SARS-CoV-2 B.1.193 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage SARS-CoV-2 B.1.202 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage SARS-CoV-2 B.1.204 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage SARS-CoV-2 B.1.271 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage SARS-CoV-2 B.1.286 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage SARS-CoV-2 B.1.290 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage SARS-CoV-2 B.1.297 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage SARS-CoV-2 B.1.299 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage SARS-CoV-2 B.1.300 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage SARS-CoV-2 B.1.303 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage SARS-CoV-2 B.1.307 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage SARS-CoV-2 B.1.317 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage SARS-CoV-2 B.1.364 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage SARS-CoV-2 B.1.365 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage SARS-CoV-2 B.1.368 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage (CA) SARS-CoV-2 B.1.8.2 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage (CA) SARS-CoV-2 B.1.352 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage (previously B.1.5.15) SARS-CoV-2 B.1.185 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage (WA) SARS-CoV-2 B.1.133 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage, reassigned from B.1.5.27 split SARS-CoV-2 B.1.228 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA lineage, reassigned from B.1.5.27 split SARS-CoV-2 B.1.230 variant 0 0
Lineage reassigned. Withdrawn: Reassigned in the current tree. USA/ Australian lineage SARS-CoV-2 B.1.296 variant 0 0
Lineage reassigned. Withdrawn: Reassigned lineage SARS-CoV-2 B.1.1.73 variant 0 0
Lineage reassigned. Withdrawn: Reassigned lineage SARS-CoV-2 B.1.150 variant 0 0
Lineage reassigned. Withdrawn: Reassigned to B.1 and additional sublineages as this lineage has lost monophyletic status and split into multiple parts of the B.1 tree. Previously had a Spanish base, European lineage/ lots of Spanish sequences towards the basal end of the subtree and exports around the globe. SARS-CoV-2 B.1.5 variant 0 0
Lineage reassigned. Withdrawn: Reassigned to B.1.222, reassigned Scottish lineage SARS-CoV-2 B.1.5.34 variant 0 0
Lineage reassigned. Withdrawn: Reassigned to B.1.416, Senegal/ Gambia lineage SARS-CoV-2 B.1.5.12 variant 0 0
Lineage reassigned. Withdrawn: Russia SARS-CoV-2 B.1.1.246 variant 0 0
Lineage reassigned. Withdrawn: Russian lineage SARS-CoV-2 B.1.1.78 variant 0 0
Lineage reassigned. Withdrawn: Russian lineage SARS-CoV-2 B.1.1.79 variant 0 0
Lineage reassigned. Withdrawn: Russian lineage SARS-CoV-2 B.1.1.140 variant 0 0
Lineage reassigned. Withdrawn: Russian lineage SARS-CoV-2 B.1.412 variant 0 0
Lineage reassigned. Withdrawn: Saudi Arabia (mixture of B.1.260 and B.1.160) SARS-CoV-2 B.1.449 variant 0 0
Lineage reassigned. Withdrawn: Saudi Arabia (was part of B.1.247) SARS-CoV-2 B.1.455 variant 0 0
Lineage reassigned. Withdrawn: Saudi Arabia lineage SARS-CoV-2 B.1.36.15 variant 0 0
Lineage reassigned. Withdrawn: Saudi Arabia lineage, reassigned to parent lineage B.1.36 SARS-CoV-2 B.1.36.5 variant 0 0
Lineage reassigned. Withdrawn: Saudi Arabia/ India lineage (now in B.1.260) SARS-CoV-2 B.1.259 variant 0 0
Lineage reassigned. Withdrawn: Saudi Arabia/ Russia lineage SARS-CoV-2 B.1.1.96 variant 0 0
Lineage reassigned. Withdrawn: Saudi Arabian lineage SARS-CoV-2 B.1.447 variant 0 0
Lineage reassigned. Withdrawn: Saudi Arabian lineage (now in B.1.260) SARS-CoV-2 B.1.261 variant 0 0
Lineage reassigned. Withdrawn: Saudi-arabian/ Indian lineage (now B.1.260) SARS-CoV-2 B.1.186 variant 0 0
Lineage reassigned. Withdrawn: Scottish lineage SARS-CoV-2 B.1.88 variant 0 0
Lineage reassigned. Withdrawn: Small Scottish lineage SARS-CoV-2 B.1.209 variant 0 0
Lineage reassigned. Withdrawn: South Africa (formerly B.1.1.66) SARS-CoV-2 B.1.1.252 variant 0 0
Lineage reassigned. Withdrawn: South Africa (mostly from B.1.1.54) SARS-CoV-2 B.1.1.206 variant 0 0
Lineage reassigned. Withdrawn: South African lineage SARS-CoV-2 B.1.1.66 variant 0 0
Lineage reassigned. Withdrawn: South African lineage SARS-CoV-2 B.1.1.156 variant 0 0
Lineage reassigned. Withdrawn: South African lineage SARS-CoV-2 B.1.144 variant 0 0
Lineage reassigned. Withdrawn: South African lineage reassigned to B.1.381 SARS-CoV-2 B.1.5.19 variant 0 0
Lineage reassigned. Withdrawn: South African lineage, reassigned B.1.417 SARS-CoV-2 B.1.5.31 variant 0 0
Lineage reassigned. Withdrawn: South African lineage, reassigned to B.1.237 SARS-CoV-2 B.1.5.16 variant 0 0
Lineage reassigned. Withdrawn: South Korea SARS-CoV-2 B.1.1.183 variant 0 0
Lineage reassigned. Withdrawn: South Korean lineage SARS-CoV-2 B.1.3.1 variant 0 0
Lineage reassigned. Withdrawn: Spanish lineage SARS-CoV-2 B.1.74 variant 0 0
Lineage reassigned. Withdrawn: Split up in current tree, reassigned to B.1. UK lineage SARS-CoV-2 B.1.5.33 variant 0 0
Lineage reassigned. Withdrawn: Split up Washington (USA), reassigned mostly to B.1.371 SARS-CoV-2 B.1.21 variant 0 0
Lineage reassigned. Withdrawn: Turkish lineage SARS-CoV-2 B.1.1.105 variant 0 0
Lineage reassigned. Withdrawn: UK (split from B.1.1.64) SARS-CoV-2 B.1.1.199 variant 0 0
Lineage reassigned. Withdrawn: UK (split from B.1.1.64) SARS-CoV-2 B.1.1.259 variant 0 0
Lineage reassigned. Withdrawn: UK (split from B.1.1.64) SARS-CoV-2 B.1.1.260 variant 0 0
Lineage reassigned. Withdrawn: UK and Australia SARS-CoV-2 B.1.1.2 variant 0 0
Lineage reassigned. Withdrawn: UK and New Zealand (split from B.1.1.7) SARS-CoV-2 B.1.1.238 variant 0 0
Lineage reassigned. Withdrawn: UK lineage SARS-CoV-2 B.1.1.20 variant 0 0
Lineage reassigned. Withdrawn: UK lineage SARS-CoV-2 B.1.1.35 variant 0 0
Lineage reassigned. Withdrawn: UK lineage SARS-CoV-2 B.1.1.64 variant 0 0
Lineage reassigned. Withdrawn: UK lineage SARS-CoV-2 B.1.1.106 variant 0 0
Lineage reassigned. Withdrawn: UK lineage SARS-CoV-2 B.1.1.108 variant 0 0
Lineage reassigned. Withdrawn: UK lineage SARS-CoV-2 B.1.1.131 variant 0 0
Lineage reassigned. Withdrawn: UK lineage SARS-CoV-2 B.1.1.146 variant 0 0
Lineage reassigned. Withdrawn: UK lineage SARS-CoV-2 B.1.1.150 variant 0 0
Lineage reassigned. Withdrawn: UK lineage SARS-CoV-2 B.1.1.151 variant 0 0
Lineage reassigned. Withdrawn: UK lineage SARS-CoV-2 B.1.1.173 variant 0 0
Lineage reassigned. Withdrawn: UK lineage SARS-CoV-2 B.1.1.195 variant 0 0
Lineage reassigned. Withdrawn: UK lineage SARS-CoV-2 B.1.1.250 variant 0 0
Lineage reassigned. Withdrawn: UK lineage SARS-CoV-2 B.1.1.278 variant 0 0
Lineage reassigned. Withdrawn: UK lineage SARS-CoV-2 B.1.1.292 variant 0 0
Lineage reassigned. Withdrawn: UK lineage SARS-CoV-2 B.1.5.30 variant 0 0
Lineage reassigned. Withdrawn: UK lineage SARS-CoV-2 B.1.98 variant 0 0
Lineage reassigned. Withdrawn: UK lineage SARS-CoV-2 B.1.177.22 variant 0 0
Lineage reassigned. Withdrawn: UK lineage SARS-CoV-2 B.1.392 variant 0 0
Lineage reassigned. Withdrawn: UK lineage reassigned B.1.223 SARS-CoV-2 B.1.5.6 variant 0 0
Lineage reassigned. Withdrawn: UK lineage, reassigned B.1- broken up in current tree SARS-CoV-2 B.1.11 variant 0 0
Lineage reassigned. Withdrawn: UK lineage, some now reassigned to B.1.5 SARS-CoV-2 B.1.79 variant 0 0
Lineage reassigned. Withdrawn: UK, Australia, USA SARS-CoV-2 B.1.512 variant 0 0
Lineage reassigned. Withdrawn: UK, Norway, South Korea, Denmark (mostly B.1.160) SARS-CoV-2 B.1.457 variant 0 0
Lineage reassigned. Withdrawn: UK/ Switzerland lineage SARS-CoV-2 B.1.1.124 variant 0 0
Lineage reassigned. Withdrawn: UK/Australia lineage SARS-CoV-2 B.1.1.295 variant 0 0
Lineage reassigned. Withdrawn: USA SARS-CoV-2 B.1.1.36 variant 0 0
Lineage reassigned. Withdrawn: USA (MI) plus England (was B.1.247, B.1.160) SARS-CoV-2 B.1.457.1 variant 0 0
Lineage reassigned. Withdrawn: USA (TX) SARS-CoV-2 B.1.1.6 variant 0 0
Lineage reassigned. Withdrawn: USA (TX) split from B.1.2 SARS-CoV-2 B.1.514 variant 0 0
Lineage reassigned. Withdrawn: USA (WA) SARS-CoV-2 B.1.1.233 variant 0 0
Lineage reassigned. Withdrawn: USA lineage SARS-CoV-2 B.1.1.65 variant 0 0
Lineage reassigned. Withdrawn: USA lineage SARS-CoV-2 B.1.1.76 variant 0 0
Lineage reassigned. Withdrawn: USA lineage SARS-CoV-2 B.1.1.85 variant 0 0
Lineage reassigned. Withdrawn: USA lineage SARS-CoV-2 B.1.1.126 variant 0 0
Lineage reassigned. Withdrawn: USA lineage SARS-CoV-2 B.1.1.287 variant 0 0
Lineage reassigned. Withdrawn: USA lineage SARS-CoV-2 B.1.196 variant 0 0
Lineage reassigned. Withdrawn: USA lineage SARS-CoV-2 B.1.216 variant 0 0
Lineage reassigned. Withdrawn: USA lineage SARS-CoV-2 B.1.283 variant 0 0
Lineage reassigned. Withdrawn: USA lineage SARS-CoV-2 B.1.312 variant 0 0
Lineage reassigned. Withdrawn: USA lineage SARS-CoV-2 B.1.331 variant 0 0
Lineage reassigned. Withdrawn: USA lineage (All NM, one AZ) SARS-CoV-2 B.1.440 variant 0 0
Lineage reassigned. Withdrawn: USA lineage (CA), reassigned to B.1.243 SARS-CoV-2 B.1.5.27 variant 0 0
Lineage reassigned. Withdrawn: USA lineage (TX) SARS-CoV-2 B.1.207 variant 0 0
Lineage reassigned. Withdrawn: USA lineage (WA) (all B.1.169) SARS-CoV-2 B.1.333.1 variant 0 0
Lineage reassigned. Withdrawn: USA lineage (WI), reassigned B.1- broken up in current tree SARS-CoV-2 B.1.19 variant 0 0
Lineage reassigned. Withdrawn: USA lineage (WI/ IL) reassigned to B.1.415 SARS-CoV-2 B.1.5.29 variant 0 0
Lineage reassigned. Withdrawn: USA lineage, reassigned B.1 SARS-CoV-2 B.1.322 variant 0 0
Lineage reassigned. Withdrawn: USA, NZ, England, one Russia SARS-CoV-2 B.1.1.223 variant 0 0
Lineage reassigned. Withdrawn: USA/Gambia lineage SARS-CoV-2 B.1.26 variant 0 0
Lineage reassigned. Withdrawn: Wales lineage SARS-CoV-2 B.1.376 variant 0 0
Lineage reassigned. Withdrawn: Wales lineage, previously part of B.1.1.30 SARS-CoV-2 B.1.1.264 variant 0 0
Lineage reassigned. Withdrawn: Wales lineage, reassigned to B.1.1.29 SARS-CoV-2 B.1.1.439 variant 0 0
Lithuanian SARS-CoV-2 B.1.1.30 variant Lithuania 100.0% 18-05-20 13 13
Lithuanian lineage SARS-CoV-2 B.1.1.280 variant Lithuania 92.0%, Norway 2.0%, United Kingdom 2.0%, Germany 1.0%, Denmark 1.0% 30-07-20 181 294
Lithuanian lineage SARS-CoV-2 B.1.1.422 variant Lithuania 80.0%, Belarus 10.0%, Poland 10.0% 26-10-20 7 10
Luxembourg SARS-CoV-2 B.1.94 variant Luxembourg 58.0%, France 13.0%, United States of America 10.0%, Germany 6.0%, Italy 3.0% 15-03-20 20 31
Luxembourg SARS-CoV-2 B.1.160.21 variant Luxembourg 95.0%, Portugal 5.0% 24-11-20 35 43
Luxembourg lineage SARS-CoV-2 B.1.258.20 variant Luxembourg 48.0%, Belgium 20.0%, Portugal 17.0%, India 7.0%, Netherlands 2.0% 23-09-20 43 54
Luxembourg lineage (also England, Belgium etc.) SARS-CoV-2 B.1.12 variant Belgium 36.0%, United Kingdom 29.0%, Luxembourg 26.0%, France 4.0%, United States of America 3.0% 04-03-20 99 112
Mainly Russian SARS-CoV-2 B.1.1.506 variant Russia 92.0%, New_Zealand 4.0%, Germany 4.0% 14-05-20 22 24
Mainly Scotland SARS-CoV-2 B.1.36.20 variant United Kingdom 72.0%, Germany 19.0%, Denmark 5.0%, Netherlands 2.0%, Switzerland 2.0% 20-08-20 49 58
Major mostly European lineage, result of opening borders summer 2020 SARS-CoV-2 B.1.177 variant United Kingdom 65.0%, Spain 9.0%, Germany 5.0%, Switzerland 5.0%, Italy 4.0% 14-02-20 ### ###
Malaysian lineage SARS-CoV-2 B.1.524 variant Malaysia 54.0%, Singapore 19.0%, Turkey 17.0%, India 1.0%, Thailand 1.0% 01-09-20 202 477
Mayotte SARS-CoV-2 B.1.160.18 variant Mayotte 70.0%, Reunion 29.0%, France 1.0% 10-11-20 71 131
Mayotte SARS-CoV-2 B.1.160.27 variant Mayotte 98.0%, Reunion 2.0% 05-01-21 43 64
Mayotte and Reunion lineage SARS-CoV-2 B.1.438.2 variant Mayotte 82.0%, Reunion 18.0% 06-01-21 53 51
Mexico, Texas SARS-CoV-2 B.1.1.344 variant United States of America 60.0%, Mexico 36.0%, Australia 1.0%, South_Korea 1.0%, South_Africa 1.0% 09-04-20 49 77
Mexico/Southwest USA SARS-CoV-2 B.1.1.322 variant United States of America 75.0%, Mexico 25.0% 13-04-20 20 76
Moroccan lineage SARS-CoV-2 B.1.528 variant Morocco 100.0% 23-04-20 20 21
Mostly Argentina, some Spain, NL, Hong Kong (was B.1.3.2) SARS-CoV-2 B.1.499 variant Argentina 96.0%, United States of America 1.0%, Mexico 1.0%, Hong_Kong 1.0%, Japan 0.0% 16-03-20 294 715
Mostly India SARS-CoV-2 B.1.1.46 variant India 76.0%, United Kingdom 15.0%, Singapore 2.0%, United States of America 2.0%, Australia 2.0% 20-04-20 84 127
Mostly italian, some swiss, some english SARS-CoV-2 B.1.177.33 variant Italy 64.0%, United Kingdom 19.0%, Germany 7.0%, Switzerland 5.0%, Iceland 2.0% 02-09-20 196 344
Mostly Russia SARS-CoV-2 B.1.1.407 variant Russia 89.0%, Finland 5.0%, United States of America 5.0% 09-06-20 12 19
Mostly South Africa SARS-CoV-2 B.1.1.99 variant South_Africa 58.0%, United Kingdom 13.0%, Zambia 6.0%, Chile 6.0%, Russia 3.0% 29-03-20 21 31
Mostly South Africa SARS-CoV-2 B.1.1.254 variant South_Africa 28.0%, United Kingdom 18.0%, United States of America 14.0%, France 12.0%, Australia 7.0% 14-03-20 48 74
Mostly Switzerland SARS-CoV-2 B.1.160.15 variant Switzerland 91.0%, Germany 5.0%, France 2.0%, Canada 1.0%, Italy 1.0% 30-09-20 96 196
Mostly Switzerland SARS-CoV-2 B.1.160.16 variant Switzerland 97.0%, Portugal 1.0%, Germany 0.0%, France 0.0%, Austria 0.0% 30-09-20 508 890
Mostly Switzerland with lots of other countries SARS-CoV-2 B.1.1.39 variant Switzerland 69.0%, Germany 15.0%, United Kingdom 5.0%, Denmark 2.0%, Norway 1.0% 06-04-20 896 ###
Mostly Switzerland, a little Europe SARS-CoV-2 B.1.160.26 variant Switzerland 84.0%, France 6.0%, Portugal 3.0%, Luxembourg 2.0%, Germany 1.0% 25-09-20 194 405
Mostly UK lineage with other northern european plus one singapore SARS-CoV-2 B.1.1.257 variant United Kingdom 80.0%, Netherlands 11.0%, Portugal 3.0%, Singapore 3.0%, France 1.0% 02-03-20 69 76
Mostly US lineage with some UK and Canada (was B.1.1.304) SARS-CoV-2 B.1.1.434 variant United States of America 92.0%, United Kingdom 7.0%, Canada 0.0%, Israel 0.0%, India 0.0% 24-06-20 965 ###
Mozambique SARS-CoV-2 C.1.1 variant Mozambique 100.0% 25-11-20 12 12
Mozambique, was C.1.1 SARS-CoV-2 B.1.1.375 variant Mozambique 78.0%, United Kingdom 11.0%, Netherlands 4.0%, Chile 4.0%, Malawi 2.0% 21-10-20 47 55
Netherland, South Africa, Denmark, USA SARS-CoV-2 B.1.8 variant Netherlands 46.0%, United States of America 12.0%, Germany 10.0%, South_Africa 8.0%, Austria 5.0% 04-03-20 359 397
Netherlands SARS-CoV-2 B.1.1.112 variant Netherlands 100.0% 08-05-20 15 16
Netherlands SARS-CoV-2 B.1.1.122 variant Netherlands 52.0%, United States of America 12.0%, Chile 12.0%, Ukraine 8.0%, United Kingdom 4.0% 10-04-20 15 25
Netherlands SARS-CoV-2 B.1.1.209 variant Netherlands 68.0%, United Kingdom 31.0%, Denmark 1.0% 06-05-20 72 84
Netherlands SARS-CoV-2 B.1.310 variant Netherlands 93.0%, Israel 7.0% 01-04-20 15 15
Netherlands / Germany SARS-CoV-2 B.1.177.50 variant Spain 32.0%, Netherlands 20.0%, United Kingdom 17.0%, Germany 13.0%, Latvia 6.0% 07-03-20 101 595
Netherlands lineage SARS-CoV-2 B.1.1.185 variant Netherlands 92.0%, Iceland 8.0% 31-03-20 11 12
Netherlands lineage SARS-CoV-2 B.1.1.282 variant Netherlands 60.0%, Japan 17.0%, Turkey 17.0%, India 4.0%, Germany 1.0% 26-03-20 51 83
Netherlands lineage SARS-CoV-2 B.1.22 variant Netherlands 81.0%, Germany 5.0%, United Kingdom 3.0%, Hungary 2.0%, Australia 2.0% 05-03-20 591 637
Netherlands lineage SARS-CoV-2 B.1.78 variant Netherlands 95.0%, United Kingdom 3.0%, South_Africa 1.0%, Germany 1.0% 12-03-20 77 73
Netherlands lineage SARS-CoV-2 B.1.96 variant Netherlands 100.0% 01-04-20 40 41
Netherlands lineage SARS-CoV-2 B.1.160.13 variant Netherlands 93.0%, Germany 7.0% 18-09-20 22 27
Netherlands lineage SARS-CoV-2 B.1.177.73 variant Netherlands 83.0%, Germany 5.0%, Belgium 3.0%, Portugal 3.0%, Sweden 1.0% 12-04-20 424 ###
Netherlands lineage SARS-CoV-2 B.1.258.18 variant Netherlands 100.0% 05-10-20 10 10
Netherlands lineage SARS-CoV-2 B.1.258.21 variant Netherlands 96.0%, Belgium 2.0%, Poland 1.0%, Germany 1.0%, Mexico 1.0% 08-10-20 109 119
Netherlands, Spain, UK SARS-CoV-2 B.1.177.74 variant Netherlands 44.0%, Spain 31.0%, United Kingdom 19.0%, Switzerland 4.0%, Belgium 2.0% 01-11-20 26 54
New York. Sublineage of B.1.526 (with spike mutations T95I and D253G) that appears to have several more unique mutations. SARS-CoV-2 B.1.526.1 variant United States of America 100.0% 30-01-21 43 50
New York. Sublineage of B.1.526 (with spike mutations T95I and D253G) that appears to have several more unique mutations. SARS-CoV-2 B.1.526.2 variant United States of America 100.0%, Denmark 0.0%, Japan 0.0%, Sint_Maarten 0.0%, Switzerland 0.0% 08-12-20 85 ###
New Zealand SARS-CoV-2 B.1.545 variant New_Zealand 56.0%, United States of America 17.0%, Poland 6.0%, Germany 6.0%, France 6.0% 25-03-20 10 18
New Zealand / Australia SARS-CoV-2 B.1.23 variant Australia 81.0%, New_Zealand 16.0%, United States of America 1.0%, South_Africa 1.0%, Spain 1.0% 18-03-20 137 148
NI & Ireland Lineage SARS-CoV-2 B.1.1.74 variant United Kingdom 83.0%, Russia 6.0%, France 4.0%, United States of America 3.0%, Ireland 1.0% 25-03-20 114 272
Nigeria/Switzerland SARS-CoV-2 B.1.467 variant Nigeria 48.0%, Switzerland 38.0%, United Kingdom 14.0% 17-05-20 17 21
Nigerian Lineage SARS-CoV-2 B.1.1.484 variant Nigeria 100.0% 31-05-20 6 6
North American SARS-CoV-2 B.1.552 variant United States of America 53.0%, Canada 31.0%, Australia 13.0%, Iceland 2.0%, Singapore 2.0% 30-03-20 49 62
North American lineage SARS-CoV-2 B.1.314 variant United States of America 85.0%, Canada 8.0%, Iceland 2.0%, New_Zealand 1.0%, Australia 1.0% 13-03-20 111 143
North Macedonia SARS-CoV-2 B.1.1.430 variant Macedonia 65.0%, Norway 25.0%, Germany 5.0%, Switzerland 5.0% 11-06-20 14 20
Northen Ireland lineage SARS-CoV-2 B.1.1.119 variant United Kingdom 100.0% 15-04-20 18 31
Northern Europe SARS-CoV-2 B.1.513 variant Austria 71.0%, Germany 11.0%, United States of America 7.0%, Denmark 4.0%, United Kingdom 1.0% 09-03-20 71 73
Northern Europe (UK, Denmark, Norway, Sweden) SARS-CoV-2 B.1.1.219 variant Denmark 51.0%, Germany 11.0%, Iceland 8.0%, Poland 6.0%, Switzerland 5.0% 01-08-20 131 180
Northern Europe (UK, Germany, Denmark, Belgium, NL) SARS-CoV-2 B.1.1.232 variant Iceland 43.0%, Germany 20.0%, Belgium 10.0%, Netherlands 9.0%, United Kingdom 4.0% 28-03-20 373 484
Northern Europe, mostly Lithuania SARS-CoV-2 B.1.177.60 variant Lithuania 72.0%, Denmark 16.0%, Norway 3.0%, Latvia 3.0%, Germany 2.0% 01-09-20 412 ###
Northern Europe, split from B.1.1.257 SARS-CoV-2 B.1.1.323 variant United Kingdom 51.0%, Iceland 18.0%, Germany 13.0%, Netherlands 7.0%, Sweden 3.0% 29-02-20 61 71
Northern European Lineage SARS-CoV-2 B.1.1.153 variant Denmark 34.0%, Germany 14.0%, Poland 14.0%, Norway 7.0%, United Kingdom 6.0% 06-08-20 406 806
Northern Ireland SARS-CoV-2 B.1.557 variant United Kingdom 85.0%, Canada 4.0%, Ireland 2.0%, United States of America 2.0%, South_Korea 1.0% 07-03-20 14 256
Northern Ireland lineage SARS-CoV-2 B.1.1.160 variant United Kingdom 100.0% 03-05-20 6 10
Northern Irish lineage SARS-CoV-2 B.1.1.83 variant United Kingdom 96.0%, Russia 3.0%, United States of America 1.0%, Switzerland 1.0% 27-03-20 205 157
Northern Irish with English root SARS-CoV-2 B.1.1.310 variant United Kingdom 98.0%, United States of America 2.0% 15-05-20 46 65
Northern USA and Canada SARS-CoV-2 B.1.308 variant United States of America 93.0%, Canada 4.0%, Ecuador 4.0% 22-03-20 26 27
Norway lineage SARS-CoV-2 B.1.1.451 variant Norway 96.0%, United Kingdom 4.0% 10-10-20 9 23
Norway lineage SARS-CoV-2 B.1.36.21 variant Norway 99.0%, United Kingdom 1.0% 07-10-20 108 298
Norway lineage SARS-CoV-2 B.1.242 variant Norway 100.0% 19-06-20 44 45
Norwegian Lineage SARS-CoV-2 B.1.1.333 variant Norway 100.0%, Denmark 0.0%, United Kingdom 0.0% 21-09-20 111 662
Now all England, was US, so probably split from something SARS-CoV-2 B.1.1.309 variant United Kingdom 100.0% 11-08-20 96 153
Oceana SARS-CoV-2 B.1.36.19 variant Indonesia 58.0%, Singapore 25.0%, Australia 7.0%, India 3.0%, Hong_Kong 3.0% 17-06-20 32 73
Oman Lineage, some UAE SARS-CoV-2 B.1.1.27 variant Oman 91.0%, United_Arab_Emirates 4.0%, Uganda 4.0%, United Kingdom 1.0%, Bahrain 1.0% 21-03-20 133 169
Pan European SARS-CoV-2 B.1.1.305 variant United Kingdom 53.0%, Germany 18.0%, Switzerland 7.0%, Norway 7.0%, Italy 4.0% 22-06-20 119 182
Panama / Costa Rica SARS-CoV-2 B.1.203 variant Costa_Rica 67.0%, Panama 17.0%, Canada 8.0%, United States of America 8.0% 05-07-20 9 12
Pan-European, big scottish section SARS-CoV-2 B.1.1.44 variant United Kingdom 79.0%, Sweden 6.0%, Germany 4.0%, Denmark 3.0%, India 2.0% 28-02-20 200 389
Pan-US SARS-CoV-2 B.1.1.329 variant United States of America 87.0%, Canada 9.0%, Mexico 2.0%, United Kingdom 2.0%, Japan 1.0% 02-06-20 65 117
Peru lineage SARS-CoV-2 B.1.1.110 variant Peru 92.0%, Finland 8.0% 24-03-20 6 13
Peruvian SARS-CoV-2 B.1.1.381 variant Peru 59.0%, Chile 32.0%, United States of America 9.0% 04-05-20 7 22
Peruvian SARS-CoV-2 B.1.205 variant Peru 97.0%, Israel 3.0% 05-03-20 28 39
Poland SARS-CoV-2 C.10 variant Poland 100.0% 22-04-20 4 4
Polish lineage SARS-CoV-2 B.1.187 variant Poland 94.0%, United States of America 3.0%, Germany 3.0% 28-03-20 29 31
Polish lineage SARS-CoV-2 B.1.213 variant Poland 58.0%, Germany 9.0%, Luxembourg 9.0%, Iceland 7.0%, United Kingdom 7.0% 10-05-20 48 57
Portugal lineage SARS-CoV-2 B.1.1.88 variant Portugal 84.0%, United States of America 5.0%, Turkey 5.0%, United Kingdom 5.0% 20-03-20 15 19
Portugal lineage SARS-CoV-2 B.1.1.394 variant Portugal 100.0% 21-06-20 37 40
Portugal lineage SARS-CoV-2 B.1.1.401 variant Japan 73.0%, Portugal 19.0%, United Kingdom 4.0%, United States of America 1.0%, Brazil 1.0% 01-04-20 15 79
Portugal lineage SARS-CoV-2 B.1.1.410 variant Portugal 83.0%, United Kingdom 9.0%, Norway 4.0%, Luxembourg 4.0% 19-05-20 21 23
Portuguese lineage SARS-CoV-2 B.1.1.421 variant Portugal 74.0%, United Kingdom 12.0%, United States of America 9.0%, France 3.0%, Switzerland 3.0% 12-03-20 27 34
Portuguese lineage SARS-CoV-2 B.1.91 variant Portugal 64.0%, United Kingdom 13.0%, Brazil 5.0%, New_Zealand 5.0%, Italy 3.0% 21-02-20 372 453
Portuguese lineage SARS-CoV-2 B.1.177.72 variant Portugal 76.0%, France 8.0%, Switzerland 7.0%, Luxembourg 5.0%, Spain 2.0% 07-11-20 151 276
Portuguese lineage SARS-CoV-2 B.1.177.85 variant Portugal 60.0%, Switzerland 20.0%, Luxembourg 14.0%, France 5.0%, United Kingdom 1.0% 23-10-20 90 177
Predominantly India lineage with 484Q, pango-designation issue #49 SARS-CoV-2 B.1.617.1 variant India 64.0%, United Kingdom 14.0%, United States of America 8.0%, Singapore 4.0%, Germany 2.0% 01-12-20 444 ###
Predominantly India lineage with 484Q, pango-designation issue #49 SARS-CoV-2 B.1.617.3 variant India 87.0%, United Kingdom 10.0%, United States of America 2.0%, Russia 2.0% 13-02-21 23 61
Predominantly India lineage with several spike mutations, pango-designation issue #38 SARS-CoV-2 B.1.617 variant 1 0
Predominantly India lineage with several spike mutations, pango-designation issue #49 SARS-CoV-2 B.1.617.2 variant United Kingdom 46.0%, India 20.0%, United States of America 12.0%, Singapore 6.0%, Australia 4.0% 12-12-20 104 ###
Predominantly Indian lineage with exports elsewhere SARS-CoV-2 B.1.1.216 variant India 72.0%, United Kingdom 8.0%, United States of America 4.0%, Japan 3.0%, Canada 3.0% 06-05-20 135 535
Predominantly Russia, includes some previous B.1.1.67 and H.1 sequences SARS-CoV-2 B.1.1.397 variant Japan 37.0%, Russia 31.0%, Estonia 9.0%, Latvia 5.0%, Israel 4.0% 08-08-20 89 608
Previously D.1, UK/ UAE lineage SARS-CoV-2 B.1.1.315 variant United_Arab_Emirates 42.0%, United Kingdom 29.0%, Germany 7.0%, Bangladesh 4.0%, Israel 4.0% 03-07-20 70 92
Prodominantly Indian lineage with global records (inc. Canada) SARS-CoV-2 B.1.36.8 variant India 52.0%, Canada 19.0%, Denmark 9.0%, United States of America 7.0%, United Kingdom 4.0% 11-04-20 496 733
Reunion lineage, pango-designation issue #58 SARS-CoV-2 B.1.622 variant Reunion 100.0% 19-01-21 62 65
Romanian lineage SARS-CoV-2 B.1.180 variant Romania 62.0%, United States of America 27.0%, United Kingdom 8.0%, Switzerland 4.0% 06-04-20 19 26
Romanian lineage SARS-CoV-2 B.1.588.1 variant Romania 100.0% 28-11-20 24 26
Russia lineage SARS-CoV-2 B.1.1.449 variant Russia 88.0%, Germany 12.0% 04-09-20 7 8
Russia lineage SARS-CoV-2 B.1.1.452 variant Russia 73.0%, Japan 18.0%, India 9.0% 10-09-20 6 11
Russia lineage, contains some formally B.1.1.167 sequences SARS-CoV-2 B.1.1.424 variant Russia 100.0% 02-05-20 11 20
Russia, Germany, Switzerland, Austria. Was B.1.412 SARS-CoV-2 B.1.264.1 variant Russia 47.0%, Germany 16.0%, Austria 11.0%, Singapore 5.0%, Iceland 5.0% 26-08-20 15 19
Russia, one “Congo” SARS-CoV-2 B.1.1.349 variant Russia 53.0%, United Kingdom 10.0%, Finland 10.0%, Mongolia 4.0%, Estonia 4.0% 04-08-20 23 51
Russia, S Korea, England SARS-CoV-2 B.1.1.364 variant Russia 62.0%, United Kingdom 25.0%, India 6.0%, South_Korea 6.0% 09-06-20 12 16
Russia, some B.1.1.129 SARS-CoV-2 B.1.1.184 variant Russia 88.0%, Ireland 6.0%, United Kingdom 6.0% 03-04-20 16 17
Russia, split from B.1.1.31 SARS-CoV-2 B.1.1.373 variant Russia 89.0%, United Kingdom 6.0%, Crimea 3.0%, Hong_Kong 3.0% 07-08-20 12 36
Russian SARS-CoV-2 B.1.1.152 variant Russia 83.0%, Germany 13.0%, Finland 4.0% 03-09-20 13 23
Russian SARS-CoV-2 B.1.1.435 variant Russia 96.0%, Luxembourg 4.0% 06-11-20 10 25
Russian and UK lineage SARS-CoV-2 B.1.1.294 variant Denmark 24.0%, United Kingdom 20.0%, Russia 15.0%, Israel 14.0%, Germany 9.0% 31-03-20 363 607
Russian lineage SARS-CoV-2 B.1.1.31 variant Russia 100.0% 07-06-20 15 15
Russian lineage SARS-CoV-2 B.1.1.127 variant Russia 100.0% 20-04-20 16 16
Russian lineage SARS-CoV-2 B.1.1.129 variant Russia 97.0%, Germany 3.0% 09-04-20 35 37
Russian lineage SARS-CoV-2 B.1.1.163 variant Russia 49.0%, Armenia 17.0%, Qatar 12.0%, Netherlands 5.0%, Australia 4.0% 01-04-20 60 121
Russian lineage SARS-CoV-2 B.1.1.317 variant Germany 52.0%, Russia 23.0%, Estonia 4.0%, Finland 2.0%, United States of America 2.0% 27-03-20 311 ###
Russian lineage SARS-CoV-2 B.1.1.336 variant Russia 80.0%, Germany 7.0%, Poland 5.0%, Switzerland 2.0%, Kazakhstan 2.0% 14-10-20 13 44
Russian Lineage SARS-CoV-2 B.1.1.427 variant Russia 100.0% 25-07-20 6 8
Russian Lineage SARS-CoV-2 B.1.1.481 variant Russia 100.0% 11-08-20 11 14
Russian lineage, some previously B.1.1.184 SARS-CoV-2 B.1.1.396 variant Russia 46.0%, Israel 38.0%, Japan 8.0%, United States of America 8.0% 25-07-20 6 13
Russian, Latvian, Netherlands SARS-CoV-2 B.1.1.141 variant Latvia 55.0%, Russia 21.0%, Germany 14.0%, Sweden 4.0%, Netherlands 1.0% 22-07-20 50 378
Russian/Serbian Lineage SARS-CoV-2 B.1.1.319 variant Russia 57.0%, Austria 15.0%, Peru 9.0%, Ireland 4.0%, United Kingdom 4.0% 02-03-20 19 47
Rwanda / Uganda SARS-CoV-2 B.1.380 variant Rwanda 97.0%, Uganda 2.0%, India 1.0%, Italy 1.0% 04-03-20 113 128
Saudi Arabia SARS-CoV-2 B.1.533 variant Saudi_Arabia 21.0%, Switzerland 19.0%, United States of America 15.0%, Finland 13.0%, India 10.0% 24-03-20 13 52
Saudi Arabia to Romania to Western Europe, contains B.1.1.161 at the base SARS-CoV-2 B.1.1.371 variant United Kingdom 50.0%, Denmark 17.0%, Switzerland 7.0%, Romania 6.0%, Saudi_Arabia 6.0% 07-03-20 39 54
Saudi Arabian lineage SARS-CoV-2 B.1.260 variant Saudi_Arabia 69.0%, Germany 20.0%, Switzerland 7.0%, India 1.0%, France 1.0% 24-03-20 110 153
Saudi lineage SARS-CoV-2 B.1.1.161 variant Saudi_Arabia 18.0%, United States of America 16.0%, Germany 16.0%, Czech_Republic 8.0%, Finland 7.0% 04-03-20 61 226
Scandinavian lineage SARS-CoV-2 B.1.177.80 variant Sweden 57.0%, Norway 23.0%, Denmark 18.0%, Switzerland 0.0%, Germany 0.0% 21-10-20 83 428
Scandinavian lineage SARS-CoV-2 B.1.177.82 variant Sweden 68.0%, Denmark 13.0%, United Kingdom 12.0%, Norway 3.0%, Finland 1.0% 26-08-20 411 ###
Scotland SARS-CoV-2 B.1.1.14 variant United Kingdom 100.0% 16-04-20 45 58
Scotland SARS-CoV-2 B.1.69 variant United Kingdom 88.0%, Italy 12.0% 06-03-20 21 26
Scotland SARS-CoV-2 B.1.70 variant United Kingdom 97.0%, United States of America 3.0% 13-03-20 25 37
Scotland SARS-CoV-2 B.1.248 variant United Kingdom 100.0% 28-03-20 24 33
Scotland SARS-CoV-2 B.1.431 variant United Kingdom 100.0% 30-03-20 17 25
Scotland SARS-CoV-2 B.1.559 variant United Kingdom 100.0% 29-03-20 31 40
Scotland lineage SARS-CoV-2 B.1.40 variant United Kingdom 96.0%, United States of America 4.0% 18-03-20 37 54
Scotland mostly, some England SARS-CoV-2 B.1.177.11 variant United Kingdom 99.0%, South_Korea 0.0%, Poland 0.0%, Denmark 0.0%, Singapore 0.0% 04-04-20 317 566
Scottish lineage SARS-CoV-2 B.1.1.43 variant United Kingdom 100.0% 25-03-20 50 66
Scottish Lineage SARS-CoV-2 B.1.9.1 variant United Kingdom 100.0% 31-03-20 28 30
Scottish lineage SARS-CoV-2 B.1.168 variant United Kingdom 100.0% 23-04-20 24 37
Scottish lineage SARS-CoV-2 B.1.215 variant United Kingdom 100.0% 20-03-20 94 103
Scottish lineage SARS-CoV-2 B.1.222 variant United Kingdom 91.0%, Germany 3.0%, Switzerland 2.0%, India 1.0%, Italy 1.0% 24-02-20 407 591
Scottish lineage SARS-CoV-2 B.1.256 variant United Kingdom 100.0% 22-03-20 50 59
Scottish lineage SARS-CoV-2 B.1.258.10 variant United Kingdom 99.0%, Denmark 1.0% 17-09-20 55 87
Scottish lineage SARS-CoV-2 B.1.418 variant United Kingdom 100.0% 24-04-20 47 63
SE Asia SARS-CoV-2 B.1.36.16 variant Thailand 61.0%, United Kingdom 13.0%, Bangladesh 8.0%, Malaysia 6.0%, Spain 4.0% 03-05-20 262 511
SE Asian (reasigned) SARS-CoV-2 B.1.456 variant Indonesia 55.0%, Singapore 24.0%, Taiwan 9.0%, Saudi_Arabia 9.0%, United States of America 3.0% 20-02-20 24 33
Senegal/ Gambian lineage, reassigned from B.1.5.12 SARS-CoV-2 B.1.416 variant Gambia 32.0%, Senegal 18.0%, France 17.0%, Lithuania 9.0%, Italy 7.0% 17-04-20 348 568
Singapore, malaysia, India, UAE, England SARS-CoV-2 B.1.1.354 variant India 30.0%, Singapore 20.0%, Malaysia 12.0%, United_Arab_Emirates 7.0%, United Kingdom 7.0% 12-07-20 83 152
South Africa SARS-CoV-2 B.1.1.52 variant South_Africa 76.0%, United States of America 24.0% 11-04-20 20 59
South Africa SARS-CoV-2 B.1.1.53 variant South_Africa 96.0%, Qatar 4.0% 12-05-20 23 27
South Africa SARS-CoV-2 B.1.381 variant South_Africa 97.0%, Zimbabwe 3.0% 15-04-20 65 75
South Africa SARS-CoV-2 C.6 variant South_Africa 100.0% 01-07-20 3 5
South African SARS-CoV-2 B.1.1.84 variant South_Africa 100.0% 22-06-20 11 11
South African SARS-CoV-2 B.1.1.383 variant South_Africa 94.0%, Australia 6.0% 29-04-20 16 16
South African SARS-CoV-2 B.1.1.456 variant South_Africa 100.0% 18-06-20 18 18
South African (was B.1.1.117) SARS-CoV-2 B.1.1.444 variant South_Africa 100.0% 27-07-20 5 5
South African (was B.1.1.54) SARS-CoV-2 B.1.1.448 variant South_Africa 96.0%, Zambia 2.0%, Mozambique 1.0%, Malawi 0.0%, Swaziland 0.0% 18-04-20 311 395
South African lineage SARS-CoV-2 B.1.1.34 variant South_Africa 93.0%, Zimbabwe 5.0%, Mozambique 2.0% 15-04-20 53 57
South African lineage SARS-CoV-2 B.1.1.40 variant South_Africa 100.0% 20-04-20 24 28
South African Lineage SARS-CoV-2 B.1.1.54 variant South_Africa 81.0%, Botswana 13.0%, United States of America 2.0%, United Kingdom 1.0%, Russia 1.0% 19-03-20 220 284
South African lineage SARS-CoV-2 B.1.1.56 variant South_Africa 100.0% 21-05-20 25 25
South African lineage SARS-CoV-2 B.1.1.62 variant South_Africa 92.0%, Zambia 4.0%, Zimbabwe 4.0% 23-06-20 24 26
South African lineage SARS-CoV-2 B.1.1.382 variant South_Africa 100.0% 22-04-20 14 19
South African lineage SARS-CoV-2 B.1.1.386 variant South_Africa 100.0% 30-05-20 12 14
South African lineage SARS-CoV-2 B.1.1.387 variant Russia 72.0%, United States of America 24.0%, Poland 4.0% 10-05-20 12 25
South African lineage SARS-CoV-2 B.1.1.412 variant South_Africa 99.0%, New_Zealand 1.0% 18-06-20 126 128
South African lineage SARS-CoV-2 B.1.140 variant South_Africa 100.0% 15-06-20 44 47
South african lineage SARS-CoV-2 B.1.237 variant South_Africa 99.0%, Australia 1.0%, Lesotho 1.0% 24-04-20 113 169
South African lineage SARS-CoV-2 B.1.417 variant South_Africa 95.0%, Spain 5.0% 02-04-20 22 22
South African lineage (some were part of Belgian lineage B.1.1.75 SARS-CoV-2 B.1.1.459 variant South_Africa 81.0%, Zimbabwe 10.0%, United States of America 5.0%, Mexico 2.0%, Turkey 2.0% 04-04-20 30 42
South African Lineage (was B.1.1.254) SARS-CoV-2 B.1.1.507 variant South_Africa 100.0% 07-09-20 19 26
South African lineage, a few English sequences, one Zimbabwe SARS-CoV-2 B.1.1.57 variant South_Africa 81.0%, Zimbabwe 6.0%, Russia 5.0%, India 5.0%, United Kingdom 2.0% 31-03-20 57 63
South african lineage, previously part of B.1.1.56 SARS-CoV-2 B.1.1.273 variant South_Africa 99.0%, Zambia 1.0% 25-05-20 137 139
South African some Argentina, now contains B.1.1.252 SARS-CoV-2 B.1.1.117 variant South_Africa 39.0%, United Kingdom 37.0%, United States of America 4.0%, Russia 3.0%, Australia 2.0% 12-03-20 58 140
South America & USA SARS-CoV-2 B.1.1.348 variant United States of America 50.0%, Chile 23.0%, Colombia 10.0%, Peru 8.0%, Ecuador 3.0% 30-04-20 56 751
South American lineage SARS-CoV-2 B.1.212 variant Brazil 70.0%, Argentina 9.0%, France 7.0%, Germany 7.0%, United States of America 4.0% 03-03-20 33 46
South Korea (was B.1.3.1) SARS-CoV-2 B.1.497 variant South_Korea 100.0%, Switzerland 0.0%, United States of America 0.0%, Japan 0.0%, Lithuania 0.0% 05-05-20 ### ###
South/ Central American lineage (mostly Trinidad and Colombia, an a small cluster from Norwich) SARS-CoV-2 B.1.111 variant United States of America 51.0%, Colombia 25.0%, Aruba 3.0%, Canada 2.0%, Spain 2.0% 07-03-20 169 644
Southern USA SARS-CoV-2 B.1.1.186 variant United States of America 99.0%, Rwanda 0.0%, France 0.0%, Japan 0.0% 25-06-20 164 239
Spain SARS-CoV-2 B.1.177.29 variant Spain 73.0%, Portugal 18.0%, United Kingdom 9.0% 07-09-20 8 11
Spain SARS-CoV-2 B.1.177.61 variant Spain 100.0% 02-12-20 11 20
Spain SARS-CoV-2 B.1.542 variant Spain 94.0%, United States of America 3.0%, Indonesia 3.0% 24-03-20 26 33
Spain lineage SARS-CoV-2 B.1.1.400 variant Spain 82.0%, United States of America 14.0%, Italy 5.0% 22-03-20 5 22
Spain, UK, Italy SARS-CoV-2 B.1.1.406 variant United Kingdom 66.0%, Spain 21.0%, Ireland 4.0%, Switzerland 3.0%, United States of America 2.0% 25-03-20 93 129
Spainish sub lineage of B.1.575 with spike mutations “S:P681H”,”S:S494P” and “S:T716I”. SARS-CoV-2 B.1.575.1 variant Spain 78.0%, Germany 6.0%, Switzerland 4.0%, United States of America 3.0%, Sweden 2.0% 04-11-20 168 223
Spanish lineage SARS-CoV-2 B.1.177.49 variant Spain 100.0% 11-09-20 14 29
Spanish lineage SARS-CoV-2 B.1.182 variant Spain 99.0%, United States of America 1.0% 13-03-20 138 137
Sri Lankan lineage SARS-CoV-2 B.1.411 variant Sri_Lanka 90.0%, Japan 2.0%, Australia 2.0%, Israel 2.0%, United States of America 2.0% 13-04-20 74 254
Sublineage of B.1.351 circulating in Botswana SARS-CoV-2 B.1.351.1 variant 7 0
Sublineage of B.1.351 circulating in Mayotte SARS-CoV-2 B.1.351.2 variant 272 0
Sublineage of B.1.351 predominantly in Bangladesh and Singapore with exports elsewhere SARS-CoV-2 B.1.351.3 variant 94 0
Suriname lineage SARS-CoV-2 B.1.219 variant Suriname 82.0%, France 7.0%, Netherlands 3.0%, Belgium 3.0%, China 1.0% 22-03-20 60 67
Sweden SARS-CoV-2 B.1.1.91 variant Sweden 100.0% 28-04-20 5 5
Sweden SARS-CoV-2 B.1.227 variant Sweden 94.0%, Turkey 6.0% 16-03-20 17 18
Sweden SARS-CoV-2 B.1.342 variant Sweden 100.0% 23-05-20 8 8
Sweden SARS-CoV-2 B.1.555 variant Sweden 66.0%, United States of America 10.0%, Russia 6.0%, Switzerland 4.0%, Germany 4.0% 11-03-20 39 50
Sweden SARS-CoV-2 B.1.614 variant Sweden 100.0% 15-06-20 8 8
Sweden and Denmark SARS-CoV-2 B.1.177.46 variant Denmark 53.0%, Sweden 46.0%, Croatia 1.0%, United Kingdom 0.0%, Germany 0.0% 29-10-20 46 538
Sweden and Denmark lineage SARS-CoV-2 B.1.1.90 variant Sweden 75.0%, Denmark 25.0% 20-05-20 8 8
Sweden lineage SARS-CoV-2 B.1.1.446 variant Sweden 75.0%, Brazil 12.0%, Russia 12.0% 19-04-20 5 8
Swedish lineage SARS-CoV-2 B.1.1.302 variant Sweden 58.0%, Denmark 28.0%, Latvia 6.0%, United Kingdom 4.0%, Norway 3.0% 06-07-20 220 433
Swedish lineage SARS-CoV-2 B.1.1.438 variant Sweden 85.0%, Bosnia_and_Herzegovina 5.0%, United Kingdom 5.0%, United States of America 5.0% 12-03-20 18 20
Swedish lineage SARS-CoV-2 B.1.1.458 variant Sweden 36.0%, Germany 32.0%, Turkey 9.0%, Switzerland 9.0%, Norway 5.0% 14-05-20 11 22
Swedish lineage SARS-CoV-2 B.1.258.22 variant Sweden 80.0%, Denmark 18.0%, Iceland 1.0%, United Kingdom 0.0%, Germany 0.0% 11-12-20 138 233
Swedish/ Danish/ Faroe Islands lineage SARS-CoV-2 B.1.1.261 variant Sweden 47.0%, Denmark 36.0%, Faroe_Islands 10.0%, Germany 5.0%, Norway 2.0% 06-04-20 97 102
Swiss and Portugese mostly SARS-CoV-2 B.1.177.32 variant Portugal 43.0%, Spain 28.0%, Switzerland 11.0%, Luxembourg 4.0%, France 3.0% 02-10-20 210 513
Swiss lineage SARS-CoV-2 B.1.1.144 variant Switzerland 74.0%, Germany 9.0%, United Kingdom 9.0%, South_Korea 3.0%, Austria 3.0% 10-08-20 27 35
Swiss Lineage SARS-CoV-2 B.1.1.327 variant Switzerland 100.0% 22-11-20 5 7
Swiss Lineage SARS-CoV-2 B.1.1.384 variant Switzerland 69.0%, Germany 31.0% 28-12-20 25 42
Swiss lineage SARS-CoV-2 B.1.146 variant Switzerland 53.0%, Germany 16.0%, Slovenia 12.0%, Austria 7.0%, Luxembourg 3.0% 23-06-20 83 161
Swiss lineage SARS-CoV-2 B.1.177.23 variant Switzerland 96.0%, Italy 2.0%, Austria 1.0%, Canada 0.0%, South_Korea 0.0% 17-08-20 189 301
Swiss lineage SARS-CoV-2 B.1.177.28 variant Switzerland 88.0%, Slovenia 7.0%, Italy 2.0%, Greece 2.0% 18-10-20 28 81
Swiss lineage SARS-CoV-2 B.1.177.31 variant Switzerland 71.0%, Germany 10.0%, Sweden 5.0%, Spain 5.0%, United Kingdom 3.0% 23-08-20 30 78
Swiss lineage SARS-CoV-2 B.1.177.71 variant Switzerland 99.0%, France 1.0% 21-09-20 63 98
Swiss lineage SARS-CoV-2 B.1.218 variant Denmark 53.0%, United Kingdom 18.0%, Turkey 10.0%, Germany 8.0%, Switzerland 8.0% 20-07-20 138 178
Swiss lineage SARS-CoV-2 B.1.236 variant Italy 38.0%, Switzerland 28.0%, United Kingdom 10.0%, Germany 7.0%, Denmark 4.0% 06-06-20 246 740
Swiss mostly SARS-CoV-2 B.1.177.44 variant Switzerland 82.0%, Italy 4.0%, Germany 4.0%, Netherlands 2.0%, United Kingdom 2.0% 18-08-20 917 ###
Swiss, then into Germany and Austria SARS-CoV-2 B.1.177.43 variant Switzerland 72.0%, Germany 17.0%, Spain 5.0%, Austria 3.0%, United Kingdom 1.0% 16-08-20 254 538
Swiss/ Danish lineage SARS-CoV-2 B.1.258.16 variant Denmark 93.0%, Switzerland 4.0%, Spain 2.0%, Iceland 0.0%, Austria 0.0% 23-11-20 466 607
Switzerland SARS-CoV-2 B.1.160.9 variant Switzerland 77.0%, Belgium 16.0%, France 6.0%, Portugal 1.0% 19-10-20 83 133
Switzerland SARS-CoV-2 B.1.160.10 variant Switzerland 94.0%, United Kingdom 3.0%, France 2.0% 10-10-20 54 121
Switzerland SARS-CoV-2 B.1.160.11 variant Switzerland 99.0%, Germany 1.0% 08-10-20 72 172
Switzerland SARS-CoV-2 B.1.160.12 variant Switzerland 99.0%, Germany 1.0%, United Kingdom 1.0% 15-10-20 80 153
Switzerland SARS-CoV-2 B.1.160.14 variant Switzerland 95.0%, France 1.0%, United States of America 1.0%, Spain 1.0%, Germany 1.0% 21-05-20 200 478
Switzerland SARS-CoV-2 B.1.160.19 variant Switzerland 100.0% 25-12-20 19 25
Switzerland SARS-CoV-2 B.1.160.20 variant Switzerland 94.0%, Qatar 2.0%, Germany 2.0%, United States of America 2.0%, Belgium 1.0% 12-10-20 40 130
Switzerland SARS-CoV-2 B.1.160.29 variant Switzerland 85.0%, France 7.0%, Portugal 6.0%, Netherlands 1.0%, Luxembourg 0.0% 26-10-20 100 227
Switzerland SARS-CoV-2 B.1.160.30 variant Switzerland 61.0%, Germany 22.0%, United Kingdom 12.0%, New_Zealand 2.0%, Poland 1.0% 07-08-20 70 340
Switzerland SARS-CoV-2 B.1.160.31 variant Switzerland 90.0%, Germany 10.0% 08-10-20 69 117
Switzerland SARS-CoV-2 B.1.160.32 variant Switzerland 85.0%, Germany 8.0%, France 2.0%, Mexico 1.0%, Denmark 1.0% 25-08-20 109 177
Switzerland and North Macedonia SARS-CoV-2 B.1.1.428 variant Switzerland 36.0%, Germany 29.0%, Denmark 10.0%, Sweden 10.0%, Macedonia 8.0% 26-10-20 32 106
Switzerland and other Northern Europe SARS-CoV-2 B.1.1.47 variant Switzerland 46.0%, Finland 12.0%, Germany 8.0%, Denmark 7.0%, United Kingdom 6.0% 01-07-20 108 156
Switzerland lineage SARS-CoV-2 B.1.1.445 variant Switzerland 100.0% 14-12-20 17 23
Switzerland lineage SARS-CoV-2 B.1.177.89 variant Switzerland 100.0% 21-11-20 27 41
Switzerland, Germany, Austria SARS-CoV-2 B.1.160.22 variant Switzerland 91.0%, Germany 4.0%, Austria 2.0%, Portugal 2.0%, France 1.0% 07-10-20 81 138
Texas SARS-CoV-2 B.1.1.177 variant United States of America 100.0% 04-06-20 26 30
Texas SARS-CoV-2 B.1.1.356 variant United States of America 98.0%, Germany 2.0% 16-05-20 45 58
Tunisia, England, France SARS-CoV-2 B.1.428.2 variant Qatar 58.0%, Tunisia 18.0%, United Kingdom 8.0%, France 5.0%, Germany 5.0% 07-04-20 10 38
UAE SARS-CoV-2 B.1.1.366 variant United_Arab_Emirates 93.0%, Oman 2.0%, Switzerland 2.0%, Zimbabwe 2.0%, United Kingdom 2.0% 16-03-20 57 58
UAE SARS-CoV-2 B.1.195 variant Brazil 34.0%, United_Arab_Emirates 20.0%, India 15.0%, Uruguay 13.0%, United Kingdom 5.0% 17-03-20 100 193
UAE and England SARS-CoV-2 B.1.1.339 variant United_Arab_Emirates 82.0%, United Kingdom 11.0%, Canada 5.0%, Jordan 1.0%, Netherlands 1.0% 19-03-20 88 93
UAE lineage SARS-CoV-2 B.1.1.391 variant United_Arab_Emirates 96.0%, United States of America 3.0%, United Kingdom 1.0% 30-03-20 114 114
UAE lineage SARS-CoV-2 B.1.1.500 variant United_Arab_Emirates 70.0%, United Kingdom 12.0%, Israel 5.0%, Peru 5.0%, Russia 2.0% 10-04-20 38 43
UAE lineage (~95%) SARS-CoV-2 B.1.1.263 variant United_Arab_Emirates 88.0%, Japan 3.0%, United States of America 2.0%, United Kingdom 2.0%, Hong_Kong 1.0% 03-04-20 275 296
UAE, Israel, Australia SARS-CoV-2 B.1.1.353 variant Reunion 42.0%, United Kingdom 10.0%, United_Arab_Emirates 10.0%, United States of America 8.0%, Australia 5.0% 08-09-20 13 40
UAE, Israel, Saudi Arabia SARS-CoV-2 B.1.1.409 variant United_Arab_Emirates 75.0%, Saudi_Arabia 6.0%, Iceland 3.0%, Switzerland 3.0%, Russia 3.0% 03-04-20 41 32
UAE, Jordan SARS-CoV-2 B.1.428.3 variant Qatar 71.0%, Australia 12.0%, United_Arab_Emirates 7.0%, Germany 2.0%, Jordan 2.0% 03-06-20 8 42
UAE/ European lineage SARS-CoV-2 B.1.1.133 variant United_Arab_Emirates 66.0%, United Kingdom 17.0%, Australia 10.0%, Canada 2.0%, Germany 2.0% 22-03-20 93 105
Uganda SARS-CoV-2 B.1.393 variant Uganda 87.0%, Rwanda 7.0%, Kenya 7.0% 04-07-20 18 30
UK SARS-CoV-2 B.1.1.13 variant United Kingdom 95.0%, Russia 5.0% 28-03-20 18 19
UK SARS-CoV-2 B.1.1.45 variant United Kingdom 100.0% 22-05-20 22 59
UK SARS-CoV-2 B.1.1.51 variant United Kingdom 99.0%, Russia 1.0%, Estonia 0.0%, Japan 0.0% 30-03-20 315 567
UK SARS-CoV-2 B.1.1.134 variant United Kingdom 85.0%, Germany 7.0%, United States of America 3.0%, Latvia 1.0%, Russia 1.0% 21-03-20 66 269
UK SARS-CoV-2 B.1.1.164 variant United Kingdom 95.0%, Australia 2.0%, Switzerland 2.0%, Japan 2.0% 16-03-20 128 62
UK SARS-CoV-2 B.1.1.200 variant United Kingdom 82.0%, Belgium 13.0%, Netherlands 3.0%, Zimbabwe 3.0% 28-03-20 75 39
UK SARS-CoV-2 B.1.1.208 variant United Kingdom 96.0%, Indonesia 1.0%, United_Arab_Emirates 1.0%, Brazil 1.0% 22-03-20 45 81
UK SARS-CoV-2 B.1.1.236 variant United Kingdom 74.0%, Germany 22.0%, Turkey 3.0%, Japan 1.0% 02-05-20 65 130
UK SARS-CoV-2 B.1.1.253 variant United Kingdom 99.0%, France 1.0%, Japan 0.0% 09-05-20 260 380
UK SARS-CoV-2 B.1.1.286 variant United Kingdom 100.0%, Netherlands 0.0% 22-06-20 220 331
UK SARS-CoV-2 B.1.1.303 variant United Kingdom 99.0%, Portugal 0.0%, Japan 0.0%, Germany 0.0% 29-03-20 244 349
UK SARS-CoV-2 B.1.1.308 variant United Kingdom 94.0%, United States of America 5.0%, Denmark 1.0% 30-04-20 66 86
UK SARS-CoV-2 B.1.36.2 variant United Kingdom 100.0% 27-09-20 65 85
UK SARS-CoV-2 B.1.36.9 variant United Kingdom 83.0%, Sweden 9.0%, Denmark 7.0%, Germany 0.0%, Saudi_Arabia 0.0% 21-04-20 197 300
UK SARS-CoV-2 B.1.36.23 variant United Kingdom 83.0%, Netherlands 9.0%, Slovenia 2.0%, Ireland 2.0%, Denmark 2.0% 27-07-20 38 53
UK SARS-CoV-2 B.1.36.28 variant United Kingdom 99.0%, Gibraltar 1.0% 09-09-20 118 170
UK SARS-CoV-2 B.1.36.34 variant United Kingdom 79.0%, Pakistan 9.0%, Japan 3.0%, Canada 3.0%, Spain 3.0% 10-06-20 24 34
UK SARS-CoV-2 B.1.36.39 variant United Kingdom 98.0%, India 1.0%, New_Zealand 1.0% 21-09-20 306 183
UK SARS-CoV-2 B.1.177.58 variant United Kingdom 92.0%, Ireland 7.0%, Switzerland 1.0%, Denmark 0.0% 25-09-20 423 724
UK SARS-CoV-2 B.1.235 variant United Kingdom 100.0% 08-06-20 248 386
UK SARS-CoV-2 B.1.379 variant United Kingdom 96.0%, Sierra_Leone 2.0%, Lithuania 2.0% 16-03-20 36 57
UK SARS-CoV-2 B.1.391 variant United Kingdom 91.0%, United States of America 7.0%, Australia 1.0%, Latvia 0.0%, Denmark 0.0% 14-03-20 632 552
UK SARS-CoV-2 B.1.553 variant United Kingdom 83.0%, United States of America 8.0%, Lithuania 4.0%, Denmark 4.0% 18-09-20 15 24
UK (reasigned from Oman lineage) SARS-CoV-2 B.1.36.7 variant United Kingdom 79.0%, Canada 8.0%, United States of America 6.0%, Turkey 4.0%, Denmark 2.0% 17-08-20 63 119
UK / Nigera SARS-CoV-2 B.1.462 variant Nigeria 71.0%, United Kingdom 16.0%, Italy 6.0%, Cameroon 3.0%, United States of America 3.0% 20-04-20 26 31
UK and Brazil SARS-CoV-2 B.1.1.378 variant United Kingdom 43.0%, Brazil 43.0%, United States of America 4.0%, Finland 2.0%, Iceland 1.0% 21-03-20 43 92
UK and italy SARS-CoV-2 B.1.1.187 variant Italy 84.0%, United Kingdom 13.0%, Bulgaria 2.0%, Turkey 1.0% 24-06-20 90 105
UK and Nigerian Lineage SARS-CoV-2 B.1.1.487 variant United Kingdom 40.0%, Nigeria 38.0%, Spain 11.0%, United States of America 3.0%, France 3.0% 22-03-20 69 105
UK and US SARS-CoV-2 B.1.1.251 variant United States of America 97.0%, Russia 3.0% 02-06-20 43 33
UK lineage SARS-CoV-2 B.1.1.37 variant United Kingdom 96.0%, Latvia 1.0%, Switzerland 1.0%, Iceland 1.0%, Netherlands 0.0% 23-03-20 ### ###
UK lineage SARS-CoV-2 B.1.1.59 variant United Kingdom 99.0%, United States of America 1.0%, Bangladesh 1.0% 01-06-20 87 151
UK lineage SARS-CoV-2 B.1.1.86 variant United Kingdom 100.0% 19-05-20 23 26
UK lineage SARS-CoV-2 B.1.1.109 variant United Kingdom 96.0%, Turkey 4.0% 01-06-20 19 25
UK lineage SARS-CoV-2 B.1.1.120 variant United Kingdom 100.0% 01-06-20 20 30
UK lineage SARS-CoV-2 B.1.1.123 variant United Kingdom 98.0%, United States of America 2.0% 21-04-20 37 55
UK lineage SARS-CoV-2 B.1.1.125 variant United Kingdom 100.0% 21-05-20 65 98
UK lineage SARS-CoV-2 B.1.1.137 variant United Kingdom 95.0%, United States of America 4.0%, Turkey 1.0% 19-03-20 48 77
UK lineage SARS-CoV-2 B.1.1.138 variant United Kingdom 100.0% 04-04-20 126 163
UK lineage SARS-CoV-2 B.1.1.145 variant United Kingdom 88.0%, Switzerland 4.0%, Guadeloupe 4.0%, Rwanda 4.0% 20-05-20 15 24
UK lineage SARS-CoV-2 B.1.1.154 variant United Kingdom 100.0% 30-03-20 24 24
UK lineage SARS-CoV-2 B.1.1.166 variant United Kingdom 79.0%, Russia 6.0%, South_Korea 6.0%, South_Africa 3.0%, Belgium 3.0% 15-03-20 24 33
UK lineage SARS-CoV-2 B.1.1.168 variant United Kingdom 75.0%, United States of America 25.0% 31-03-20 29 40
UK lineage SARS-CoV-2 B.1.1.171 variant United Kingdom 93.0%, United States of America 2.0%, Iceland 1.0%, Spain 1.0%, Australia 1.0% 09-03-20 163 533
UK lineage SARS-CoV-2 B.1.1.196 variant United Kingdom 100.0% 26-08-20 123 165
UK lineage SARS-CoV-2 B.1.1.197 variant United Kingdom 100.0% 09-04-20 14 26
UK lineage SARS-CoV-2 B.1.1.204 variant Norway 40.0%, United Kingdom 40.0%, Germany 11.0%, Denmark 3.0%, Sweden 1.0% 07-03-20 83 217
UK lineage SARS-CoV-2 B.1.1.217 variant United Kingdom 96.0%, Japan 1.0%, Italy 1.0%, Sweden 1.0%, United States of America 0.0% 26-04-20 193 285
UK lineage SARS-CoV-2 B.1.1.220 variant United Kingdom 69.0%, United States of America 10.0%, Germany 4.0%, Japan 3.0%, Russia 2.0% 22-03-20 184 335
UK lineage SARS-CoV-2 B.1.1.240 variant United Kingdom 97.0%, Belgium 2.0%, Germany 1.0% 27-08-20 152 198
UK lineage SARS-CoV-2 B.1.1.255 variant United Kingdom 100.0%, Turkey 0.0% 21-05-20 219 314
UK lineage SARS-CoV-2 B.1.1.256 variant United Kingdom 100.0% 30-04-20 51 73
UK lineage SARS-CoV-2 B.1.1.262 variant 53 0
UK lineage SARS-CoV-2 B.1.1.270 variant United Kingdom 96.0%, United States of America 2.0%, New_Zealand 1.0%, Nigeria 1.0% 21-03-20 78 101
UK lineage SARS-CoV-2 B.1.1.289 variant United Kingdom 100.0% 20-03-20 411 475
UK lineage SARS-CoV-2 B.1.1.296 variant United Kingdom 98.0%, Turkey 2.0% 20-03-20 43 53
UK lineage SARS-CoV-2 B.1.1.299 variant United Kingdom 99.0%, India 1.0% 22-05-20 48 80
UK lineage SARS-CoV-2 B.1.1.300 variant United Kingdom 98.0%, Turkey 1.0%, Germany 1.0% 20-03-20 57 92
UK lineage SARS-CoV-2 B.1.1.301 variant United Kingdom 98.0%, Germany 2.0%, Bulgaria 0.0%, Romania 0.0%, South_Korea 0.0% 22-05-20 521 821
UK lineage SARS-CoV-2 B.1.1.307 variant United Kingdom 98.0%, Poland 1.0%, United States of America 1.0%, Spain 0.0%, India 0.0% 25-03-20 235 374
UK lineage SARS-CoV-2 B.1.1.341 variant United Kingdom 100.0% 14-09-20 14 14
UK lineage SARS-CoV-2 B.1.1.408 variant United Kingdom 100.0% 11-07-20 23 9
UK lineage SARS-CoV-2 B.1.13 variant United Kingdom 89.0%, Australia 3.0%, France 2.0%, Iceland 1.0%, Canada 1.0% 09-03-20 305 404
UK lineage SARS-CoV-2 B.1.36.17 variant United Kingdom 95.0%, Switzerland 1.0%, India 1.0%, United States of America 1.0%, Denmark 0.0% 16-07-20 ### ###
UK lineage SARS-CoV-2 B.1.81 variant United Kingdom 88.0%, Germany 7.0%, United States of America 5.0% 18-03-20 27 41
UK lineage SARS-CoV-2 B.1.93 variant United Kingdom 90.0%, Switzerland 3.0%, Ireland 3.0%, France 1.0%, United States of America 1.0% 06-03-20 694 ###
UK lineage SARS-CoV-2 B.1.110.2 variant United Kingdom 100.0% 03-04-20 5 6
UK lineage SARS-CoV-2 B.1.117 variant United Kingdom 100.0% 04-04-20 51 63
UK lineage SARS-CoV-2 B.1.151 variant United Kingdom 81.0%, Ireland 9.0%, France 3.0%, United States of America 2.0%, Germany 1.0% 13-03-20 78 91
UK lineage SARS-CoV-2 B.1.177.4 variant United Kingdom 98.0%, Italy 1.0%, France 0.0%, Denmark 0.0%, Germany 0.0% 03-06-20 ### ###
UK lineage SARS-CoV-2 B.1.177.9 variant United Kingdom 100.0%, Denmark 0.0% 10-09-20 479 633
UK lineage SARS-CoV-2 B.1.177.16 variant United Kingdom 98.0%, Sweden 2.0%, India 0.0%, Germany 0.0%, Denmark 0.0% 10-09-20 990 ###
UK lineage SARS-CoV-2 B.1.177.26 variant United Kingdom 100.0% 03-10-20 102 140
UK lineage SARS-CoV-2 B.1.177.48 variant United Kingdom 100.0%, Australia 0.0% 24-09-20 214 314
UK lineage SARS-CoV-2 B.1.177.53 variant Italy 27.0%, Spain 22.0%, United Kingdom 16.0%, United States of America 10.0%, Switzerland 8.0% 03-08-20 123 260
UK lineage SARS-CoV-2 B.1.177.54 variant United Kingdom 84.0%, Ireland 15.0%, Netherlands 1.0%, France 0.0%, Canada 0.0% 17-08-20 ### ###
UK lineage SARS-CoV-2 B.1.177.56 variant United Kingdom 91.0%, Ireland 8.0%, Spain 0.0%, Portugal 0.0%, Cyprus 0.0% 12-08-20 971 ###
UK lineage SARS-CoV-2 B.1.177.57 variant United Kingdom 99.0%, France 0.0%, Ireland 0.0%, New_Zealand 0.0%, Australia 0.0% 02-06-20 ### ###
UK lineage SARS-CoV-2 B.1.177.69 variant United Kingdom 98.0%, Spain 1.0%, Netherlands 0.0%, Norway 0.0%, Germany 0.0% 16-09-20 413 500
UK lineage SARS-CoV-2 B.1.177.84 variant United Kingdom 97.0%, Italy 1.0%, Iceland 1.0%, Sweden 1.0%, Spain 1.0% 16-09-20 111 144
UK lineage SARS-CoV-2 B.1.177.87 variant United Kingdom 94.0%, France 1.0%, Germany 1.0%, Canada 1.0%, Denmark 1.0% 25-08-20 834 ###
UK lineage SARS-CoV-2 B.1.198 variant United Kingdom 100.0% 03-04-20 13 14
UK lineage SARS-CoV-2 B.1.201 variant United Kingdom 95.0%, Egypt 1.0%, United States of America 1.0%, Australia 1.0%, Portugal 1.0% 06-03-20 143 168
UK lineage SARS-CoV-2 B.1.221.1 variant United Kingdom 96.0%, Germany 1.0%, Belgium 1.0%, Slovenia 1.0%, France 1.0% 18-08-20 216 319
UK lineage SARS-CoV-2 B.1.223 variant United Kingdom 79.0%, Spain 13.0%, Ecuador 3.0%, Poland 2.0%, Netherlands 2.0% 16-03-20 245 244
UK lineage SARS-CoV-2 B.1.225 variant United Kingdom 90.0%, France 3.0%, Netherlands 1.0%, Senegal 1.0%, Ecuador 1.0% 19-03-20 40 68
UK lineage SARS-CoV-2 B.1.229 variant United Kingdom 83.0%, United States of America 11.0%, Ireland 2.0%, Mexico 2.0%, Switzerland 1.0% 19-03-20 57 84
UK lineage SARS-CoV-2 B.1.238 variant United Kingdom 99.0%, United States of America 1.0% 14-05-20 46 73
UK lineage SARS-CoV-2 B.1.258 variant Germany 21.0%, United Kingdom 19.0%, Denmark 17.0%, Switzerland 6.0%, Sweden 6.0% 22-03-20 ### ###
UK lineage SARS-CoV-2 B.1.258.3 variant United Kingdom 79.0%, Ireland 7.0%, Germany 5.0%, Romania 3.0%, Spain 2.0% 06-07-20 338 546
UK lineage SARS-CoV-2 B.1.258.4 variant United Kingdom 100.0% 03-09-20 187 260
UK lineage SARS-CoV-2 B.1.258.5 variant United Kingdom 99.0%, United States of America 1.0% 09-09-20 82 113
UK lineage SARS-CoV-2 B.1.258.6 variant United Kingdom 94.0%, Germany 4.0%, Australia 2.0% 10-09-20 37 51
UK lineage SARS-CoV-2 B.1.258.7 variant United Kingdom 99.0%, Italy 0.0%, Germany 0.0%, Switzerland 0.0% 29-08-20 418 507
UK lineage SARS-CoV-2 B.1.258.12 variant United Kingdom 94.0%, Czech_Republic 2.0%, Germany 2.0%, Singapore 1.0%, Finland 1.0% 20-09-20 93 120
UK lineage SARS-CoV-2 B.1.282 variant United Kingdom 99.0%, India 1.0% 01-06-20 44 69
UK lineage SARS-CoV-2 B.1.362.1 variant United Kingdom 100.0% 19-09-20 12 13
UK lineage SARS-CoV-2 B.1.362.2 variant United Kingdom 88.0%, Israel 6.0%, Denmark 4.0%, Germany 1.0%, Hong_Kong 1.0% 01-09-20 168 198
UK lineage SARS-CoV-2 B.1.407 variant United Kingdom 100.0% 09-06-20 19 25
UK lineage SARS-CoV-2 B.1.460 variant United Kingdom 98.0%, India 2.0% 10-09-20 32 47
UK lineage SARS-CoV-2 B.1.563 variant United States of America 40.0%, United Kingdom 40.0%, Germany 20.0% 06-12-20 18 60
UK lineage of concern, associated with the N501Y mutation. More information can be found at cov-lineages.org/global_report.html SARS-CoV-2 B.1.1.7 variant United Kingdom 41.0%, United States of America 15.0%, Germany 10.0%, Denmark 6.0%, Sweden 4.0% 07-02-20 ### ###
UK lineage, includes some formally B.1.1.193 sequences SARS-CoV-2 B.1.1.419 variant United Kingdom 66.0%, United States of America 22.0%, Bahrain 2.0%, Portugal 2.0%, Armenia 2.0% 14-03-20 69 131
UK lineage, now contains former B.1.1.235 SARS-CoV-2 B.1.1.115 variant United Kingdom 99.0%, Japan 1.0% 09-05-20 62 109
UK lineage, previously part of B.1.1.279 SARS-CoV-2 B.1.1.395 variant United Kingdom 100.0% 27-04-20 18 18
UK lineage, previously part of B.1.235 SARS-CoV-2 B.1.610 variant Spain 41.0%, United Kingdom 28.0%, United States of America 5.0%, Chile 4.0%, Japan 3.0% 25-01-20 180 ###
UK with global representaion SARS-CoV-2 B.1.471 variant United Kingdom 67.0%, Pakistan 6.0%, Denmark 6.0%, Norway 6.0%, United States of America 3.0% 25-03-20 214 338
UK, contains B.1.466 which is reassigned (see below) SARS-CoV-2 B.1.465 variant United Kingdom 77.0%, Austria 12.0%, Denmark 6.0%, India 2.0%, Portugal 1.0% 14-03-20 187 171
UK, merged with B.1.177.13 SARS-CoV-2 B.1.177.17 variant United Kingdom 98.0%, Germany 2.0%, Switzerland 0.0%, Italy 0.0% 02-06-20 798 ###
UK, mostly Scotland SARS-CoV-2 B.1.177.5 variant United Kingdom 100.0%, Netherlands 0.0% 29-08-20 508 776
UK/ Luxembourg lineage SARS-CoV-2 B.1.1.15 variant United Kingdom 100.0% 09-06-20 46 40
UK/ Luxembourg lineage SARS-CoV-2 B.1.1.198 variant United Kingdom 72.0%, Luxembourg 11.0%, Portugal 4.0%, Ireland 3.0%, Germany 2.0% 09-03-20 447 639
UK/ Romanian lineage SARS-CoV-2 B.1.408 variant United Kingdom 59.0%, Romania 10.0%, Spain 6.0%, Netherlands 6.0%, Germany 5.0% 12-05-20 107 208
UK/ Spanish lineage SARS-CoV-2 B.1.157 variant United Kingdom 57.0%, Spain 36.0%, United States of America 2.0%, Belgium 1.0%, Canada 1.0% 08-03-20 170 196
UK/Australia SARS-CoV-2 B.1.523 variant United Kingdom 39.0%, Denmark 18.0%, United States of America 17.0%, Canada 9.0%, Colombia 5.0% 29-03-20 203 457
UK/Denmark lineage SARS-CoV-2 B.1.1.170 variant Denmark 33.0%, Germany 16.0%, United Kingdom 13.0%, Iceland 9.0%, Norway 7.0% 19-07-20 427 708
UK/Global SARS-CoV-2 B.1.36.31 variant United Kingdom 29.0%, Canada 21.0%, United States of America 15.0%, Denmark 9.0%, Sweden 6.0% 08-03-20 124 380
UK/USA lineage SARS-CoV-2 B.1.1.304 variant United States of America 98.0%, United Kingdom 1.0%, Turkey 0.0%, Chile 0.0%, Denmark 0.0% 31-03-20 251 323
United Arab Emirates SARS-CoV-2 B.1.1.462 variant United_Arab_Emirates 85.0%, United Kingdom 4.0%, Portugal 2.0%, Latvia 2.0%, United States of America 2.0% 25-03-20 93 107
US SARS-CoV-2 B.1.1.135 variant United States of America 89.0%, Japan 6.0%, Israel 1.0%, Togo 1.0%, United Kingdom 1.0% 12-03-20 105 155
US SARS-CoV-2 B.1.1.337 variant United States of America 99.0%, Japan 1.0% 27-06-20 91 193
US SARS-CoV-2 B.1.1.453 variant United States of America 93.0%, Mexico 1.0%, Canada 1.0%, Russia 1.0%, Germany 1.0% 05-08-20 68 75
US and Mexico SARS-CoV-2 B.1.1.432 variant United States of America 85.0%, Mexico 13.0%, Canada 1.0%, Germany 1.0%, Norway 0.0% 24-04-20 179 514
US and Mexico SARS-CoV-2 B.1.1.440 variant United States of America 98.0%, Northern_Mariana_Islands 2.0% 09-05-20 37 47
US CA lineage SARS-CoV-2 B.1.1.463 variant United States of America 100.0% 11-05-20 16 16
US lineage SARS-CoV-2 B.1.1.72 variant United States of America 79.0%, Switzerland 21.0% 25-07-20 23 28
US Lineage SARS-CoV-2 B.1.1.77 variant United States of America 96.0%, Australia 4.0% 28-05-20 21 23
US Lineage SARS-CoV-2 B.1.1.93 variant United States of America 97.0%, Mexico 3.0% 16-06-20 26 29
US lineage SARS-CoV-2 B.1.1.98 variant United States of America 98.0%, Germany 2.0% 05-04-20 35 44
US lineage SARS-CoV-2 B.1.1.128 variant United States of America 97.0%, Argentina 1.0%, Mexico 1.0%, United Kingdom 1.0% 19-05-20 69 96
US Lineage SARS-CoV-2 B.1.1.132 variant United States of America 79.0%, Japan 11.0%, Spain 6.0%, United Kingdom 1.0%, Russia 1.0% 17-03-20 58 72
US lineage SARS-CoV-2 B.1.1.148 variant United States of America 97.0%, United Kingdom 2.0%, India 2.0% 12-04-20 60 61
US Lineage SARS-CoV-2 B.1.1.480 variant United States of America 100.0% 13-04-20 22 30
US Lineage SARS-CoV-2 B.1.1.482 variant United States of America 45.0%, Japan 30.0%, United Kingdom 23.0%, France 2.0% 24-03-20 20 44
US Lineage SARS-CoV-2 B.1.1.486 variant United States of America 98.0%, Russia 1.0%, Japan 1.0%, Singapore 0.0%, Canada 0.0% 26-05-20 149 496
US lineage SARS-CoV-2 B.1.1.514 variant United States of America 100.0% 01-05-20 16 17
US lineage (NY) SARS-CoV-2 B.1.1.467 variant United States of America 97.0%, Canada 3.0% 08-10-20 20 33
US lineage (NY) SARS-CoV-2 B.1.1.513 variant United States of America 100.0% 16-03-20 81 81
US Lineage (TX) SARS-CoV-2 B.1.1.118 variant United States of America 99.0%, Canada 1.0% 11-05-20 62 73
US TX lineage SARS-CoV-2 B.1.1.461 variant United States of America 97.0%, New_Zealand 2.0%, Canada 2.0% 02-04-20 39 58
US/Mexico SARS-CoV-2 B.1.1.512 variant United States of America 76.0%, Mexico 24.0% 21-07-20 18 25
USA SARS-CoV-2 B.1.1.139 variant United States of America 97.0%, Latvia 3.0% 15-06-20 29 37
USA SARS-CoV-2 B.1.1.172 variant United States of America 100.0% 06-04-20 47 50
USA SARS-CoV-2 B.1.1.182 variant United Kingdom 58.0%, United_Arab_Emirates 33.0%, Japan 8.0% 20-06-20 8 12
USA SARS-CoV-2 B.1.1.192 variant United States of America 88.0%, Bahamas 3.0%, United Kingdom 2.0%, Israel 1.0%, Latvia 1.0% 21-03-20 151 297
USA SARS-CoV-2 B.1.1.207 variant United States of America 98.0%, New_Zealand 1.0%, Mexico 0.0%, Japan 0.0%, Peru 0.0% 14-08-20 181 630
USA SARS-CoV-2 B.1.1.225 variant United States of America 98.0%, Japan 1.0%, Canada 1.0% 16-06-20 104 120
USA SARS-CoV-2 B.1.1.342 variant United States of America 100.0% 16-06-20 13 15
USA SARS-CoV-2 B.1.1.358 variant United States of America 100.0% 26-09-20 10 20
USA SARS-CoV-2 B.1.1.362 variant United States of America 95.0%, Mexico 4.0%, Japan 2.0% 09-06-20 34 112
USA SARS-CoV-2 B.1.1.367 variant United States of America 100.0% 14-05-20 11 13
USA SARS-CoV-2 B.1.1.380 variant United States of America 98.0%, United Kingdom 2.0% 12-06-20 80 91
USA SARS-CoV-2 B.1.1.403 variant United States of America 85.0%, Canada 8.0%, Mexico 4.0%, Ghana 4.0% 21-08-20 9 26
USA SARS-CoV-2 B.1.2 variant United States of America 97.0%, Canada 1.0%, Germany 0.0%, Mexico 0.0%, Denmark 0.0% 02-02-20 ### ###
USA SARS-CoV-2 B.1.9.2 variant United States of America 100.0% 20-04-20 10 10
USA SARS-CoV-2 B.1.38 variant United States of America 100.0% 17-03-20 30 31
USA SARS-CoV-2 B.1.103 variant United States of America 98.0%, Germany 2.0% 16-03-20 39 44
USA SARS-CoV-2 B.1.106 variant United States of America 100.0% 23-04-20 29 31
USA SARS-CoV-2 B.1.108 variant United States of America 95.0%, Australia 4.0%, Japan 1.0% 14-03-20 121 135
USA SARS-CoV-2 B.1.161 variant United States of America 100.0% 27-03-20 46 48
USA SARS-CoV-2 B.1.163 variant United States of America 100.0% 16-03-20 32 39
USA SARS-CoV-2 B.1.194 variant United States of America 100.0% 23-05-20 20 23
USA SARS-CoV-2 B.1.199 variant United States of America 91.0%, Israel 4.0%, Spain 1.0%, Denmark 1.0%, France 1.0% 16-03-20 140 186
USA SARS-CoV-2 B.1.206 variant United States of America 100.0%, India 0.0%, Germany 0.0%, Mexico 0.0%, South_Korea 0.0% 09-04-20 719 852
USA SARS-CoV-2 B.1.240 variant United States of America 96.0%, Canada 2.0%, United Kingdom 1.0%, Bahamas 0.0%, Switzerland 0.0% 22-03-20 ### ###
USA SARS-CoV-2 B.1.268 variant United States of America 99.0%, Spain 1.0% 18-03-20 87 93
USA SARS-CoV-2 B.1.280 variant United States of America 92.0%, Iceland 3.0%, India 1.0%, Cote_d’Ivoire 1.0%, Germany 1.0% 14-06-20 73 202
USA SARS-CoV-2 B.1.293 variant United States of America 87.0%, United Kingdom 8.0%, New_Zealand 3.0%, Germany 2.0% 16-03-20 38 62
USA SARS-CoV-2 B.1.304 variant United States of America 100.0% 05-06-20 40 42
USA SARS-CoV-2 B.1.320 variant United States of America 97.0%, Australia 1.0%, Mexico 1.0%, Norway 1.0%, Russia 0.0% 07-03-20 616 672
USA SARS-CoV-2 B.1.324 variant United States of America 99.0%, Northern_Mariana_Islands 0.0%, Mexico 0.0%, Costa_Rica 0.0%, Colombia 0.0% 15-03-20 184 513
USA SARS-CoV-2 B.1.328 variant United States of America 100.0% 23-05-20 30 30
USA SARS-CoV-2 B.1.332 variant United States of America 93.0%, Canada 4.0%, Denmark 2.0%, Israel 1.0%, Australia 0.0% 10-03-20 214 247
USA SARS-CoV-2 B.1.360 variant United States of America 95.0%, Japan 2.0%, Finland 1.0%, United Kingdom 1.0% 17-03-20 70 84
USA SARS-CoV-2 B.1.378 variant United States of America 91.0%, Switzerland 3.0%, Cuba 2.0%, Bahamas 2.0%, Kenya 2.0% 14-03-20 52 99
USA SARS-CoV-2 B.1.382 variant United States of America 97.0%, Belgium 2.0%, Canada 2.0% 13-04-20 47 65
USA SARS-CoV-2 B.1.385 variant United States of America 98.0%, Northern_Mariana_Islands 2.0% 22-06-20 54 63
USA SARS-CoV-2 B.1.390 variant United States of America 99.0%, United Kingdom 1.0% 25-03-20 63 89
USA SARS-CoV-2 B.1.399 variant United States of America 97.0%, Mexico 2.0%, Japan 1.0%, Iceland 0.0% 26-04-20 211 341
USA SARS-CoV-2 B.1.413 variant United States of America 91.0%, Canada 4.0%, United Kingdom 1.0%, New_Zealand 1.0%, Vietnam 1.0% 12-03-20 137 172
USA SARS-CoV-2 B.1.415 variant United States of America 61.0%, Canada 23.0%, Australia 5.0%, Chile 4.0%, Mexico 3.0% 16-03-20 53 75
USA SARS-CoV-2 B.1.439 variant United States of America 66.0%, United Kingdom 22.0%, Canada 8.0%, Finland 1.0%, Norway 1.0% 13-03-20 115 139
USA SARS-CoV-2 B.1.442 variant United States of America 96.0%, South_Korea 4.0% 12-03-20 24 25
USA SARS-CoV-2 B.1.518 variant United States of America 97.0%, Qatar 3.0% 21-03-20 26 29
USA SARS-CoV-2 B.1.539 variant United States of America 100.0% 25-10-20 14 50
USA SARS-CoV-2 B.1.543 variant United States of America 100.0% 30-08-20 33 70
USA SARS-CoV-2 B.1.546 variant United States of America 100.0% 03-06-20 174 207
USA – Arizona SARS-CoV-2 B.1.289 variant United States of America 97.0%, Australia 1.0%, South_Africa 0.0%, India 0.0%, Togo 0.0% 28-03-20 245 301
USA – Arizona and Texas SARS-CoV-2 B.1.566 variant United States of America 75.0%, Brazil 10.0%, Spain 5.0%, Germany 3.0%, Colombia 2.0% 16-03-20 37 92
USA – Colorado SARS-CoV-2 B.1.492 variant United States of America 100.0% 20-04-20 47 59
USA – contains previous B.1.139 SARS-CoV-2 B.1.565 variant United States of America 91.0%, Denmark 2.0%, Germany 2.0%, Slovenia 1.0%, Switzerland 1.0% 28-03-20 414 829
USA – contains previous B.1.404 SARS-CoV-2 B.1.561 variant United States of America 95.0%, Mexico 4.0%, Canada 1.0%, Peru 0.0%, Aruba 0.0% 04-06-20 377 ###
USA – FL SARS-CoV-2 B.1.437 variant United States of America 100.0% 03-06-20 37 41
USA – Texas SARS-CoV-2 B.1.284 variant United States of America 98.0%, France 2.0% 16-03-20 53 57
USA – Texas SARS-CoV-2 B.1.285 variant United States of America 100.0% 10-06-20 10 12
USA – TX SARS-CoV-2 B.1.487 variant United States of America 98.0%, Mexico 2.0% 24-05-20 34 40
USA – UT SARS-CoV-2 B.1.435 variant United States of America 100.0% 10-04-20 61 84
USA – WI and MN SARS-CoV-2 B.1.294 variant United States of America 100.0% 16-06-20 30 30
USA (AZ and NM) SARS-CoV-2 B.1.516 variant United States of America 100.0%, France 0.0% 14-04-20 427 482
USA (AZ) SARS-CoV-2 B.1.445 variant United States of America 100.0% 05-04-20 60 81
USA (AZ) SARS-CoV-2 B.1.595.2 variant United States of America 100.0% 14-06-20 19 22
USA (AZ) formally part of B.1.516 SARS-CoV-2 B.1.579 variant United States of America 98.0%, Australia 2.0% 25-03-20 73 85
USA (CA and TX) SARS-CoV-2 B.1.453 variant United States of America 99.0%, Canada 1.0%, India 1.0% 19-03-20 184 167
USA (CA and TX) SARS-CoV-2 B.1.569 variant United States of America 94.0%, India 6.0% 27-06-20 28 54
USA (CA) SARS-CoV-2 B.1.267 variant United States of America 98.0%, Mexico 2.0% 24-03-20 32 42
USA (CA) SARS-CoV-2 B.1.452 variant United States of America 97.0%, Ireland 1.0%, Australia 1.0% 12-05-20 65 67
USA (California) SARS-CoV-2 B.1.1.376 variant United States of America 99.0%, Brazil 1.0% 11-05-20 127 152
USA (CO) SARS-CoV-2 B.1.344 variant United States of America 100.0% 02-04-20 59 61
USA (CO) SARS-CoV-2 B.1.570 variant United States of America 82.0%, Canada 11.0%, Denmark 4.0%, Germany 2.0% 23-06-20 20 45
USA (could be dissolved – sequences jumped out, previously split from B.1.3) SARS-CoV-2 B.1.496 variant United States of America 100.0% 15-03-20 5 5
USA (FL into Lousiana) SARS-CoV-2 B.1.595.1 variant United States of America 99.0%, Hong_Kong 1.0% 16-05-20 122 148
USA (FL) SARS-CoV-2 B.1.318 variant United States of America 100.0% 22-06-20 20 26
USA (FL) SARS-CoV-2 B.1.493 variant United States of America 100.0% 03-04-20 16 24
USA (MA) SARS-CoV-2 B.1.486 variant United States of America 100.0% 28-04-20 9 9
USA (MI, NY, split from B.1.3) SARS-CoV-2 B.1.507 variant United States of America 100.0% 15-03-20 70 75
USA (MN) SARS-CoV-2 B.1.330 variant United States of America 100.0% 24-03-20 29 29
USA (MN) SARS-CoV-2 B.1.595.4 variant United States of America 100.0% 20-04-20 132 134
USA (MN) lineage SARS-CoV-2 B.1.126 variant United States of America 99.0%, Mexico 1.0%, Canada 0.0%, United Kingdom 0.0% 16-04-20 171 432
USA (mostly AZ) SARS-CoV-2 B.1.517 variant United States of America 99.0%, Canada 1.0%, Italy 0.0%, Guadeloupe 0.0%, Australia 0.0% 18-08-20 413 ###
USA (north east) SARS-CoV-2 B.1.298 variant United States of America 94.0%, Japan 5.0%, Canada 1.0%, Australia 0.0%, Peru 0.0% 20-03-20 121 357
USA (NY) SARS-CoV-2 B.1.323 variant United States of America 100.0% 13-03-20 30 40
USA (NY, AZ, split from B.1.3) SARS-CoV-2 B.1.508 variant United States of America 100.0% 28-04-20 37 38
USA (NY, split from B.1.3) SARS-CoV-2 B.1.506 variant United States of America 97.0%, Canada 3.0% 20-04-20 33 37
USA (NY/PR) lineage SARS-CoV-2 B.1.588 variant United States of America 99.0%, Ireland 1.0%, Aruba 0.0%, Mexico 0.0%, Switzerland 0.0% 02-08-20 246 986
USA (OR) lineage SARS-CoV-2 B.1.188 variant United States of America 98.0%, Bulgaria 2.0% 03-06-20 34 63
USA (OR) lineage SARS-CoV-2 B.1.587 variant United States of America 100.0% 23-04-20 135 296
USA (OR, WA, HI) SARS-CoV-2 B.1.357 variant United States of America 100.0% 21-05-20 74 103
USA (removed the polytomy at the base of the lineage) SARS-CoV-2 B.1.313 variant United States of America 98.0%, Australia 2.0%, Spain 1.0% 13-05-20 110 129
USA (Split from B.1.3) SARS-CoV-2 B.1.494 variant United States of America 100.0% 13-03-20 25 22
USA (Split from B.1.3) SARS-CoV-2 B.1.495 variant United States of America 100.0% 19-04-20 55 108
USA (Split from B.1.3) SARS-CoV-2 B.1.498 variant United States of America 83.0%, Denmark 9.0%, Argentina 7.0%, Brazil 2.0% 27-04-20 36 46
USA (split from B.1.3) SARS-CoV-2 B.1.500 variant United States of America 100.0% 27-07-20 10 15
USA (Split from B.1.3) SARS-CoV-2 B.1.501 variant United States of America 100.0% 27-04-20 93 116
USA (Split from B.1.3) SARS-CoV-2 B.1.502 variant United States of America 100.0% 07-06-20 19 19
USA (Split from B.1.3) SARS-CoV-2 B.1.503 variant United States of America 99.0%, Mexico 0.0%, United Kingdom 0.0% 01-04-20 206 253
USA (split from B.1.3, mostly FL) SARS-CoV-2 B.1.509 variant United States of America 97.0%, Switzerland 2.0%, Canada 1.0%, South_Korea 0.0%, United Kingdom 0.0% 18-04-20 562 886
USA (Texas), split from B.1.1.177 SARS-CoV-2 B.1.1.402 variant United States of America 100.0% 12-05-20 44 46
USA (TX some B.1.361) SARS-CoV-2 B.1.582 variant United States of America 98.0%, Denmark 1.0%, United Kingdom 0.0%, India 0.0%, Brazil 0.0% 05-06-20 775 ###
USA (TX) SARS-CoV-2 B.1.1.210 variant United States of America 99.0%, Ireland 1.0% 21-03-20 115 131
USA (TX) SARS-CoV-2 B.1.1.258 variant United States of America 100.0%, Indonesia 0.0% 17-04-20 192 237
USA (TX) SARS-CoV-2 B.1.325 variant United States of America 100.0% 26-04-20 86 106
USA (TX) SARS-CoV-2 B.1.326 variant United States of America 97.0%, Spain 2.0%, South_Africa 2.0% 25-04-20 55 59
USA (TX) SARS-CoV-2 B.1.450 variant United States of America 60.0%, Canada 37.0%, France 1.0%, Kenya 1.0%, Japan 1.0% 14-03-20 65 123
USA (TX) SARS-CoV-2 B.1.581 variant United States of America 100.0% 18-06-20 61 67
USA (TX) SARS-CoV-2 B.1.608 variant United States of America 99.0%, India 1.0% 20-06-20 47 184
USA (up the east coast) SARS-CoV-2 B.1.595.3 variant United States of America 100.0% 27-06-20 27 36
USA (UT) SARS-CoV-2 B.1.264 variant United States of America 83.0%, Finland 8.0%, Japan 3.0%, Denmark 2.0%, Australia 2.0% 17-03-20 42 59
USA (UT) lineage SARS-CoV-2 B.1.258.23 variant United States of America 100.0% 10-12-20 31 37
USA (UT) lineage SARS-CoV-2 B.1.426 variant United States of America 100.0%, Canada 0.0%, Australia 0.0%, Northern_Mariana_Islands 0.0% 06-04-20 726 866
USA (UT) lineage SARS-CoV-2 B.1.554 variant United States of America 99.0%, Japan 1.0% 02-05-20 66 77
USA (Utah) SARS-CoV-2 B.1.515 variant United States of America 98.0%, Italy 2.0% 17-04-20 50 63
USA (was B.1.2) SARS-CoV-2 B.1.595 variant United States of America 99.0%, Canada 0.0%, Singapore 0.0%, Mexico 0.0%, Japan 0.0% 09-03-20 ### ###
USA , some B.1.2 merged in SARS-CoV-2 B.1.301 variant United States of America 99.0%, Mexico 1.0% 01-04-20 130 158
USA / CA SARS-CoV-2 B.1.245 variant United States of America 84.0%, Mexico 16.0% 24-03-20 22 25
USA / Mexico SARS-CoV-2 B.1.1.222 variant United States of America 79.0%, Mexico 19.0%, Spain 0.0%, Canada 0.0%, Germany 0.0% 04-04-20 721 ###
USA / Mexico SARS-CoV-2 B.1.189 variant United States of America 61.0%, Mexico 36.0%, Guatemala 1.0%, Aruba 1.0%, United Kingdom 1.0% 14-04-20 71 147
USA / WA SARS-CoV-2 B.1.124 variant United States of America 99.0%, Switzerland 1.0% 26-03-20 119 126
USA and Aruba lineage with spike mutations “S:P681H”,”S:S494P” and “S:T716I”. SARS-CoV-2 B.1.575 variant United States of America 92.0%, Spain 3.0%, Bonaire 1.0%, Aruba 1.0%, Switzerland 1.0% 23-10-20 ### ###
USA and Australia SARS-CoV-2 B.1.319 variant United States of America 86.0%, Australia 12.0%, Germany 0.0%, United Kingdom 0.0%, Canada 0.0% 05-03-20 225 634
USA and Canada SARS-CoV-2 B.1.1.335 variant United States of America 94.0%, Germany 6.0% 17-04-20 17 51
USA and Canada SARS-CoV-2 B.1.1.368 variant United States of America 96.0%, Canada 1.0%, Guatemala 1.0%, Australia 0.0%, British_Virgin_Islands 0.0% 03-08-20 66 201
USA and England SARS-CoV-2 B.1.377 variant United States of America 91.0%, United Kingdom 8.0%, Colombia 1.0% 19-04-20 64 142
USA and Mexico SARS-CoV-2 B.1.1.334 variant United States of America 86.0%, Mexico 14.0% 23-05-20 6 7
USA Lineage SARS-CoV-2 B.1.1.26 variant United States of America 99.0%, Japan 1.0% 02-04-20 179 189
USA lineage SARS-CoV-2 B.1.1.61 variant United States of America 88.0%, Italy 8.0%, Japan 3.0%, Canada 1.0% 29-02-20 93 101
USA lineage SARS-CoV-2 B.1.1.116 variant United States of America 94.0%, India 6.0% 17-06-20 16 17
USA lineage SARS-CoV-2 B.1.1.158 variant United States of America 92.0%, Peru 7.0%, Germany 1.0% 01-06-20 54 74
USA lineage SARS-CoV-2 B.1.1.169 variant United States of America 97.0%, Switzerland 3.0% 24-04-20 30 35
USA lineage SARS-CoV-2 B.1.1.174 variant United States of America 76.0%, India 6.0%, Ireland 5.0%, United Kingdom 3.0%, Germany 3.0% 27-03-20 175 233
USA lineage SARS-CoV-2 B.1.1.180 variant United States of America 97.0%, Chile 3.0% 08-06-20 80 93
USA lineage SARS-CoV-2 B.1.1.205 variant United States of America 99.0%, Japan 1.0%, Mexico 1.0% 16-05-20 80 187
USA lineage SARS-CoV-2 B.1.1.226 variant United States of America 97.0%, Canada 3.0% 21-04-20 102 117
USA lineage SARS-CoV-2 B.1.1.231 variant United States of America 90.0%, United Kingdom 2.0%, Ecuador 2.0%, Germany 1.0%, Denmark 1.0% 09-03-20 149 254
USA lineage SARS-CoV-2 B.1.1.239 variant United States of America 93.0%, Ghana 7.0% 22-06-20 24 28
USA lineage SARS-CoV-2 B.1.1.244 variant United States of America 73.0%, Japan 20.0%, Mexico 5.0%, South_Korea 2.0% 07-04-20 33 64
USA lineage SARS-CoV-2 B.1.1.265 variant United States of America 98.0%, United Kingdom 0.0%, Costa_Rica 0.0%, Japan 0.0%, Italy 0.0% 11-04-20 107 246
USA lineage SARS-CoV-2 B.1.1.268 variant United States of America 95.0%, United Kingdom 5.0% 09-04-20 43 55
USA lineage SARS-CoV-2 B.1.1.290 variant United States of America 100.0% 11-05-20 36 40
USA Lineage SARS-CoV-2 B.1.1.291 variant United States of America 98.0%, Latvia 1.0%, Canada 0.0%, Chile 0.0%, Colombia 0.0% 06-04-20 ### ###
USA lineage SARS-CoV-2 B.1.1.320 variant United States of America 100.0% 01-09-20 39 45
USA lineage SARS-CoV-2 B.1.1.345 variant United States of America 100.0% 10-11-20 8 22
USA lineage SARS-CoV-2 B.1.1.352 variant United States of America 80.0%, Switzerland 20.0% 08-10-20 8 10
USA lineage SARS-CoV-2 B.1.1.357 variant United States of America 100.0% 01-07-20 7 8
USA lineage SARS-CoV-2 B.1.1.392 variant United States of America 100.0% 16-09-20 17 17
USA lineage SARS-CoV-2 B.1.1.416 variant United States of America 93.0%, Australia 5.0%, Chile 1.0%, Japan 0.0%, New_Zealand 0.0% 19-03-20 272 640
USA lineage SARS-CoV-2 B.1.1.418 variant United States of America 100.0% 06-10-20 21 28
USA lineage SARS-CoV-2 B.1.1.423 variant United States of America 100.0% 19-05-20 14 16
USA lineage SARS-CoV-2 B.1.1.426 variant United States of America 100.0% 21-05-20 16 24
USA lineage SARS-CoV-2 B.1.1.437 variant United States of America 100.0% 08-06-20 25 44
USA lineage SARS-CoV-2 B.1.1.441 variant United States of America 100.0% 24-04-20 19 20
USA lineage SARS-CoV-2 B.1.1.447 variant United States of America 79.0%, Poland 21.0% 05-05-20 15 19
USA lineage SARS-CoV-2 B.1.1.450 variant United States of America 100.0% 20-11-20 23 28
USA lineage SARS-CoV-2 B.1.1.517 variant United States of America 88.0%, Mexico 12.0%, Japan 1.0% 08-12-20 22 104
USA lineage SARS-CoV-2 B.1.3 variant United States of America 99.0%, Canada 1.0% 21-04-20 216 314
USA lineage SARS-CoV-2 B.1.37 variant United States of America 100.0% 10-03-20 62 62
USA lineage SARS-CoV-2 B.1.110.3 variant United States of America 99.0%, Russia 0.0%, United Kingdom 0.0%, Canada 0.0%, Finland 0.0% 15-03-20 206 600
USA lineage SARS-CoV-2 B.1.116 variant United States of America 100.0% 29-04-20 85 84
USA lineage SARS-CoV-2 B.1.119 variant United States of America 100.0% 12-03-20 55 60
USA lineage SARS-CoV-2 B.1.134 variant United States of America 99.0%, Germany 1.0% 01-04-20 133 182
USA lineage SARS-CoV-2 B.1.137 variant United States of America 100.0% 06-04-20 128 162
USA lineage SARS-CoV-2 B.1.139 variant United States of America 100.0% 09-04-20 812 ###
USA lineage SARS-CoV-2 B.1.162 variant United States of America 98.0%, Canada 2.0% 15-03-20 158 183
USA lineage SARS-CoV-2 B.1.166 variant United States of America 97.0%, Canada 2.0%, Denmark 1.0%, Israel 1.0% 04-03-20 110 121
USA lineage SARS-CoV-2 B.1.181 variant United States of America 100.0% 20-04-20 44 47
USA lineage SARS-CoV-2 B.1.233 variant United States of America 99.0%, Switzerland 1.0% 16-06-20 43 69
USA lineage SARS-CoV-2 B.1.234 variant United States of America 99.0%, Japan 0.0%, Switzerland 0.0%, Canada 0.0%, United Kingdom 0.0% 03-06-20 ### ###
USA lineage SARS-CoV-2 B.1.239 variant United States of America 96.0%, Mexico 2.0%, Canada 0.0%, New_Zealand 0.0%, United Kingdom 0.0% 25-03-20 198 435
USA lineage SARS-CoV-2 B.1.241 variant United States of America 93.0%, Mexico 5.0%, Israel 0.0%, Japan 0.0%, Germany 0.0% 24-03-20 379 891
USA lineage SARS-CoV-2 B.1.243 variant United States of America 96.0%, Mexico 2.0%, Canada 0.0%, Northern_Mariana_Islands 0.0%, Sweden 0.0% 16-03-20 ### ###
USA lineage SARS-CoV-2 B.1.265 variant United States of America 95.0%, Canada 5.0%, Thailand 0.0%, Rwanda 0.0%, South_Korea 0.0% 15-03-20 304 546
USA lineage SARS-CoV-2 B.1.276 variant United States of America 93.0%, Italy 2.0%, United Kingdom 2.0%, France 2.0% 22-03-20 37 43
USA lineage SARS-CoV-2 B.1.287 variant United States of America 97.0%, Switzerland 3.0% 13-05-20 30 30
USA lineage SARS-CoV-2 B.1.306 variant United States of America 100.0% 03-06-20 67 130
USA lineage SARS-CoV-2 B.1.309 variant United States of America 100.0% 29-06-20 17 19
USA lineage SARS-CoV-2 B.1.311 variant United States of America 99.0%, Canada 1.0%, Sweden 0.0%, Japan 0.0%, Philippines 0.0% 19-03-20 828 ###
USA lineage SARS-CoV-2 B.1.315 variant United States of America 100.0% 25-03-20 32 42
USA lineage SARS-CoV-2 B.1.334 variant United States of America 98.0%, New_Zealand 2.0% 20-03-20 55 59
USA lineage SARS-CoV-2 B.1.335 variant United States of America 99.0%, Finland 1.0% 11-03-20 72 75
USA lineage SARS-CoV-2 B.1.336 variant United States of America 95.0%, Nigeria 2.0%, Canada 1.0%, Panama 1.0%, Mexico 0.0% 13-03-20 226 304
USA lineage SARS-CoV-2 B.1.337 variant United States of America 100.0% 25-07-20 56 99
USA lineage SARS-CoV-2 B.1.340 variant United States of America 98.0%, United Kingdom 2.0%, South_Korea 1.0% 06-04-20 86 125
USA lineage SARS-CoV-2 B.1.341 variant United States of America 100.0% 25-04-20 33 34
USA lineage SARS-CoV-2 B.1.346 variant United States of America 53.0%, Japan 41.0%, Canada 6.0%, Saint_Vincent_and_the_Grenadines 0.0% 19-07-20 125 552
USA lineage SARS-CoV-2 B.1.348 variant United States of America 100.0% 07-10-20 34 51
USA lineage SARS-CoV-2 B.1.349 variant United States of America 98.0%, Canada 1.0%, India 0.0%, Turkey 0.0%, Aruba 0.0% 05-06-20 435 904
USA lineage SARS-CoV-2 B.1.355 variant United States of America 99.0%, Chile 1.0% 01-04-20 32 73
USA lineage SARS-CoV-2 B.1.359 variant United States of America 93.0%, Canada 7.0% 09-03-20 26 43
USA lineage SARS-CoV-2 B.1.363 variant United States of America 100.0% 19-06-20 11 15
USA lineage SARS-CoV-2 B.1.366 variant United States of America 96.0%, Mexico 3.0%, Switzerland 1.0% 27-04-20 123 179
USA lineage SARS-CoV-2 B.1.384 variant United States of America 99.0%, Turkey 1.0%, Australia 0.0%, Vietnam 0.0%, Luxembourg 0.0% 15-03-20 279 359
USA lineage SARS-CoV-2 B.1.396 variant United States of America 95.0%, Mexico 4.0%, Canada 0.0%, South_Korea 0.0%, Switzerland 0.0% 06-04-20 499 981
USA lineage SARS-CoV-2 B.1.397 variant United States of America 83.0%, Mexico 17.0% 15-04-20 56 131
USA lineage SARS-CoV-2 B.1.400 variant United States of America 97.0%, Mexico 1.0%, Switzerland 0.0%, Canada 0.0%, Germany 0.0% 08-04-20 548 ###
USA lineage SARS-CoV-2 B.1.401 variant United States of America 97.0%, Turkey 2.0%, Spain 1.0% 27-03-20 55 102
USA lineage SARS-CoV-2 B.1.402 variant United States of America 73.0%, Sweden 26.0%, Mexico 1.0% 19-06-20 58 109
USA lineage SARS-CoV-2 B.1.403 variant United States of America 100.0% 07-04-20 64 97
USA lineage SARS-CoV-2 B.1.404 variant United States of America 97.0%, Mexico 2.0%, India 0.0%, Canada 0.0%, Germany 0.0% 16-03-20 134 540
USA lineage SARS-CoV-2 B.1.405 variant United States of America 66.0%, Australia 21.0%, Canada 5.0%, United Kingdom 4.0%, Mexico 2.0% 04-04-20 26 56
USA lineage SARS-CoV-2 B.1.409 variant United States of America 99.0%, United Kingdom 0.0%, Portugal 0.0%, Denmark 0.0%, Israel 0.0% 23-09-20 352 912
USA lineage SARS-CoV-2 B.1.421 variant United States of America 96.0%, Canada 2.0%, France 2.0% 29-07-20 35 51
USA lineage SARS-CoV-2 B.1.423 variant United States of America 100.0% 01-07-20 60 83
USA lineage SARS-CoV-2 B.1.424 variant United States of America 100.0% 16-03-20 106 119
USA lineage SARS-CoV-2 B.1.425 variant United States of America 100.0% 07-05-20 233 272
USA lineage SARS-CoV-2 B.1.432 variant United States of America 98.0%, India 2.0% 05-06-20 37 52
USA lineage SARS-CoV-2 B.1.433 variant United States of America 100.0% 10-09-20 104 249
USA lineage SARS-CoV-2 B.1.438.3 variant United States of America 100.0% 01-02-21 10 11
USA lineage SARS-CoV-2 B.1.438.4 variant United States of America 100.0% 01-11-20 22 34
USA lineage SARS-CoV-2 B.1.443 variant United States of America 100.0% 18-04-20 85 118
USA lineage SARS-CoV-2 B.1.448 variant United States of America 98.0%, Finland 1.0%, Russia 1.0% 15-04-20 86 195
USA lineage SARS-CoV-2 B.1.473 variant United States of America 78.0%, Switzerland 17.0%, France 2.0%, Germany 2.0% 01-04-20 25 46
USA lineage SARS-CoV-2 B.1.478 variant United States of America 100.0% 08-09-20 28 65
USA lineage SARS-CoV-2 B.1.479 variant United States of America 96.0%, Brazil 4.0% 25-03-20 14 26
USA lineage SARS-CoV-2 B.1.483 variant United States of America 100.0% 15-03-20 9 9
USA lineage SARS-CoV-2 B.1.485 variant United States of America 100.0% 25-03-20 52 55
USA lineage SARS-CoV-2 B.1.499.1 variant United States of America 100.0% 30-11-20 5 6
USA lineage SARS-CoV-2 B.1.511 variant United States of America 96.0%, Turkey 4.0% 02-05-20 23 24
USA lineage SARS-CoV-2 B.1.521 variant United States of America 95.0%, Canada 4.0%, Australia 1.0% 17-03-20 126 160
USA lineage SARS-CoV-2 B.1.541 variant United States of America 96.0%, Switzerland 1.0%, Spain 1.0%, Australia 1.0%, Luxembourg 1.0% 01-07-20 135 188
USA lineage SARS-CoV-2 B.1.550 variant United States of America 100.0% 03-10-20 55 64
USA lineage SARS-CoV-2 B.1.551 variant United States of America 94.0%, Mexico 5.0%, Canada 0.0%, United Kingdom 0.0%, South_Korea 0.0% 01-05-20 112 555
USA lineage SARS-CoV-2 B.1.556 variant United States of America 99.0%, Mexico 1.0% 10-06-20 83 105
USA lineage SARS-CoV-2 B.1.585 variant United States of America 100.0% 13-10-20 11 21
USA lineage SARS-CoV-2 B.1.589 variant United States of America 99.0%, Canada 1.0% 15-03-20 86 96
USA lineage SARS-CoV-2 B.1.590 variant United States of America 98.0%, Canada 2.0%, United Kingdom 0.0%, Germany 0.0% 09-03-20 108 644
USA lineage SARS-CoV-2 B.1.591 variant United States of America 100.0% 27-08-20 61 72
USA lineage SARS-CoV-2 B.1.593 variant United States of America 100.0% 11-09-20 86 86
USA lineage SARS-CoV-2 B.1.594 variant United States of America 100.0% 27-03-20 28 29
USA lineage SARS-CoV-2 B.1.596 variant United States of America 99.0%, Mexico 0.0%, Canada 0.0%, Australia 0.0%, South_Korea 0.0% 03-01-20 ### ###
USA lineage SARS-CoV-2 B.1.601 variant United States of America 90.0%, Costa_Rica 10.0% 09-11-20 11 20
USA lineage SARS-CoV-2 B.1.602 variant United States of America 100.0% 07-07-20 47 83
USA lineage SARS-CoV-2 B.1.603 variant United States of America 99.0%, Cambodia 1.0% 10-11-20 19 90
USA lineage SARS-CoV-2 B.1.604 variant United States of America 98.0%, India 2.0% 28-07-20 7 45
USA lineage SARS-CoV-2 B.1.605 variant United States of America 100.0% 12-05-20 33 96
USA lineage (CA) SARS-CoV-2 B.1.14 variant United States of America 100.0% 16-03-20 53 55
USA lineage (CA) SARS-CoV-2 B.1.427 variant United States of America 98.0%, Mexico 1.0%, Aruba 0.0%, United Kingdom 0.0%, Sweden 0.0% 02-03-20 872 ###
USA lineage (circulating in Connecticut with the 69-70del, which leads to SGTF. However, they express 484E and 501N in their spike proteins.) SARS-CoV-2 B.1.375 variant United States of America 99.0%, Germany 0.0%, Mexico 0.0%, Spain 0.0%, Brazil 0.0% 03-08-20 553 905
USA lineage (previously part of B.1.320 that jumped to a new part of the tree) SARS-CoV-2 B.1.586 variant United States of America 99.0%, Germany 1.0% 12-03-20 81 86
USA lineage (previously part of B.1.325 that jumped to a new part of the tree) SARS-CoV-2 B.1.606 variant United States of America 99.0%, Canada 1.0% 21-05-20 101 117
USA lineage (split from whatever Chris reassigns B.1.361 to) SARS-CoV-2 B.1.361 variant United States of America 99.0%, Ghana 0.0%, Northern_Mariana_Islands 0.0%, Netherlands 0.0%, Japan 0.0% 02-08-20 345 630
USA lineage (VA), previously B.1.328 and B.1.317 SARS-CoV-2 B.1.451 variant United States of America 100.0% 18-04-20 66 107
USA lineage WA SARS-CoV-2 B.1.333 variant United States of America 100.0% 24-03-20 86 93
USA lineage, alias of B.1.1.10.4 SARS-CoV-2 L.4 variant United States of America 100.0% 29-06-20 16 18
USA lineage, cleaned up a lot in release 2021-01-20 SARS-CoV-2 B.1.370 variant United States of America 100.0% 19-03-20 99 117
USA lineage, formally part of B.1.2 SARS-CoV-2 B.1.567 variant United States of America 97.0%, Canada 2.0%, Iceland 0.0%, Mexico 0.0% 23-03-20 106 214
USA lineage, formally part of B.1.2 SARS-CoV-2 B.1.577 variant United States of America 97.0%, Canada 1.0%, Netherlands 0.0%, United Kingdom 0.0%, France 0.0% 09-03-20 366 ###
USA lineage, formally part of B.1.363 SARS-CoV-2 B.1.576 variant United States of America 97.0%, Germany 1.0%, Switzerland 0.0%, Denmark 0.0%, Hong_Kong 0.0% 16-03-20 420 623
USA lineage, split out from B.1.361 SARS-CoV-2 B.1.568 variant United States of America 99.0%, United Kingdom 0.0%, France 0.0%, Australia 0.0% 05-10-20 111 616
USA lineage, split out from B.1.361 SARS-CoV-2 B.1.612 variant United States of America 82.0%, Canada 15.0%, South_Africa 2.0%, South_Korea 0.0%, Turkey 0.0% 11-03-20 189 708
USA lineage, split out from B.1.363 SARS-CoV-2 B.1.574 variant United States of America 100.0% 01-05-20 231 381
USA lineage, split out from B.1.369 SARS-CoV-2 B.1.564 variant United States of America 99.0%, Mexico 0.0%, New_Zealand 0.0%, South_Africa 0.0%, Denmark 0.0% 11-03-20 ### ###
USA lineage, split out from B.1.369 SARS-CoV-2 B.1.571 variant United States of America 100.0% 15-06-20 55 70
USA liniage reassigned from previous tree SARS-CoV-2 B.1.436 variant United States of America 100.0% 08-07-20 55 306
USA Southern (some B.1.361) SARS-CoV-2 B.1.580 variant United States of America 98.0%, South_Africa 1.0%, Mexico 1.0% 21-04-20 34 96
USA Utah lineage SARS-CoV-2 B.1.444 variant United States of America 100.0% 21-05-20 13 17
USA, Canada (previously part of B.1.311 that jumped to a new part of the tree) SARS-CoV-2 B.1.599 variant United States of America 96.0%, Canada 3.0%, Mexico 1.0% 20-05-20 48 169
USA, Canada, England, Germany etc. (could be dissolved / reassigned to B.1) SARS-CoV-2 B.1.520 variant Germany 46.0%, Sweden 23.0%, United Kingdom 8.0%, Romania 4.0%, Spain 4.0% 25-03-20 17 26
USA, England, Finland, Denmark SARS-CoV-2 B.1.1.351 variant United States of America 25.0%, Denmark 15.0%, United Kingdom 10.0%, Germany 10.0%, Finland 10.0% 10-09-20 57 157
USA, formally part of B.1.313 SARS-CoV-2 B.1.578 variant United States of America 88.0%, Cameroon 6.0%, Mexico 3.0%, Canada 3.0% 17-03-20 19 32
USA, mostly TX SARS-CoV-2 B.1.305 variant United States of America 99.0%, Canada 0.0%, Latvia 0.0%, Spain 0.0% 27-05-20 200 401
USA, New England SARS-CoV-2 B.1.302 variant United States of America 92.0%, Indonesia 3.0%, Canada 3.0%, Spain 2.0% 12-03-20 32 64
USA, some B.1.333 SARS-CoV-2 B.1.446 variant United States of America 73.0%, Qatar 6.0%, Australia 4.0%, Canada 3.0%, Germany 3.0% 01-03-20 30 288
USA, some previously B.1.333.1 SARS-CoV-2 B.1.169 variant United States of America 100.0% 31-03-20 56 66
USA, split from B.1.325 SARS-CoV-2 B.1.572 variant United States of America 100.0% 02-04-20 33 37
USA/ Indonesian lineage SARS-CoV-2 B.1.1.398 variant Indonesia 65.0%, United States of America 18.0%, Singapore 3.0%, Japan 3.0%, Latvia 2.0% 31-03-20 95 203
USA/ Mexico lineage SARS-CoV-2 B.1.1.518 variant United States of America 93.0%, Mexico 6.0%, Canada 1.0% 03-06-20 49 101
USA/ Mexico lineage SARS-CoV-2 B.1.1.519 variant United States of America 66.0%, Mexico 29.0%, Germany 1.0%, Switzerland 1.0%, Netherlands 0.0% 01-11-20 379 ###
USA/ Mexico lineage SARS-CoV-2 B.1.558 variant United States of America 74.0%, Mexico 24.0%, South_Korea 1.0%, Kenya 1.0%, Japan 1.0% 06-04-20 88 164
USA/ Mexico lineage SARS-CoV-2 B.1.609 variant United States of America 83.0%, Mexico 15.0%, India 1.0%, Canada 0.0%, United Kingdom 0.0% 15-03-20 382 ###
USA/ New Zealand lineage SARS-CoV-2 B.1.369 variant United States of America 93.0%, New_Zealand 3.0%, Canada 1.0%, India 1.0%, Mexico 0.0% 11-03-20 ### ###
USA/ Scottish lineage SARS-CoV-2 B.1.232 variant United States of America 90.0%, United Kingdom 6.0%, Mexico 3.0%, Ireland 1.0%, Denmark 0.0% 06-04-20 558 ###
USA/UAE SARS-CoV-2 B.1.466.1 variant United States of America 32.0%, United Kingdom 22.0%, United_Arab_Emirates 8.0%, Germany 7.0%, Denmark 5.0% 09-06-20 35 74
USA/UT SARS-CoV-2 B.1.112 variant United States of America 99.0%, United Kingdom 1.0% 06-04-20 161 196
Used to be just Turkey, now lots of Canadian SARS-CoV-2 B.1.1.181 variant Canada 77.0%, Turkey 23.0% 22-03-20 86 94
Utah lineage SARS-CoV-2 B.1.274 variant United States of America 100.0% 01-05-20 70 81
Wales SARS-CoV-2 B.1.1.38 variant United Kingdom 100.0% 11-06-20 17 4
Wales SARS-CoV-2 B.1.1.49 variant United Kingdom 100.0% 23-03-20 54 57
Wales SARS-CoV-2 B.1.1.114 variant United Kingdom 100.0% 30-03-20 16 15
Wales SARS-CoV-2 B.1.1.237 variant United Kingdom 100.0% 15-05-20 109 174
Wales SARS-CoV-2 B.1.1.360 variant United Kingdom 100.0% 07-04-20 28 15
Wales SARS-CoV-2 B.1.1.363 variant United Kingdom 98.0%, Indonesia 1.0%, Chile 1.0%, Poland 1.0% 30-03-20 137 167
Wales SARS-CoV-2 B.1.1.379 variant United Kingdom 100.0% 05-04-20 31 31
Wales SARS-CoV-2 B.1.177.63 variant United Kingdom 95.0%, Gibraltar 3.0%, Spain 2.0% 13-10-20 227 370
Wales SARS-CoV-2 B.1.177.65 variant United Kingdom 100.0%, Netherlands 0.0%, France 0.0%, Germany 0.0% 06-08-20 939 ###
Wales SARS-CoV-2 B.1.252 variant United Kingdom 97.0%, Australia 3.0% 27-03-20 148 149
Wales SARS-CoV-2 B.1.383 variant United Kingdom 88.0%, United States of America 7.0%, Netherlands 3.0%, Singapore 2.0%, Switzerland 1.0% 01-03-20 100 114
Wales SARS-CoV-2 B.1.395 variant United Kingdom 76.0%, United States of America 14.0%, Bahamas 2.0%, Norway 2.0%, India 1.0% 06-03-20 83 118
Wales and Norway SARS-CoV-2 B.1.489 variant United Kingdom 88.0%, Norway 8.0%, Republic of Serbia 4.0% 26-03-20 23 24
Wales lineage SARS-CoV-2 B.1.1.82 variant United Kingdom 86.0%, Germany 7.0%, Japan 7.0% 06-04-20 19 28
Wales lineage SARS-CoV-2 B.1.1.190 variant United Kingdom 100.0% 25-03-20 15 17
Wales lineage SARS-CoV-2 B.1.35 variant United Kingdom 100.0% 20-03-20 118 119
Wales lineage SARS-CoV-2 B.1.44 variant United Kingdom 100.0% 23-03-20 99 120
Wales lineage SARS-CoV-2 B.1.67 variant United Kingdom 77.0%, Ecuador 23.0% 23-03-20 22 22
Wales lineage SARS-CoV-2 B.1.120 variant United Kingdom 100.0% 27-03-20 113 130
Wales lineage SARS-CoV-2 B.1.142 variant United Kingdom 99.0%, Switzerland 0.0%, Sweden 0.0%, United States of America 0.0% 12-03-20 279 340
Wales lineage SARS-CoV-2 B.1.177.6 variant United Kingdom 97.0%, Ireland 2.0%, Portugal 0.0%, Netherlands 0.0%, Tunisia 0.0% 07-07-20 590 895
Wales lineage SARS-CoV-2 B.1.177.7 variant United Kingdom 99.0%, Norway 0.0%, Ireland 0.0%, Lithuania 0.0%, Portugal 0.0% 21-03-20 ### ###
Wales lineage SARS-CoV-2 B.1.177.8 variant United Kingdom 98.0%, Poland 0.0%, Czech_Republic 0.0%, Denmark 0.0%, Iceland 0.0% 03-09-20 819 ###
Wales lineage, formerly temporarily assigned B.1.1.439 due to an error (see designation issue 50) SARS-CoV-2 B.1.1.29 variant United Kingdom 100.0% 08-04-20 113 96
Wales with European base SARS-CoV-2 B.1.1.16 variant United Kingdom 58.0%, Japan 11.0%, Peru 5.0%, Latvia 5.0%, Belgium 5.0% 11-03-20 14 19
Was part of B.1.160.7 but this is now split on tree. English lineage last seen 2020-11-18 in uk, but long branch to a recent French sample sticking out SARS-CoV-2 B.1.160.33 variant United Kingdom 95.0%, France 3.0%, Switzerland 1.0%, Belgium 0.0% 30-10-20 130 205
Welsh and English lineage SARS-CoV-2 B.1.177.3 variant United Kingdom 100.0% 24-08-20 78 118
Welsh Lineage SARS-CoV-2 B.1.1.249 variant United Kingdom 100.0% 26-03-20 14 14
West African lineage SARS-CoV-2 B.1.476 variant Cote_d’Ivoire 62.0%, India 25.0%, Nigeria 12.0% 29-03-20 6 8
Western Europe, USA SARS-CoV-2 B.1.1.420 variant Italy 22.0%, Luxembourg 19.0%, Spain 11.0%, France 10.0%, Senegal 9.0% 29-08-20 47 679
Western USA SARS-CoV-2 B.1.1.113 variant United States of America 97.0%, United Kingdom 1.0%, Austria 1.0% 15-03-20 60 71
Netherlands 92.0%, United Kingdom 2.0%, United States of America 2.0%, Iceland 1.0%, Belgium 1.0% 13-03-20 83 88